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The fluorescent protein phosphatase inhibition assay (PPINA), modified into a pre-
biosensor design that utilises a micro-filter plate, was assessed on its performance to detect 
okadaic acid (OA), the major diarrhetic shellfish poisoning (DSP) toxin, and microcystins 
(Me), using two enzymes, protein phosphatase type 2A (PP-2A) and a recombinant protein 
phosphatase type I (RPP-l). The pre-biosensor design consisted of immobilising the enzyme 
prior to conducting the assay, so that the enzyme could be retained for re-use. Modifications 
were made to the immobilised PP-2A and RPP-l method to maximise the activity and 
stability of the enzyme. These modifications involved adjusting cofactors in the assay, 
altering pH and adjusting components in the buffers during the immobilisation procedure. 
Both of these enzymes showed high activity in the optimised, immobilised system and were 
stable over a long period oftime (600 hours). 
The feasibility of the immobilised PPINA for use as a biosensor, for MC and OA 
detection, was determined by constructing dose-response curves for each toxin with PP-2A 
and RPP-I. Under the optimised, immobilised assay conditions, OA and MC-LR inhibited 
PP-2A dose-dependently, with ICso values of 55 and 80 nM, respectively. Similarly, 
immobilised RPP-I was inhibited by MC dose-dependently, with an ICso value of 150 nM, 
under optimised assay conditions. This compares with ICso values of 5.5 and 3.2 nM for PP-
2A against OA and MC-LR respectively, and 0.9 nM for RPPI against MC-LR, in the 
standard, unimmobilised PPINA format. Thus, the sensitivities of the immobilised enzymes 
were at least 10-fold less for MC-LR and OA detection, compared to the unimmobilised 
PPINA format. These detection limits for the immobilised PP-2A and RPP-I enzymes were 
outside the proposed guidelines of I ~g of MC-LR/L for drinking water set by the WHO, and 
160 ~g of OA equivalents/kg in mussel meat set by the European Commission on Standards. 
Furthermore, RPP-l was not suitable for detecting OA, as immobilised and unimmobilised 
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enzyme activity was induced (rather than inhibited) between 10-200 nM and 1-100 nM of 
OA, respectively. PP-2A is the preferred enzyme over RPP-1 for OA and MC detection, 
because of the greater sensitivity of this enzyme to both toxins. 
The immobilised enzyme assay system (using PP-2A and RPP-1) was tested for 
re-usability, by determining if the toxin inhibitors (i.e. OA and MC-LR) can be removed from 
the system by washing with Tris buffer (PH 7.0). Removal of the toxins should result in 
enzyme activity being restored in the assay to pre-toxin levels, which would render the assay 
suitable for repeated use. The immobilised PP-2A enzyme was not suitable for re-use, as 
permanent binding occurred between the enzyme and both toxins. Consequently, this 
prevents the use of non-replaceable PP-2A enzyme in a biosensor format. In contrast, RPP-1 
showed some potential suitability in this format for MC detection, as enzyme activity was 
restored to pre-toxin levels after 20 washes. 
The immobilised RPP-1 and PP-2A enzyme assays were applied to the analysis of 
algal and mussel samples naturally contaminated with MCs and DSP toxins, respectively. 
This was carried out to compare the sensitivity of the immobilised PPINA with LC-MS and 
other PPINA methods. The mussel and algal tests gave an insight into the applicability of the 
pre-biosensor method. Firstly, matrix effects, caused by confounding substances in sample 
extracts, were shown to interfere with the enzyme-toxin binding. Secondly, sample dilution 
was found to be important to maximise toxin detection. Further studies to address these issues 
are discussed. 
This study is the first to assess the suitability of the immobilised PPINA method for 
translation into a prototype biosensor format. The results indicate that while PP-2A is the 
preferred epzyme because of its enhanced sensitivity over RPP-1, it is not amenable for re-
use in a biosensor format. Nevertheless, the enzyme could be used in a biosensor as a 
disposable component. However, further improvements to enhance sensitivity to the toxins 
are necessary before translation to a biosensor format is considered. This study is also the 
first to demonstrate the use of the fluorimetric substrate, MUMP for the RPP-1 enzyme 
assay. 
Keywords: protein phosphatase inhibition assay; protein phosphatase type 2A; recombinant 
protein phosphatase type 1; okadaic acid; microcystin; diarrhetic shellfish toxins; biosensor 
11l 
Acknowledgements 
I would like to thank the Foundation of Research and Science Technology (FRST) for 
financial support which made this study at Lincoln University possible. Particular thanks to 
AoteaBio Ltd and Lincoln Ventures Ltd for providing the Enterprise contribution and the 
Ministry of Education for matching these funds. I would like to acknowledge and thank the 
Cawthron Institute for providing the facility and materials to carry out the research. I would 
also like to thank Lincoln Ventures Ltd for contributing towards some of the research costs. 
I w9uld like to extend my sincere thanks to my supervIsor Dr Ravi Gooneratne for 
introducing me to the field of toxicology. His constant source of guidance, encouragement 
and criticism were essential to keep me on track and focused. His patience and kindness were 
also great! y appreciated. 
I would like to thank my associate supervisor Dr Douglas Mountfort, for assistance during 
every step of my research project. This work would not have been possible without his 
guidance, technical support and constant feedback. 
I would like to thank Dr Neil Pasco, Lincoln Ventures, for his enthusiasm, encouragement 
and the numerous discussions we have had. 
I would like to thank the Cawthron Institute for welcoming me and making me feel a valuable 
member of their team. Particular thanks goes to all the staff in the Biosecurity Division: Mike 
Taylor, Dr Douglas Mountfort, Dr Mike Packer, Dr Krystyna Ponikla, Janet Adamson, 
Veronica Beuzenberg, Dr Lesley Rhodes, Ashley Coutts, Tim Dodgshun and Lincoln 
MacKenzie, for their support and making my time at Cawthron so enjoyable. Special thanks 
goes to Dr Mike Packer, whose constant source of help was endless and still continues to be 
even for the most trivial of matters. Appreciation goes to staff in the Biotoxin Division 
particularly, Pat Holland and Roel Vanginkel, for technical assistance during my research. 
IV 
Thanks also to Gretchen Skea, Dr Mike Packer, Dr Krystyna Ponikla, Christina Friedman and 
Audrey Bonin, for providing a jovial, supportive and memorable laboratory environment to 
work in. 
Thank you to the following people for their technical advice and assistance during my 
research: Martin Welby in the Agricultural and Life Sciences Division, and Alistair Galbraith 
in the Instrumental Division at Lincoln University 
I would like to thank Alison Lister in the Bioprotection and Ecology Division at Lincoln 
University, and Ian Westbrook in the Research, Development and Improvement Division at 
the Department of Conservation, for their assistance in statistical analyses. 
Appreciation goes to Mairead Murphy and Kirsty Smith for reviewing part of this thesis. 
I would like to thank the following people in the Agricultural and Life Sciences Division for 
their friendship and making my time at Lincoln University so enjoyable and memorable: 
Thayalini Shanmuganathan, Sanne Schaffsma, Brian Patrick, Jenny Abrams, and Fred 
Leusch. 
I would li~e to extend a special thanks to Anniliese Sitterly and Mairead Murphy who have 
provided me with endless laughter and support through out this research. 
Finally, I would like to thank my family who have been an invaluable source of inspiration, 
love, support and encouragement. I owe this achievement to them. Special thanks goes to my 
mother, Valerie Allum, who gave me the opportunity to live and study in the beautiful 
country of New Zealand and make it my home. 
v 
Table of Contents 
Abstract ..................................................................................................................................... ii 
Acknowledgements .................................................................................................................. iv 
Table of Contents ..................................................................................................................... vi 
List of Tables ............................................................................................................................ xi 
List of Figures ............. -............................................................................................................ xii 
Terms and Abbreviations ....................................................................................................... xiv 
Chapter 1 Introduction ............................................................................................................... l 
1.1 Microalgae and Cyanoprokaryotes .................................................................................. 1 
1.2 Algal and Cyanobacterial Toxins ..................................................................................... 2 
1.3 Microcystin and Okadaic Acid Detection ......... ; .............................................................. 3 
1.4 Research Aims and Objectives ........................................................................................ 4 
1.4.1 Research aim ............................................................................................................. 4 
1.4.2 Specific objectives .................................................................................................... 5 
1.5 Hypotheses ....................................................................................................................... 5 
Chapter 2 Literature Review ...................................................................................................... 6 
2.1 Introduction ...................................................................................................................... 6 
2.2 Algal and Cyanobacterial Toxins ..................................................................................... 6 
2~2.1-Microcystins .............................................................................................................. 6 
2.2.2 Diarrhetic shellfish poisoning toxins ........................................................................ 8 
2.2.3 Mechanism of Action .............................................................................................. 10 
2.2.4 Health Implications ................................................................................................. 12 
2.2.4.1 Acute health incidents ...................................................................................... 12 
2.2.4.2 Symptoms of acute toxin exposure .................................................................. 13 
2.2.4.3 Chronic health incidents ................................................................................... 14 
2.2.4.4 Effects on terrestrial and aquatic animals ........................................................ 14 
2.2.5 Toxin Tolerance levels ............................................................................................ 15 
2.2.6 Global Increase of Algal Toxins ............................................................................. 16 
2.2.7 Toxin synthesis ....................................................................................................... 18 
VI 
2.2.8 Functional roles of toxins ........................................................................................ 19 
2.2.9 Depuration ............................................................................................................... 20 
2.3 Microalgae and Cyanobacteria in New Zealand and Methods of Detection ................. 21 
2.3.1 Microalgae and Cyanobacteria in New Zealand ..................................................... 21 
2.3.1.1 Marine Microalgae ........................................................................................... 21 
2.3.1.2 Cyanobacteria ................................................................................................... 22 
2.3.2 Current Methods of Toxin Detection ...................................................................... 23 
2.3.3 Protein Phosphatase Inhibition Assay ..................................................................... 24 
2.3.3.1. Developments in the PPINA ........................................................................... 26 
2.3.3.2 Method Specificity ........................................................................................... 28 
2.4 Biosensors ...................................................................................................................... 30 
2.4.1 Biosensor development ........................................................................................... 30 
2.4.2 Application of the PPINA as a biosensor ................................................................ 31 
Chapter 3 Method Development .............................................................................................. 34 
3.1 Introduction ................................................................................................................... 34 
3.2 Materials and Preparations ............................................................................................. 35 
3.2.1 Materials .................................................................................................................. 35 
3.2.1.1 Chemicals ......................................................................................................... 35 
3.2.1.2 Enzymes ........................................................................................................... 36 
3.2.2 Preparations ............................................................................................................. 36 
3.2.2.1 Substrate and BSA preparations ...................................................................... 36 
.3.2.,-2.2._Enzyme preparations ........................................................................................ 36 
3.2.2.3 Buffer preparations ........................................................................................... 36 
3.3 Assay and Immobilisation Methods for PP-2A ............................................................ .37 
3.3.1 Protein phosphatase 2A inhibition assay ................................................................ 37 
3.3.2 Protocols for the immobilised PP-2A assay ............................................................ 38 
3.4 Experiments for Optimisation Studies .......................................................................... .41 
3.4.1 Optimisation experiments for PP-2A ........................................................... ~ .......... 41 
3.4.1.1 Optimal coupling buffer and stability of enzyme activity .............................. .41 
3.4.1.2 Optimal assay pH ............................................................................................. 41 
3.4.1.3 Optimal coupling buffer pH for immobilisation .............................................. 42 
3.4.1.4 Optimal assay co factors .................................................................................. .43 
3.4.1.5 Recovery of enzyme activity in immobilising procedures .............................. .43 
Vll 
3.4.2 Optimisation experiments for unimmobilised RPP-1 ............................................ 44 
3.4.2.1 Optimal storage, temperature and pH conditions ............................................ .45 
3.4.2.2 Optimal assay cofactors ................................................................................... 45 
3.4.3 Optimisation experiments for immobilised RPP-1 ............................................... .47 
3.4.3.1 Optimal enzyme concentration for immobilisation .......................................... 48 
3.4.3.2 Optimal coupling buffer and stability of enzyme activity .............................. .48 
3.4.3.3 Optimal assay pH ............................................................................................. 48 
3.4.3.4 Optimal coupling buffer pH ............................................................................ .49 
3.4.3.5 Optimal assay cofactors .................................................................................. .49 
3.4.3.6 Recovery of enzyme activity in immobilising procedures .............................. .49 
3.4.4. Statistical analysis .................................................................................................. 50 
3.5 Optimisation Results ...................................................................................................... 50 
3.5.1 Optimisation experiments for unimmobilised RPP-1 ............................................ 50 
3.5.1.1 Optimal storage conditions and optimal assay buffer, temperature and pH .... 50 
3.5.1.2 Optimal assay cofactors ................................................................................... 54 
3.5.2 Optimisation experiments for immobilised enzyme ............................................... 58 
3.5.2.1 Optimal RPP-1 concentration for immobilisation ........................................... 58 
3.5.2.2 Optimal coupling buffer and stability of enzyme activity ............................... 58 
3.5.2.3 Optimal assay pH ............................................................................................. 61 
3.5.2.4 Optimal coupling buffer pH ......................................... ~:-.................................. 61 
3.5.2.5 Optimal assay co factors ................................................................................... 64 
3.5.3 Recovery of the enzymes in immobilising procedures ........................................... 65 
3,6 Disc·~lssion ...................................................................................................................... 68 
Chapter 4 Feasibility Studies for Development of a Biosensor for Okadaic Acid and 
Microcystins ............................................................................................................................. 73 
4.1 Introduction .................................................................................................................... 73 
4.2 Materials and Preparations ............................................................................................. 73 
4.2.1 Toxins ...................................................................................................................... 73 
4.2.2 Preparation of algal extracts for PPINA and LC-MS ............................................. 74 
4.2.3 Preparation of mussel extracts for PPINA .............................................................. 74 
4.2.4 Preparation of mussel extracts for LC-MS ............................................................. 74 
4.3 Methods .......................................................................................................................... 75 
4.3.1 Protocol for the immobilised PPINA ...................................................................... 75 
Vlll 
4.3.2 Method for the unimmobilised PPINA ................................................................... 75 
4.3.3 Dose-Response Curves ........................................................................................... 76 
4.3.3.1 Okadaic acid calibration curve ......................................................................... 76 
4.3.3.2 Microcystin-LR calibration curve .................................................................... 77 
4.3.4 Recovery ofimmobilised enzyme activity after treatment with OA and MC-LR .. 78 
4.3.5 Analysis of environmental samples using the modified PPINA ............................. 79 
4.3.5.1 Detection of okadaic acid in mussel extracts ................................................... 80 
4.3.5.2 Detection of microcyst ins in algal extracts ...................................................... 81 
4.3.6 Analysis of environmental samples using other PP-2A inhibition assays .............. 82 
4.3.6.1 Detection of okadaic acid in mussel extracts ................................................... 82 
4.3.6.2 Detection of microcyst in in algal extracts ........................................................ 82 
4.3.7 Analysis of environmental samples using LC-MS ................................................. 83 
4.3.7.1 Detection of okadaic acid in mussel extracts using LC-MS ............................ 83 
4.3.7.2 Detection ofmicrocystin-LR in algal extracts using LC-MS .......................... 83 
4.3.8 Statistical Analysis .................................................................................................. 84 
4.4 Results ............................................................................................................................ 84 
4.4.1 Dose-response curves .............................................................................................. 84 
4.4.1.1 Dose-response curves for OA .......................................................................... 84 
4.4.1.2 Dose-response curves for MC-LR ................................................................... 85 
4.4.1.3 Dose-response curves for MC-LR utilising different as-say conditions ........... 87 
4.4.2 Recovery ofimmobilised enzyme activity after testing with toxins ....................... 90 
4.4.2.1 Recovery ofimmobilised PP-2A activity after testing with OA and MC-LR .90 
. 4.4).2Recovery ofimmobilised R.PP-1 activity after testing with MC-LR .............. 90 
4.4.3 Determination of toxins in naturally contaminated samples ................................... 91 
4.4.3.1 Determination ofDSP toxins in naturally contaminated mussel extracts ........ 91 
4.4.3.2 Determination ofMCs in naturally contaminated algal extracts ..................... 94 
4.5 Discussion ...................................................................................................................... 96 
Chapter 5 Discussion and Future Research ............................................................................ 1 01 
Chapter 6 References ............................................................................................................. 1 05 
IX 
Chapter 7 Appendices ............................................................................................................ 119 
Appendix 7-1: Common microcystin structures ............................................................ 119 
Appendix 7-2: Microcystin and Nodularin toxicity values ............................................ 119 
Appendix 7-3: Calculation ofDSP toxins in mussel extracts ........................................ 123 
Appendix 7-4: Calculation ofMCs in algal extracts ...................................................... 124 
Appendix 7-5: Reaction kinetics for immobilised PP-2A showing the lag effect in 
enzyme stability as a result of washing frequency ......................................................... 125 
x 
List of Tables 
Table 2-1: Common microcystins and nodularins identified from species and strains of 
Anabaena, Microcystis, and Nodularia ............................................................................. 9 
Table 2-2: Common diarrhetic shellfish toxins identified from Dinophysis, Prorocentrum spp. 
and Lingulodium sp .......................................................................................................... 11 
Table 2-3: Comparison-of Methods ......................................................................................... 24 
Table 3-1: Layout of coupling buffer test for immobi1ised PP-2A .......................................... 42 
Table 3-2: Layout matrix for immobilised PP-2A cofactor test ............................................. .43 
Table 3-3: Layout of matrix for unimmobi1ised RPP-l cofactor test .................................... .46 
Table 3-4: Layout of matrix for unimmobi1ised RPP-lmeta1 cofactors ................................ .47 
Table 3-5: Comparison of unimmobi1ised RPP-l reaction rates utilising different assay and 
storage conditions ................................................ ~ ............................................................ 51 
Table 3-6: Comparison ofRPP-1 reaction rates (nmol/m1/min) utilising different temperature 
and assay pHs ................................................................................................................... 53 
Table 3-7: Comparison ofRPP-l reaction rates (nmo1/m1/min) using different assay 
co factors and assay buffers .............................................................................................. 55 
Table 3-8: Comparison ofRPP-1 reaction rates using different assaY_90factors in Tris ........ 55 
Table 3-9: Comparison ofRPP-l reaction rates using different concentrations ofBSA ........ 57 
Table 3-10: Comparison ofRPP-l reaction rates using different concentrations ofMnCh in 
Tris buffer ......................................................................................................................... 57 
Table 3":1 f:Tlie recovery of enzyme immobilised on microbeads .......................................... 68 
Table 4-1: Comparison of ICso (nM) values and toxin detection range for MC-LR and OA 
inhibition of, PP-2A and R.PP-l .............................................................................................. 89 
Table 4-2: The concentration of OA equivalents (nM) in the mussel samples using the 
immobilised and unimmobilised PP-2A enzyme assays .................................................. 92 
Table 4-3: Comparison ofDSP toxin (OA and DTXs) concentrations in mussels between the 
unimmobilised and immobilised PP-2A inhibition assay and LC-MS ............................ 93 
Table 4-4: The concentration ofMC equivalents (nM) in the algal samples using the RPP-l 
and PP-2A enzyme assays ................................................................................................ 95 
Table 4-5: Comparison ofMC toxin concentrations in algal extracts among the 
unimmobi1ised and immobilised RPP-1 inhibition assay and LC-MS ........................... 96 
Xl 
List of Figures 
Figure 2-1. Structures of five common microcystins ................................................................. 7 
Figure 2-2. Structure ofnodularin .............................................................................................. 8 
Figure 2-3. Structure of common DSP toxins .......................................................................... 10 
Figure 2-4. The global increase of reported marine algal toxins. .. ......................................... 18 
Figure 2-5. Schematic diagram of a typical 'fill and flow' channel biosensor ........................ 33 
Figure 3-1. Photos of a 96-well micro filter plate (a), and a 96- microwell plate (b). .. .......... 35 
Figure 3-2. A photo of the filtration system using the 96-well micro filter plate .................... .40 
Figure 3-3. futeraction plot showing the influence of storage buffer and enzyme storage 
conditions on R.PP-l activity ........................................................................................... 52 
Figure 3-4. Boxplot ofRPP-l activity (log transformed) against temperature and pH .......... 54 
Figure 3-5. futeraction plot showing the influence of metal chloride and BSA on RPP-l 
activity ......................................................... ; .................................................................... 56 
Figure 3-6. Reaction kinetics for RPP-l showing activity at different concentrations ofBSA 
on a log scale and MnCb ................................................................................................. 59 
Figure 3-7. Reaction kinetics overtime for immobilised RPP-l utilising MUMP at different 
enzyme concentrations during the experimental period of 450 h~_:: ................................. 60 
Figure 3-8. Reaction kinetics overtime for immobilised PP-2A and RPP-l with different 
coupling buffers ............................................................................................................... 62 
Figure 3-9. Reaction kinetics for immobilised PP-2A using a different assay pH .................. 63 
Figure 3-10: The mean reaction rate for immobilised PP-2A showing the influence of assay 
pH on phosphatase activity .............................................................................................. 64 
Figure 3-11. Reaction kinetics for immobilised RPP-l at different assay pHs ...................... 65 
Figure 3-12. Reaction kinetics overtime for immobilised PP-2A at different coupling buffer 
pHs ................................................................................................................................... 66 
Figure 3-13. Reaction kinetics overtime for immobilised RPP-l at a different coupling buffer 
pH ..................................................................................................................................... 66 
Figure 3-14. Reaction kinetics for immobilised PP-2A and RPP-l with different assay 
cofactors ........................................................................................................................... 67 
Figure 4-1. Dose-response curves for the inhibition/stimulation ofPP-2A and RPP-l by OA 
.......................................................................................................................................... 86 
xu 
Figure 4-2. Dose-response curve for the inhibition ofunimmobilised PP-2A by MC-LR at pH 
7 and pH 8 ........................................................................................................................ 87 
Figure 4-3: Dose-response curves for inhibition of MC-LR by PP-2A and R.PP-1 ............... 88 
Figure 4-4: Dose-response curves for immobilised PP-2A with BSA at 5.02 JLM and without 
BSA at pH 7 .0 .................................................................................................................. 89 
Figure 4-5: Recovery ofimmobilised PP-2A activity after treatment with toxins .................. 90 
Figure 4-6: Recovery of immobilised R.PP-1 activity after washing following treatment with 
MC-LR .............................................................................................................................. 91 
Appendix 7-1: Common microcystin structure ...................................................................... 119 
Appendix 7-2: Microcystin and N odularin toxicity values .................................................... 119 
X111 
Terms and Abbreviations 
AP 
ASP 
BSA 
CFP 
DDAO 
DiFMUP 
DSP 
DTT 
DTX 
EDl'A 
EGTA 
ELISA 
FDP 
GOD 
HAB 
HEPES 
lp 
ICso 
LC-MS 
LCso 
LDso 
MC 
MC-LR 
MgCb 
MPL 
MOPS 
MU 
MUMP 
MUM 
NODLN 
acid phosphatase 
amnesic shellfish poisoning 
bovine serum albumin 
ciguatera fish poisoning 
dimethylacridinone phosphate 
difluoromethylumbelliferyl phosphate 
diarrhetic shellfish poisoning 
dithiothreitol 
dinophysistoxins 
ethylenediaminetetraacetic acid 
ethylene-bis[ oxyethylenenitrilo ] tetraacetic acid 
enzyme linked immunosorbent assay 
fluorescein diphosphate 
glucose oxidase 
harmful algal bloom 
4-(2-Hydroxyethyl) piperazine-I-ethansulfonic acid 
intraperitoneal 
inhibiting concentration 50% 
liquid chromatography with mass spectrometry 
-Iethal concentration 50% 
lethal dose 50% 
microcystin 
microcystin-LR 
magnesium chloride 
maximum permissible level 
3-Morpholinopropanesulfonic acid 
mouse unit 
methylumbelliferyl phosphate 
methylumbelliferone 
nodularin 
XIV 
NSP neurotoxic shellfish poisoning 
OA okadaic acid 
PCB polychlorinated biphenyls 
pNPP para-nitrophenyl phosphate 
PPINA protein phosphatase inhibition assay 
PP-l protein phosphatase 1 
PP-2A protein phosphatase type 2A 
PSP paralytic shellfish poisoning 
PTX pectenotoxin 
RPP-l recombinant protein phosphatase type 1 
TDI total daily intake 
WRT with reference to 
YTX yessotoxin 
xv 
Chapter 1 Introduction 
1. 1 Microa/gae and Cyanoprokaryotes 
Microalgae play an important role in biological ecosystems as they are a crucial food 
source in the aquatic food chain. Of the several thousand known species of microalgae, a small 
number can proliferate to form algal blooms. Blooms may contain between 20,000-50,000 algae 
in 1m1 of water (Klassen and Watkins, 1999) and usually last for short periods, at particular 
times of the year. Only a few bloom forming algae are capable of producing potent toxins and 
are responsible for the phenomenon known as 'harmful algal blooms' (RABs) . 
. Cyanobacteria, formally known as blue-green algae, are cyanoprokaryotes that can also 
form water blooms and can produce potent toxins (cyanotoxins). Cyanobacteria constitute a 
major source of natural toxin input into the environment, particularly in freshwater systems 
(Carmichael, 1997). In New Zealand freshwaters, blooms that contain 15,000-20,000 cells/ml of 
cyanobacteria, is generally used as the cut-off level for recreational contact with the water body 
(K. Smith, personal communication, 14th November 2005). 
Both micro algal toxins and cyanotoxins are found within cells, biological tissue of 
consumers (due to bioaccumulation) and in watersheds when they are either released by the cell 
or loosely bound, so that changes in cell permeability or age allow their release into the 
environment (Carmichael, 2001). Primary exposure routes to these toxins are through drinking 
contaminat~d \yater (gastrointestinal exposure), contact with contaminated recreational waters 
( dermal exposure), or consuming contaminated seafood. Algal and cyanobacterial blooms can be 
triggered during appropriate conditions of temperature, light, pH, calm conditions, carbon 
availability, turbidity, nutrients and/or water salinity (Pitois et al., 2001). 
Although algal and cyanobacterial blooms have occurred throughout history, public 
health and economic impacts of these events have increased in frequency, intensity and 
geographic distribution in recent years (Daranas et aI., 2001). A number of explanations have 
been proposed for the apparent increase in blooms (Hallegraeff, 1995): 
~ increased scientific awareness of toxic species (through increased technologies to detect 
them) 
1 
~ increased utilisation of coastal water for aquaculture 
~ stimulation of plankton blooms by eutrophication and/or unusual climatic conditions or 
global climate change 
~ transport of dinoflagellates as resting cysts, either in ships ballast water or associated with 
translocation of shellfish stocks, from one area to another. 
1.2 Algal and Cyanobacterial Toxins 
Marine algal toxins are estimated to be responsible for greater than sixty-thousand human 
toxicity incidents per year, with an overall mortality rate of 1.5% (van Dolah, 2000). These 
incidents have occurred through consuming seafood contaminated with toxic algae, and through 
breatPing aerosolised (e.g. brevetoxins) or volatilised (e.g. Pfiesteria toxin) toxins. Many marine 
algal toxins act on similar mechanisms within the nervous system. However, the resultant 
biological effect varies for each toxin group, from minor short-term effects to fatality. These 
effects have been classified into the following syndromes: diarrhetic shellfish poisoning (DSP), 
paralytic shellfish poisoning (PSP), neurotoxic shellfish poisoning (NSP), ciguatera fish 
poisoning (CFP), amnesic shellfish poisoning (ASP) and estuary syndrome (Pfiesteria spp.). 
Toxic marine algae of primary concern are the unicellular phytoplankton species, of which 
dinoflagellates comprise the greatest number of members, however diatoms also account for a 
small proportion. Bloom forming cyanobacteria are predominantly fresh- and brackish water 
residing, although some studies have highlighted there presence in the coastal environment 
(Chen et al:-'.1993; Williams et al., 1997). 
Two of the toxins mentioned here, are relevant to my research and will be further 
discussed. Microcystins (MCs) are toxins produced from several cyanobacterial species from the 
following taxa, Microcystis, Anabaena, Nostoc, Oscillatoria and Planktothrix (Carmichael, 
2001). Microcystins are capable of inflicting serious gastrointestinal illness in humans, livestock 
and wildlife, through drinking contaminated water (Carmichael, 1997). More than sixty-seven of 
these hepatotoxins have been identified in which most have been isolated from laboratory strains 
of Microcystis (greater than 70%) (Codd et al., 2001). Microcystin-LR (MC-LR) is considered 
the most toxic of all MCs (Carmichael, 1997). Therefore, analytical methods generally use 
MC-LR as the standard in which to measure MC toxicity against. 
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Okadaic acid (OA) is a marine toxin produced by toxic dinoflagellates and is associated 
with the gastrointestinal syndrome, DSP. The DSP toxin family also consist of analogues ofOA, 
dinophysistoxins-1, -2, and -3 (Mountfort et ai., 2001). Poisoning occurs from ingesting shellfish 
contaminated with high levels of these toxins in their tissues (Quilliam, 1995; Mountfort et ai., 
1999). Globally, the most common DSP producing dinoflagellates are Dinophysis spp. and 
Prorocentrum spp. (Yasumoto et ai., 1995; Vieytes et ai., 1997; Cordova et ai., 2001). 
Microcystins and OA have a similar mechanism of action in biological systems as both 
toxin families share the same pharmacologic receptors, protein phosphatase enzymes, which are 
the primary sites of toxin action. The toxins are potent and specific inhibitors of protein 
phosphatase type 2A (PP-2A) and protein phosphatase type 1 (PP-1), which are two of four 
major phosphatases in mammalian cells responsible for dephosphorylating serine and threonine 
residp.es (Vieytes et ai., 1997). Consequently, diarrhetic effects are produced when these toxins 
are orally ingested. Symptoms usually begin within a couple of hours and resolve within 2-3 
days (van Dolah, 2000). Okadaic acid and MCs have also been implicated in long-term health 
effects, including severe damage to intestinal mucosa (Hungerford and Wekell, 1992b) and 
tumour promotion (Carmichael, 1997; Pitois et ai., 2001). These toxins have a worldwide-
occurrence and pose a potential threat to the public and animal health, and also to the shellfish 
industry. 
1.3 Microcystin and Okadaic Acid Detection 
Several countries have imposed limits on the level of acceptable MCs and DSP toxins, in 
potable water and shellfish, respectively, in order to protect the consumers (Shumway, 1990; 
Chorus and Bartram, 1999). The overseas market represent a significant export trade for New 
Zealand shellfish products (>75%) (P. McNabb, personal communication, 14 November 2005). 
Thus, there is a strong incentive to comply with international regulatory levels. The principal 
quality control method used to measure MC and DSP toxins in the environment, is the mouse 
bioassay (Mountfort et aI., 1999). However, there are many disadvantages in using this method, 
such as low sensitivity and the propensity to give false positives (Ramstad, 2001b). 
Consequently, considerable effort has been channelled towards developing more suitable and 
sensitive analytical methods for routine toxin detection. Chromatographic methods and chemical 
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assays have been tailored to detect all major marine and freshwater algal toxins. These methods 
differ largely in their approach and method of analysis. The protein phosphate inhibition assay 
(PPINA) is an example of an enzyme assay that utilises the inhibitory effect of the toxin on 
protein phosphatase enzymes. The PPINA has been developed for OA and MC detection with 
several protein phosphatase enzymes, the most common include PP-2A (Bialojan and Takai, 
1988; Cohen et a!., 1989; Honkanen et al., 1990; MacKintosh et al., 1990; Takai and Mieskes, 
1991; Takai et al., 1992a; Takai et al., 1992b; Simon and Vemoux, 1994; Ash et al., 1995; Takai 
et al., 1995; Tubaro et a!., 1996; Vieytes et al., 1997; Shimizu et al., 1998; Hummert, 2000; 
Leira et al., 2000), PP-1 (Honkanen et al., 1990; MacKintosh et al., 1990; Takai and Mieskes, 
1991; Takai et al., 1992a; Ash et al., 1995; Takai et al., 1995; Shimizu et al., 1998; Hummert, 
2000; Holmes et al., 2002) and recombinant forms of PP-1 (Zhang et al., 1992; An and 
Carmichael, 1994; Zhang, 1994; Shimizu et al., 1998; Heresztyn and Nicholson, 2001; Rapala et 
al., 2002). The PPINA has the advantage over chromatographic methods in being able to detect 
the total potential toxicity, rather than identifying specific toxin congeners (Rap ala et al., 2002). 
The PPINA has been designed into a biosensor format by Mountfort et a!., (manuscript in 
preparation-a), whereby the enzyme is immobilised onto microbeads before incorporation into 
the assay. The immobilised PPINA is essentially carried out in a micro filter plate, rather than the 
standard multiwell plate, so that enzyme is retained in each well after an assay. The assay 
modification affords a means by which the conditions for operating a fill-flow type biosensor 
(Gooding and Hall, 1998) can be reproduced in rapid format, i.e. multiple environmental samples 
can potentially be analysed for OA and MC in the field. Performance evaluation of the 
immobilised enzyme (i.e. pre-biosensor format) would need to be carried out prior to design of 
the prototype device. 
1.4 Research Aims and Objectives 
1.4.1 Research aim 
To optimise conditions for an immobilised PPINA, which utilises a micro filter plate, 
using two enzymes, PP-2A and a recombinant PP-1 (R.PP-1), and to evaluate the feasibility of 
this method for use in a prototype biosensor, for MC and OA detection. 
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1.4.2 Specific objectives 
1. To optimise conditions for the immobilised PPINA using PP-2A and a RPP-1 enzyme. 
2. To determine the feasibility of using the immobilised PPINA in a pre-biosensor format 
by constructing dose-response curves, and determining the ICso and assay detection limit 
for MC-LR and OA, with PP-2A and RPP-l. 
3. To determine if the immobilised assay system is reusable with PP-2A and RPP-1, after 
treatment with toxin inhibitors. 
4. To test the robustness of the method by analysing environmental samples that are 
naturally contaminated with MCs and DSP toxins. 
1.5 flypotheses 
1. The immobilised protein phosphatase enzymes 'can be optimised by varying components 
during the immobilisation process (coupling buffer and pH), and in the assay (cofactors 
and pH). 
2. Dose-response studies can be conducted for each enzyme against OA and MC-LR, to 
determine the sensitivity, and detection range of the assay. 
3. Inhibited PP-2A and RPP-1 enzyme activity can recover when washed with Tris buffer. 
4. Environmental samples can be tested using the pre-biosensor format to determine the 
concentration ofDSP (OA and DTXs) and MC toxins, in each sample. 
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Chapter 2 Literature Review 
2. 1 Introduction 
This literature review has been set out in three main sections. The fIrst section reviews 
MCs and DSP toxins in detail and discusses their structure, mechanism of action, health effects, 
global increase, functional roles and depuration. The second section discusses current toxic 
micro algal and cyanobacterial problems in New Zealand and reviews past and present methods 
of detection, including an in depth look at the PPINA. The third section reviews biosensors, as 
on-site detection tools for micro algal and cyanobacterial toxins, and discusses the application of 
the PPINA for use as a biosensor, in place of current methods for MC and DSP detection in New 
Zealand. 
2.2 Algal and Cyanobacterial Toxins 
2.2.1 Microcystins 
The general structure ofMCs is cyclo [-D-Ala-"X"-D-MeAsp-"Y"-ADDA-D-Glu-Mdha] 
, where X and Y are variable L-amino acids, X equals leucine (L), arginine (R) and tyrosine (Y) 
and Y equals arginine (R), alanine (A) and methionine (M) (Figure 2-1) (Carmichael, 1997). The 
D-MeAsp is D-erythro-~-methylaspartic acid, Mdha is N-methyldehydroalanine, and ADDA is a 
hydropllObi<?. p~amino acid (2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8,-trimethyl-l O-phenyldeca-
4E,6E-dienoic acid (Carmichael, 1997). The 6E geometry in the ADDA moiety is considered a 
prerequisite for toxicity in microcystin congeners (Fischer et aI., 2001). Structural and 
compositional variations of MCs differ in the two amino acids and additional 
methylationldemethylation of the other amino acids, particularly methyl aspartic acid and/or 
methyldehydroalanine (Rinehart et ai., 1994). Other MC variants have modifIed ADDA units 
and include acetyl-demethyl (ADMADDA) and demethyl (DMADDA) variants. The X and Y 
combinations for the heptapeptide toxins typically include LR, LA, Y A, YM, RR, YR, WR, AR 
and FR. Microcystins are typically hydrophilic, with the exception of hydrophobic MC-LL, -LV 
and -LM identifIed from Microcystis spp. in Canada (Craig et ai., 1993). Table 2-1 lists some of 
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the common cyanobacterial hepatotoxins (refer to appendix 7.1 for a more comprehensive list). 
Microcystin-LR is considered the most toxic of all MCs considering its low intraperitoneal LDso 
in rodents (50 ).!g/kg) (refer to appendix 7.2 for a list of toxicity values for common MCs) and 
comparatively high number of conjugates identified (Rinehart et al., 1994). Microcystin-LR is 
also the most commonly isolated Me. Thus, MC-LR is used as the standard in most analytical 
methods to measure MC toxicity against. 
Gill 
x Y 
Microcystin-LA Leu Ala 
Microcystin-LR Leu Arg 
Microcystin-YR Tyr Arg 
Microcystin-Y A Tyr Ala 
Microcystin-YM Tyr Met 
Figure 2-1. Structures of five common microcystins (Botes et ai., 1985) 
Closely related to MCs is the low molecular weight, mono cyclic pentapeptide, nodularin 
(NODLN), which is produced by cyanobacteria. Nodularins also contain ADDA but lack one of 
the L- and D-amino acids found in the MCs. Nodularin structure is cyclo [-D-MeAsp-L-Arg-
ADDA-D-Glu-2-(methylamino )-2-dehydrobutyric acid (known as Mdhb)] (Figure 2-2) (Sivonen, 
1996). Approximately, five congeners of NODLNs have been identified (Fischer et al., 2001). 
Nodularia spp. are the primary producers of NODLN and have been reported typically in 
brackish waters worldwide, with N spumigena being the first cyanobacterium reported in the 
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literature in 1878 (Carmichael et al., 1988). Nodularia spumigena was first characterised in New 
Zealand and like all Nodularia spp. was identified as being able to produce potent, hepatotoxic 
peptides of similar composition but lower molecular weight than the heptapeptide MCs 
(Carmichael et al., 1988). 
Figure 2-2. Structure ofnodularin (Rl, R2 = CH3) (Harada, 1996). 
2.2.2 Diarrhetic shellfish poisoning toxins 
Diarrhetic shellfish poisoning toxins are structurally unrelated to MCs (Figure 2-3). They 
consist of a class of acidic polyether toxins with OA and dinophysistoxin-1 (DTX-1) being the 
primary congeners. Structural derivatives of DTXs include DTX-2, -3, -4, -5 and -6. 
Dinophysistoxin-2 has only been discovered and identified in Irish mussels (Carmody et al., 
1995), where it continues to be the predominant toxin in the form ofDTX-2B and -2C (Draisci et 
al., 1998). Dinophysistoxin-3 has a fatty acyl group attached through the 7-0H group of OA, 
hence it has-been named acyl OA (Figure 2-3). Ester derivatives of OA, referred to as the diol 
esters, have been isolated and identified from differing strains of Prorocentrum lima (Norte et 
al., 1994). Dinophysistoxin-4 is not an end-product of toxin synthesis but is enzymatically 
transformed to OA-diol ester 8 and then to OA, thus it acts as a precursor for lipophilic toxins 
such as OA (Pan et aI., 1999). Structural studies by Holmes etal. (1990) have suggested that the 
free carboxyl group, the hydroxyl group at the 24th carbon chain, and the spatial conformation 
are all essential for toxin activity. Table 2-2 lists the common DSP toxins and the species 
associated with their production. 
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Table 2-1: Common microcystins and nodularins identified from species and strains of 
Anabaena, Microcystis, and Nodularia (Rinehart et al., 1994; Carmichael, 1997). 
Toxin Strain MW* Molecular fonnula Toxin Producing Reference 
Species 
MC-LR 994 C49H74N10012 A. jlos-aquae (Cannichael et al., 1988) 
M aeruginosa (Watanabe et al., 1988) 
M viridis 
MC-LA 909 C46H67N7012 M aeruginosa (Botes et al., 1985) 
MC-AR 952 C49H6gN 100 12 M aeruginosa (Namikoshi et al., 1992) 
MC-YA 959 C49H6SN7013 M aeruginosa (Botes et al., 1985) 
MC-LF 985 CS2H7lN7012 M aeruginosa (Azevedo et al., 1994) 
MC-LY 1001 CS2H7lN7013 M aeruginosa (Stoner et al., 1989) 
MC-FR 1028 CS2HnNIOOI2 M aeruginosa (Namikoshi et al., 1992) 
MC-YM 1035 CSIH69N7014S M aeruginosa (Botes et al., 1985) 
MC-RR 1037 C49H7SN13012 A. jlos-aquae (Sivonen et al., 1992) 
M. aeruginosa (Zhang et al., 1991) 
M viridis (Kusumi et al., 1987) 
MC-YR 1044 CS2HnNI0013 M aeruginosa (Botes et al., 1985) 
M viridis (Watanabe et al., 1988) 
MC-WR 1067 CS4H73Nl1012 M aeruginosa (Namikoshi et aI., 1992) 
NODLN 824 C4IH60NgOlO N. spumigena (Laubet al., 2002) 
Strain L575 
* MW- molecular weight 
Pectenotoxins (PTX) are a family of cyclic polyether macrolide toxins that have been 
isolated from shellfish involved in DSP (Daranas et al., 2001). Yessotoxin (YTX), a de sulfated 
polyether toxin, has also co-occurred with DTX-l and DTX-3 from scallops collected in Mutsu 
Bay, Japan (Murata et al., 1987). Pectenotoxin has been shown to be hepatotoxic and 
diarrheagenic in high concentrations only (Zhou et al., 1994). Yessotoxin, when given orally (i.e. 
consumed), doesn't get absorbed and is mainly excreted in the faeces. Studies have shown YTX 
to be only mildly diarrheagenic with pathogenic effects evident through intraperitoneal (i.p.) 
injection only (Ogino et al., 1998). Although YTX and PTX have tentatively been included in 
the greater DSP toxin family, they are not protein phosphatase inhibitors (Food Standards 
Agency, 2003). 
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Prorocentrolide and prorocentrolide B, nitrogenous polyether lactones, have additionally 
been isolated from DSP producing species, P. lima and P. macuiosum, respectively (Daranas et 
ai., 2001). Although the mechanism of action of these fast acting toxins is not yet understood, 
they are not considered protein phosphatase inhibitors (Daranas et ai., 2001). 
Okadaic acid: R1 =CH3; R2,R3,~=H 
DTX1: Rh R2=CH3; R3,~=H 
DTX2: Rl=H; R2=CH3; R3,~=H 
DTX3: RJ,R2=CH3; R3=acyl; ~~H 
Figure 2-3. Structure of common DSP toxins (Daranas et al., 2001). 
2.2.3 Mechanism of Action 
Microcystins and DSP toxins have a high affinity for the liver and utilise the bile acid 
transport system to enter the hepatocytes (Dawson and Holmes, 1999). In the liver, MCs and 
DSP toxins bind to and inhibit serine/threonine protein phosphatases for selective classes, protein 
phosphatase type 1 (PP-l) and protein phosphatase type 2A (PP-2A). Microcystins inhibit both 
of these en_zYlIles equivalently (ICso~O.l nM (MacKintosh et ai., 1990)), whilst DSP toxins 
inhibit PP-2A at an equivalent sensitivity (ICso 0.1 nM) but inhibit PP-l at a reduced sensitivity 
(ICso 10 nM) under similar conditions (Cohen et ai., 1989). 
Protein phosphatase type 1 and PP-2A are two of four major classes of protein 
phosphatases that have been identified in eukaryotic cells (Vieytes et ai., 1997). Protein 
phosphatase type 1 dephosphorylates the /3-subunit of phosphorylase kinase C specifically, 
whereas PP-2A dephosphorylate the a-subunit of phosphorylase kinase C preferentially (Cohen 
and Cohen, 1989). Protein phosphatase type 2 enzymes also comprise PP-2B and PP-2C. Protein 
phosphatase type 2B is 1000 fold less sensitive than PP-2A to MC-LR, and PP-2C is not 
inhibited by MC-LR (Honkanen et ai., 1990). 
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Table 2-2: Common diarrhetic shellfish toxins identified from Dinophysis, 
Prorocentrum spp. and Lingulodium sp. (Yasumoto et al., 1995) 
Toxin Mw Molecular 
DTX-l 
DTX-2 
DTX-3b 
PTX-l 
PTX-2 
YTX 
formula 
818 
804 
1056 C61HlO0014 
874 C47H7001S 
858 C47H70014 
a intraperitoneal injection to mice 
Toxicitya Toxic 
J..lg/kg Species 
200 Dfortii 
160 
250 
250 
230 
D.acuta, 
D.acuminata 
P.lima 
Dfortii, 
D.mitra, 
D.rotundata, 
D.tripos 
D.acuta, 
D.norvegica 
P.lima 
D.acuta, 
D.acuminata 
D.acuta 
D.acuta 
D.acuta 
Dfortii 
D.caudata 
Reference 
(MacKenzie et al., 2002) 
(Imai et al., 2003) 
(Ramstad et al., 2001) 
(Carmody et al., 1995) 
(Rhodes et al., 2001) 
(MacKenzie et al., 2002) 
(Draisci et al., 1996) 
(MacKenzie 2002) 
P. reticulatum (Mackenzie et al., 1998; 
Lingulodium Rhodes et al., 2001) 
polyedra 
b 7-0-palmitoyl DTX-l, the most abundant component 
Serine/threonine protein phosphatases are essential in the signalling cascades III 
eukaryotic cells, which regulate important cellular processes such as IOn balance, 
neurotransmission and metabolism (Anderson, 1994). Signalling is achieved through regulating 
the number of phosphate groups on protein chains. Inhibition of these enzymes therefore leads to 
hyperphosphorylation of cellular proteins such as cytokeratin 8 and 18, and vimentin, causing 
dramatic cell deformation through disaggregation of the intermediate filaments (Chou et al., 
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1990; Eriksson et al., 1990; Eriksson et al., 1992). An early symptom of exposure is diarrhea 
caused by the continual secretion of sodium from intestinal cells (Eriksson et al., 1992). The 
structural changes in the liver of animals from an acute lethal dose of MC or NODLN, are a 
breakdown in liver tissue architecture and blood accumulation in the liver, with blood loss to the 
circulatory system and subsequent death (Falconer, 2001). Increased phosphorylation has also 
been associated with tumour promotion in various organs. Protein phosphatase type 1 and PP-2A 
are believed to function, in part, as tumour suppressors in normal cells as they are the chief 
enzymes that reverse the action of protein kinase C (Cohen and Cohen, 1989). Thus, MC and 
DSP toxins act as tumour promoters by inhibiting these enzymes. 
2.2.4 Health Implications 
2.2.4.1 Acute health incidents 
Exposure to cyanobacterial blooms has been linked to many cases of illness, since the 
first publication on cyanobacteria toxicity in 1878 (Flint, 1966). The most clearly demonstrated 
effects have been due to the ingestion ofMCs (Falconer, 2001). Incidents have been documented 
in North and South America, Europe, Australia, Canada, Asia, South Africa, New Zealand, 
Israel, China and the Soviet Union (Flint, 1966; Craig et al., 1993; Azevedo et a!., 1994; Chorus 
and Bartram, 1999; Domingos et al., 1999; Fastner et a!., 1999; Giovannardi et al., 1999; de 
Magalhaes et al., 2001). A review of poisoning events in toxic cyanobacterial research can be 
found in Carmichael (2001). Most toxicity cases have only produced sub-lethal health effects, 
such as the suspected involvement of cyanobacteria in the Half disease, which historically 
affected fisli~eating people along the Baltic coast in the 1920's and 1930's (Pitois et al., 2001). In 
Australia, a sickness known as Barcoo fever was believed to be caused by the ingestion of 
cyanobacteria which produced diarrhetic effects (Dawson and Holmes, 1999). There have also 
been numerous reports of gastro- and hepatoenteritis (inflammation of the stomach and 
intestines, and liver, respectively), and contact irritation following exposure to MC in drinking 
and recreational water, respectively (Chorus and Bartram, 1999; Falconer, 2001). The only 
confirmed human deaths (55 fatalities) from MC have been limited to exposure through renal 
dialysis at a haemodialysis centre in Caruaru, Brazil in 1996 (Domingos et al., 1999; Carmichael, 
2001). 
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Unlike incidents involving MCs, DSP has only been a documented problem for a 
relatively short period. The first incidence of human shellfish related illness from DSP toxins 
occurred in Japan in the late 1970's, in which Dinophysis fortii was identified as the causative 
organism (van Dolah, 2000). Since this time, seasonal occurrences of DSP have been reported in 
a number of countries, including Japan, Europe, North and South America, Australia, India, 
Thailand, Indonesia and New Zealand (Draisci et al., 1996; Mackenzie et al., 1998; van Dolah, 
2000; Ramstad, 2001a; Uribe et al., 2001; Imai et al., 2003). In some countries, DSP blooms 
have been a more significant problem than other algal blooms, due to the characteristically 
longer bloom period (Sivonen, 1996). In humans, most DSP toxicity cases have produced 
diarrhetic effects and symptoms are self-limiting. Routine shellfish monitoring in developed 
countries can prevent human poisonings, as contaminated shellfish beds are identified and closed 
to t4e public. However, in developing countries which have not adopted monitoring 
programmes, particularly those areas that rely heavily on the sea for food, have a higher 
incidence of illness as a result of toxic algal blooms (Carmichael, 1997). There have been no 
confinned human deaths as a result ofDSP to date. 
2.2.4.2 Symptoms of acute toxin exposure 
Symptoms of dermal exposure to cyanotoxins include allergic reactions, skin irritation, 
blisters and itching, shortly followed by dermatitis (Carmichael,-2001). Ingestion related 
illnesses include gastroenteritis and hepatoenteritis, with symptoms including vomiting, diarrhea, 
nausea, throat irritations, headache, abdominal pain, respiratory difficulty, and other pneumonia-
related symptoms (Carmichael, 2001). 
Symptoms of DSP are similar to MC toxicity, as they both share the same pharmacologic 
receptors. However, there is potential for exposure to higher oral concentrations ofDSP toxins as 
exposure is to seafood bioaccumulated with DSP toxins, rather than in the water. Hence, 
symptoms of gastrointestinal exposure to seafood containing DSP toxins can be more severe. 
Severe cases of DSP can induce symptoms within 30 minutes, whereas mild cases may take 
several hours to develop after ingestion (van Dolah, 2000). Recovery of DSP takes 
approximately 2-3 days regardless of treatment. Diarrhetic shellfish toxins have varying 
toxicities (cell densities of Dfortii as low as 200 cells/L have resulted in DSP) and only OA, 
DTX-1 and DTX-3, are thought to be responsible for diarrhea (Hungerford and Wekell, 1992a). 
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2.2.4.3 Chronic health incidents 
Initial epidemiological evidence from chronic, long-term exposure to MCs was obtained 
from Dr Shun Zhang at the Shanghai Medical University, China and Wayne Carmichael at 
Wright State University in the United States (Carmichael, 1997). They revealed a positive 
correlation between drinking surface water (containing MC) and high rates of primary liver 
cancer in certain areas of China. Another study of chronic exposure, was undertaken on human 
lymphocytes in vitro (Pitois et al., 2001). The study concluded that MCs produced more 
chromosomal damage than known carcinogens, benzene and sodium arsenite, and produce 
similar damage to polychlorinated biphenyls (PCBs). Their results suggest that toxic 
cyanobacteria are a more serious environmental hazard than previously thought. A report by Ito 
et al. (1997), confirmed the carcinogenic activity of MCs in mice, as they developed large 
tumour nodules in the livers after one-hundred i.p. injections of the toxin. 
Considering that DSP is a relatively newly identified toxin, cases of chronic human 
exposure have yet to be identified. However, the tumour promoting activity of MC and DSP 
toxins has been well described in laboratory studies as discussed in several publications 
(Haystead et al., 1989; Humpage and Falconer, 1999; Falconer, 2001; Pitois et al., 2001). 
2.2.4.4 Effects on terrestrial and aquatic animals 
A large number of livestock poisonings have been reported for MC, some have been 
reported in detail, while others are anecdotal. There have been a number of reported livestock 
(sheep, cattle, waterfowl, lambs and turkeys) and domestic animal (horses and dogs) deaths in 
several cOllDtries (including NZ) as a result of MC exposure. A review of these animal poisoning 
events can be found in Chorus and Bartram (1999), Carmichael (2001) and Falconer (2001). 
Chronic exposure of livestock to cyanobacteria (Carbis et al., 1994) has revealed a substantial 
reduction in bile acid synthesis in sheep due to the inhibition of PP-1 and PP-2A in the liver by 
cyanotoxins. A decrease in the bile acid pool results in a cascade of digestion related problems in 
sheep, which is of obvious concern to the livestock industry. 
A number of studies have demonstrated that MCs and DSP toxins can negatively impact 
on aquatic organisms, such as amphibians, fish and zooplankton (Chen et al., 1993; Williams et 
al., 1997; Amorim and Vasconcelos, 1999; Holland et al., 2005). For example, glycogen 
synthase activity (regulated by PP-1 and PP-2A) was shown to be effected in rainbow trout, 
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Oncorhynchus mykiss, following exposure to OA (Svensson and Forlin, 1998). Acute effects on 
heart rate and development were shown in zebrafish following MC exposure (Oberemm et at., 
1999). The inhibitory effects of MC on zooplankton protein phosphatases have also been 
reported (DeMott and Dhawale, 1995). In a comparative study between fish, crustaceans and 
phytoplankton, deposit feeding crustaceans were found to have the highest MC concentration 
with a maximum value of 103.3 /-Lg/kg (Total Daily Intake (TDI) 0.52 /-Lg/kg/day), even during 
periods oflow ambient concentration (water concentration <0.02 /-Lg/l) (Magalhaes et at., 2003). 
Considering that MC are degraded by absorption to clay material and bacterial degradation 
(Magalhaes et at., 2003), benthic sediment feeders, such as crustaceans, would be expected to be 
most at risk of exposure. 
Microcystins have been a problem for cultivated speCIes. For example, MCs were 
believed to cause disease in some freshwater farm-reared fish and maricultured shrimp 
(Carmichael, 2001). Microcystins were also believed to have been responsible for the net-pen 
liver disease of farm-reared Atlantic salmon in the Pacific Northwest (Andersen et at., 1993). 
This disease had devastating effects on farmed salmon and caused the loss of millions of dollars 
to the fish farming industry in British Columbia and Washington State (Dawson and Holmes, 
1999). 
Microcystins have also been identified in estuaries and coastal waters (Vasconcelos, 
1995; Codd, 1998). For example, the presence of MC and NODLN in oceanic and coastal 
shellfish has been reported at concentrations three-fold higher than acceptable quarantine levels 
for OA (Chen et at., 1993). A recent report to the NZ Food Safety Authority measured the levels 
on MCin the Pacific Oyster using ELISA, LC-MS/MS and the PP2A assay, and revealed that 
guideline value (l/-Lg/l) had been exceeded in some cases (Holland et at., 2005). 
2.2.5 Toxin Tolerance levels 
The World Health Organisation (WHO) has set a provisional guideline value for MC-LR 
in drinking water of 1/-Lg/L (1 nM) (World Health Organization, 2003). The WHO recommends 
a maximum total daily intake for consumption of cyanobacterial products (MCs) as 0.04 /-Lg/kg 
as a safe dose. International guidelines for the protection of bathers in recreational waters have 
been discussed by Chorus and Bartram (1999). These include the following guidance levels 
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which have been taken from human epidemiological studies, WHO drinking water guidelines 
and case histories of animal and human poisonings: 
1. To post on-site advisory signs and inform relevant authorities when cyanobacterial 
cell counts exceed 20 000 per ml or 1 0 ~g/L of Chlorophyll a (Chl a) with dominance 
of cyanobacteria. 
2. To restrict bathing and investigate further when cyanobacterial cell counts exceed 100 
000 per ml 01' 50 ~g/L of ChI a with dominance of cyanobacteria. 
3. To take immediate action to prevent contact with scum and possibly prohibit bathing 
when cyanobacterial scum formation occurs in bathing areas. 
In New Zealand, warning signs are typically put out when cell concentrations of cyanobacteria 
are above 20000 cells/ml (this is a guideline value only) (K. Smith, personal communication, 22 
November, 2005). The Ministry of Health (2005) has now included cyanotoxins (including MC 
and NODLN) in the new Drinking-water Standards for New Zealand 2005, which has set a 
guideline value consistent with that for MCs in drinking water set by the WHO (1 ~g/L). 
Most countries with established regulations for DSP toxins have set tolerance levels at 
the limit of detection for the mouse bioassay. One mouse unit (MU) corresponds with 4 ~g OA 
in 100 g mussel meat, which is the minimum quantity of toxin capable of killing a 20 g mouse 
within 24 hours after an i.p. injection (Ramstad, 2001b). An accept~~le level of 4-5 MU per 
100 g (Luckas, 1992) is usually applied or 16-20 ~g of OA in 100 g mussel meat (equivalent to 
0.8 ~g/g hepatopancreas) (Carmody et ai., 1995; Ramstad, 2001b). The acceptable guidelines are 
now expressed as 160 ~g/kg (European Commission, 2002). The minimum dose of OA and 
DTX-l necessary to induce diarrhea in adults is estimated to be 40 and 36~g, respectively 
(Ramstad, 2001b, 2001a). European guidelines also have a limit for YTX which is 1 ~g/g 
(European Commission, 2002). The New Zealand mussel industry must comply with these 
guidelines for export trade to Europe, as it accounts for approximately 15% of shellfish export in 
New Zealand (P. McNabb, personal communication, 14 November, 2005). 
2.2.6 Global Increase of Algal Toxins 
The eutrophication of lakes, reservoirs and low tidal flushing watersheds has without 
doubt been the most consequential factor leading to increased cyanobacterial blooms worldwide 
(Pitois et ai., 2001). Conditions that facilitate cyanobacterial blooms depend on nutrient 
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concentration (namely P and NH3), light intensity, temperature, pH, population stability, degree 
of mixing and mass of water body (Herath, 1997; Chorus and Bartram, 1999; Pitois et aI., 2001). 
Other biological factors such as presence of herbivores (i.e. zooplankton that directly feed on 
algae) can also play a role in decreasing bloom abundance (Herath, 1997). Although 
eutrophication is a natural process, anthropogenic eutrophication is believed to be largely 
responsible for increased blooms (Pitois et al., 2001), as a result of intensive agricultural and 
industrial activities. Due to the wide-spread distribution of cyanobacteria (particularly as cysts) 
in lakes and rivers (Chorus and Bartram, 1999), any inland and low tidal flushing watershed that 
exists within agricultural, industrial or metropolitan areas is potentially at risk of a cyanobacterial 
bloom. 
Figure 2-4, shows the global increase of reported marine HABs as reported in 1970 and 
1999. There have been a number of hypotheses to explain the global increase of algal blooms as 
discussed in section 1.1. The global transport of algal cysts and motile cells in ships ballast water 
is potentially one of the most significant factors leading to the global distribution of toxic algae 
in coastal waters. Ballast water has been responsible for the transfer of pathogenic bacteria, 
protists, algae, zooplankton, benthic invertebrates and fish (Ruiz et aI., 1997). For example, 
potentially harmful and non-indigenous dinoflagellates were detected in over 50% of ballast 
water samples taken from one hundred and twenty-seven boats in a Scottish port (Macdonald and 
Davidson, 1998). Algal cysts or cells in receiving waters may bloom if the environmental 
conditions are favourable, which can be facilitated during periods of anomalous weather events, 
such as El Ninq andlor global climate change. For example, the first documented marine HAB 
in New Zealand was caused by Gymnodinium mikimotoi, a neurotoxin producer now known as 
Karenia cf mikimotoi, which was bought in by an oceanic Japanese vessel during an El NiCb 
event (Rhodes et al., 2001). 
Recently, there has been some discussion as to the correlation between increased marine 
farming practises and marine algal blooms. In New Zealand, aquaculture is mostly based on filter 
feeding molluscs that probably produce a net loss of nutrients from the ecosystem (Rhodes et al., 
2001), in comparison to sea-cage finfish farms and alike, that add nutrients to the ecosystem (of 
which there are few, in New Zealand). Rhodes et al. (2001), suggest there has been no evidence 
that the expansion of mussel farms in the Marlborough Sounds (major shellfish growing area in 
New Zealand) has resulted in the increased incidence ofHABs. 
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Figure 2-4. The global increase of reported manne algal toxins. Encircled areas indicate where outbreaks have 
occurred or toxin has been detected at levels sufficient to cause harm to humans or the environment (van Dolah, 
2000). PSP = paralytic shellfish poisoning, NSP = neurotoxic shellfish poisoning, DSP = diarrhetic shellfish 
poisoning, ASP = amnesic shellfish poisoning, Ciguatera = ciguatera fish poisoning, and Pfiesteria = estuary 
syndrome (Pfiesteria sp.). 
2.2.7 Toxin synthesis 
Not all toxigenic species of cyanobacteria will produce toxic blooms at all times, as 
toxicity can be variable within, and between blooms of the same species (Falconer, 2001). The 
toxin content of cyanobacteria is thought to be influenced by similar physiochemical parameters 
that influence algal blooms (this is in addition to species and strain of toxin, bloom 
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heterogeneity, culture age, and other factors that contribute to toxin degradation) (Falconer, 
2001). For example, Orr and Jones (1998) found that environmental parameters ultimately 
influenced toxin production by influencing cell division rates of cyanobacteria rather than by 
directly affecting the metabolic pathways of toxin production. White et al. (2003) supported this 
theory by showing that in tropical environments, light and nutrient availability played a key role 
in allowing high toxin production by cyanobacteria, by influencing cell division rates and 
degradation of the toxin in the water column. 
As for DSP toxins, geographic and temporal variation seems to affect toxin synthesis. For 
example, DTX-1 is a common toxin produced by D fortii in Japan, whilst OA is the 
predominating toxin produced by D. fortii in Europe (Hungerford and Wekell, 1992a). 
Intraspecies toxin synthesis has also been shown to vary within a given area, from season to 
season and with depth. For example, Edebo et al., (1988) revealed differences in the total DSP 
concentration at variable depths within the same sampling site. 
Factors affecting toxin synthesis in marine algae have been studied by several authors 
(Quilliam et a!., 1996; Pan et al., 1999; Imai et al., 2003). Growth rate (Pan et a!., 1999) and age-
dependant (Quilliam et al., 1996) toxicity has been demonstrated in OA producing 
dinoflagellates. Recent research by Imai et al. (2003), supported the hypothesis that particular 
toxic phytoplankton species such as Dinophysis spp., may originally be non-toxic and may only 
become toxic secondarily, through the ingestion of toxic small-sized phytoplankton (nano-andlor 
picophytoplankton) as a result of mixotrophy (i.e. autotrophic and heterotrophic). 
2.2.8 Functional roles of toxins 
The physiological and ecological roles of Mes remain largely unclear. Possible 
explanations for the functional roles of Mes have been summarised by Hitzfield et a!. (2000). 
These include: provide protection from grazers; provide an ecological advantage over algae; 
regulate protein phosphatase; or simply act as storage substances. Keating (1978) provided some 
evidence to suggest that Mes inhibit the growth of diatoms. However, this was not supported by 
the recent finding by Shi et al. (1999) that cyanobacterial phosphatases are insensitive to Mes. 
The functional roles of DSP toxins are less clear and very limited information exists in the 
literature. 
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2.2.9 Depuration 
Depuration is the natural or unnatural process of removing toxins from shellfish, algae or 
water. Natural detoxification is an effective way to reduce toxicity, whereby shellfish are 
maintained in the sea for several weeks once the outbreak has subsided (Gonzalez et al., 2002). 
Natural depuration however is slow and depends on the metabolic rate of the shellfish, which is 
subsequently affected by varying environmental conditions, such as low temperature and salinity 
(Gonzalez et al., 2002): Depuration rate also differs between shellfish species. For example, 
higher concentrations of OA have been found in blue mussels (Mytilus galloprovincialis) than in 
Greenshell™ mussels (Perna canaliculus) in NZ, with the conversion product DTX-3 (7-0-acyl 
OA) also being found in Greenshell™ mussels (Rhodes et al., 2001). This latter finding 
suggested that the diol ester derivative acyl OA is a more important contaminant in New Zealand 
shellfish than previously thought (Mountfort et al., 2001). Croci et al. (1994) reviewed the 
literature on the depuration of OA in shellfish and revealed that some studies showed 30 days 
were required before all traces of OA in toxic mussels in aquaculture ponds were eliminated. 
This review also highlighted the significant variability in toxin concentration reported within a 
matter of days and suggested that weekly sampling of shellfish beds may not be sufficient for 
maximum protection of public health. 
Due to the extreme thermo-resistance of DSP toxins, thermal treatment has not been an 
effective solution to reduce toxicity (Gonzalez et al., 2002). Only two other studies have 
experimented with increasing depuration efficiency. The first reported study used ozonised water 
to reduce toxicity whereby a considerable reduction in toxicity occurred within 3 days for some 
cases (variable results were obtained however) (Croci et al., 1994). Further studies by Gonzalez 
et aI., (2002) exposed OA to a supercritical mixture of carbon dioxide with acetic acid. This non-
toxic and food compatible treatment was highly effective with 90% of the toxin eliminated in 
30 minutes for some samples. Croci et al. (1994) believes that not all components of the DSP 
toxins are capable of being removed once they have accumulated in shellfish, and future studies 
are needed to determine this. 
Microcystins are extremely stable and resistant to many chemical processes at neutral pH, 
such as boiling, chemical hydrolysis or oxidation. Natural detoxification processes are only 
effective at high temperatures, and at elevated or low pH. For example, MC undergo slow 
photochemical breakdown in full sunlight which can be accelerated with humic substances which 
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act as photosensitises (Chorus and Bartram, 1999). A number of treatment techniques are 
currently used in the treatment of watersheds contaminated with Me. These typically include 
aeration, treatment with algicides (copper sulphate has proved most effective), biological agents 
(e.g. bacteria) and activated carbon (Carmichael, 1997). 
The depuration of MC from shellfish has been studied by several authors. Williams et al. 
(1997) revealed that the mussel, M edulis, can rapidly clear MC from their tissues (both 
unbound and covalently bound to protein phosphatase enzymes) in a short period (4 days) when 
they were regularly flushed with untreated seawater. Amorin and Vasconcelos (1999) revealed 
that depuration of MCs by the mussel, M galloprovincialis, was a slow process when mussels 
were not exposed to a flow-through water system, as the mussels were being re-contaminated by 
their faeces containing MCs. It is likely that the former study performed tests under more natural 
conditions. 
2.3 Microalgae and Cyanobacteria in New Zealand and Methods of 
Detection 
2.3.1 Microalgae and Cyanobacteria in New Zealand 
2.3.1.1 Marine Microalgae 
New Zealand has a substantial Greenshell™ mussel (P. canaliculus) industry with a fifty-
five country export trade and earnings of approximately US$62 million (Mussel Industry Council 
Records, Rliodes et a!., 2001). Since the first outbreak of shellfish poisoning in New Zealand 
during summer 1992/1993, (DSP was responsible, in part) (Epstein and Jenkinson, 1993), New 
Zealand's aquaculture industry has been acutely aware of the potential of algal toxins to risk 
consumer safety and inhibit international trade in shellfish products. In New Zealand, the 
shellfish.industry and the government are actively involved in routine monitoring of shellfish 
beds. The shellfish industry funds, by levies of marine farm license holders, weekly 
phytoplankton monitoring at 30 commercial harvesting sites (Rhodes et aI., 2001). The central 
government is responsible for biotoxin monitoring at approximately 80 public sites throughout 
the country (Rhodes et al., 2001). These figures have likely increased since 2001. Monitoring has 
avoided the harvesting of contaminated shellfish. For example, in 2001 the north-west coast of 
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the South Island was issued public health warnings against consuming local shellfish, as mussels 
were found to be contaminated, in part, with DSP toxins (MacKenzie et aI., 2002). 
New Zealand tests for all major toxin classes, whilst most other countries only test for 1 
or 2 toxin groups (Garthwaite, 2000). All major classes of shellfish toxins have now been 
detected in NZ with levels above the maximum permissible level (MPL) for all classes at some 
time in the last 5 years (Garthwaite, 2000). The analyses of seawater samples for micro algae are 
carried out at the Cawthfon Institute, Nelson. This laboratory has been awarded International 
Accreditation New Zealand (IANZ), which is covered under the ISO-IES Guide 25 as the 
recognised international laboratory standard (Rhodes et ai., 2001). 
Seasonal marine HABs in New Zealand commonly start with diatoms in early spring, 
followed by dinoflagellates in summer and further diatom blooms in autumn (Rhodes et ai., 
2001). Dinophysis acuta, D. acuminata and Prorocentrum lima are common bloom forming, 
DSP producing phytoplankton in New Zealand. Although D. acuta and D. acuminata are 
producers of DTX-2 in Europe, OA is the main toxin related to these two phytoplankton species 
in New Zealand. These species are thought to co-occur possibly as a result of favouring the same 
environmental conditions (a high water column with a high nutrient status and a shallow strongly 
defmed pycnocline) (MacKenzie et ai., 2002). 
2.3.1.2 Cyanobacteria 
The first published record of the suspected involvement of toxic cyanobacteria in 
livestock deaths in New Zealand, occurred in a farm in lake Waipukurau, in which a bloom of 
M aeruginosa was accountable (Flint, 1966). Current cyanobacterial blooms in New Zealand are 
common in the Rotorua Lakes, Lake Ellesmere and Lake Forsyth in Canterbury, Lake Waihola 
in Dunedin and a number of lakes in Waikato, Northland, Wellington and Horowhenua (A. 
Crowe, personal communication, 9 December 2004). Many unrecorded accounts of poisoning by 
cyanobacteria in New Zealand were also believed to have occurred throughout the last century 
(Flint, 1966). Recorded cyanobacterial blooms have been increasing in frequency in recent 
decades, particularly in Australia (Carmichael, 2001). Thus, it is possible that a similar pattern 
may occur within New Zealand. For example, large scale agricultural farming in New Zealand, 
particularly in the livestock industry, can facilitate the inland eutrophication of watersheds, and 
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give rise to favourable conditions for cyanobacteria to multiply. Thus, many fresh- and brackish 
watersheds are potential candidates for cyanobacterial blooms in New Zealand. 
The analyses of freshwater samples for cyanobacteria are carried out III the 
Phytoplankton Laboratory at the Cawthron Institute. These analyses typically include State of the 
Environment periphyton monitoring, drinking water supply monitoring, oxidation pond 
monitoring and bloom monitoring and are mainly for regional, district and city councils (K. 
Smith, personal communication, 22 November, 2005). 
2.3.2 Current Methods of Toxin Detection 
The main regulatory method to date for micro algal toxin detection involves the mouse 
bioassay and it remains the primary detection method in New Zealand and throughout the rest of 
the ~or1d. Confirmation of toxin identification in the mouse bioassay is usually followed by an 
enzyme linked immunosorbent assay (ELISA) or LC-MS. In 2001, liquid chromatography with 
mass spectrometry (LC-MS) was accredited in New Zealand for routine detection at the 
Cawthron Institute, Nelson, which detects domoic acid (DA) (responsible for ASP) and DSP 
toxins. 
There are many disadvantages of the mouse bioassay and other alternative methods 
appear to be more sensitive for screening toxins (Table 2-3). All methods available have 
advantages and disadvantages (Table 2-4). The mouse bioassaynas low sensitivity and 
specificity, is a lengthy procedure and relies on live animals for testing. The PPINA is rapid, 
cheap and sensitive, and has a high throughput format, however it lacks specificity. 
Chromatographic methods are very expensive and require highly skilled personnel to operate the 
equipment. Stoichiometric methods, such as LC-MS and ELISA are also constrained by the 
availability of standards for the full range of DSP toxins, MC and NODLN variants in a sample. 
An exception, is the development of a new indirect ELISA developed by Fischer et al. (2001) for 
MC detection, which uses antibodies to the ADDA moiety. Most microcystins have an ADDA 
moiety and the 6E geometry moiety is responsible for toxicity in microcystin congeners. Thus, 
the new ELISA can recognise many toxic congeners. However, stoichiometric methods do not 
provide any indication of toxicity of a sample and assign equal weight to toxin congeners that 
differ in their toxic potential. 
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The major advantage of the PPINA over the former methods is its ability to detect total 
bioactivity of toxins as detection is based on functional activity rather than on specific structural 
components (Carmichael and An, 1999). This is useful as toxicity is directly proportional to 
inhibitory activity on the enzyme, thus indicating unsafe toxin levels. The PPINA is the method 
that has been further developed for the purpose of this thesis. 
Table 2-3: Comparison of Methods 
Method Sensitivity Specificity References 
Mouse Bioassay Low (ppm range) Low (Cannichael and An 1999) 
Le-MS Higha (ppb-ppt range) High (Lawrence et al., 2001) 
ELISA Higha (ppb-ppt range) HighiLowb (Cannichael and An 1999) 
PPINA Higha (ppb-ppt range) Low (Cannichael and An 1999) 
a detection limit <1 Ilg/I00 g mussel tissue 
b Only low specificity for MC detection with Fischer et al. (2001) method. 
2.3.3 Protein Phosphatase Inhibition Assay 
Purified catalytic subunits of PP-2A and PP-l have been used-to develop a PPINA, for 
the qualitative measurement of DSP toxins and MCs in the aquatic environment. Protein 
phosphatase type 1 and PP-2A are the most abundant phosphatases in mammalian tissues with 
catalytic subunits of 38 and 36 kDa, respectively (Toivola et al., 1994). Protein phosphatase type 
2A is found mainly in the cytosolic fraction, whereas PP-l is found mainly in the mitochondrial 
and post-mitochondrial particulate fractions (Toivola et al., 1994). These phosphatases 
dephosphorylate serine/threonine residues on a variety of regulatory and structural proteins 
(Cohen, 1989). Microcystins and DSP toxins specifically bind to and inhibit the activity of these 
phosphatases (Takai and Mieskes, 1991; Takai et al., 1992a; Honkanen et al., 1994). As a result, 
the PPINA was developed based on the ability of these toxins to prevent protein phosphatase 
enzymes dephosphorylating colorimetric or fluorimetric substrates. The assay is carried out in 
96-multiwell plates and the hydrolysis of the substrate is qualitatively measured on a 
spectrometer or fluorimeter. The decrease in hydrolysis of the substrate is inversely proportional 
to the concentration of toxin. 
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Table 2-4: Advantages and disadvantages of available methods for microcystin and 
diarrhetic shellfish poisoning detection. 
Method 
Mouse 
Bioassay 
LC 
ELISA 
PPINA 
Advantages 
Detects toxicity in biological 
tissue, hence the bioactive 
component of the sample. 
High sensitivity. Good 
correlation with other 
methods. 
Broad specificity for cyclic 
peptide toxin congeners. 
Based on the structural 
components of the sample. 
Cheap and easy to perfonn. 
Good correlation with other 
methods. 
Rapid (lh), cheap and 
sensitive. Detects total toxin 
bioactivity. Good correlation 
with other methods. 
Disadvantages 
Low specificity, sensitivity and 
long procedure. Relies on large 
samples oflive animals for testing. 
Only suitable for detection of acute 
levels. Expensive. Tendency to 
produce false positives. I.p. 
administration may not parallel 
natural exposures. 
Expensive and required highly 
skilled personnel. Constrained by 
the availability of standards for the 
full range of toxin variants found 
in samples. Provides no indication 
of toxicity. 
References 
(Cannichael and An 1999) 
(Laub et al. 2002) 
(Lawrence et al. 2001) 
(Fischer et al. 2001) 
Provides no indication oftoxicity.-{Fischer et al. 2001) 
Assigns equal weight to toxin 
congeners, even though they may 
differ in their toxic potential. 
Non-specific. Cross reactivity of 
interference substances with toxin 
variants can sometimes occur. 
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(Cannichael and An 1999) 
(Mountfort et al. 2001) 
(Mountfort et al. 2005) 
2.3.3.1. Developments in the PPINA 
Initial enzyme assay developments began with radioactive protein phosphatase involving 
32P-Iabelled substrates (histone or phosphorylase), with the assay end-point being the inhibition 
of release of 32p from the substrate by purified PP-2A (Honkanen et al., 1996b). An alternative to 
the radioisotope method, was the development of a microplate format for high throughput use of 
the colourmetric substrate, para-nitrophenyl phosphate (pNPP) , developed by Tubaro et al. 
(1996). Para-nitrophenyl phosphate is a commonly used colorimetric substrate for alkaline 
phosphatases (PP-2A and PP-1) as it is dephosphorylated by protein phosphatase enzymes and 
converted from a clear to a yellow solution (para-nitrophenol). The binding of MCs and DSP 
toxins to protein phosphatase enzymes prevents the production of para-nitrophenol. The level of 
toxin in the system is qualitatively measured by reading the absorbance of para-nitrophenol on a 
microplate spectrometer and comparing this to a standard inhibition curve. The detection limit 
for MC using the colorimetric assay is 0.5 IlglmL (below the WHO guideline of 1.0 IlgiL 
drinking water) (Tubaro et al., 1996). 
The PPINA assay has been further modified using fluorescent substrates: fluorescein 
diphosphate (FDP), methylumbelliferyl phosphate (MUMP) , difluoromethylumbelliferyl 
phosphate (DiFMUP) and dimethylacridinone phosphate (DDAO). The fluorescent PPINA is 
based on a similar method to the colorimetric PPINA, however it usf!_~ fluorimetric substrates. 
The hydrolysis of fluorimetric substrates is determined by fluorescence detection on a 
fluorescent microplate reader in 96-well microtiter plates. A comparative study by Leira et al. 
(2000) found no specific advantages of any of these PP-2A substrates as the sensitivity, 
reproducibility and recovery percentages were all similar. Similar findings using OA have also 
been obtained in other studies (Vieytes et al., 1997; Mountfort et al., 1999). Microcystins inhibit 
PP-1 and PP-2A with similar potency, with an ICso of 0.3 and 0.5 nM, respectively (Toivola et 
al., 1994). Protein phosphatase type 2A however is believed to form a more stable complex with 
MC-LR relative to the PP-1 toxin complex (Toivola et aI., 1994). Nodularins are believed to 
inhibit PP-1 with similar potency, but inhibit PP-2A at a higher selectivity (van Dolah and 
Ramsdell, 2001). Diarrhetic shellfish toxins also have a differing binding affinity to protein 
phosphatase enzymes. Protein phosphatase type 2A is more strongly inhibited by OA (inhibition 
concentration of OAso ~ 0.2nM) than PP-1 (inhibition concentration of OAso ~ 20nM) (Holmes 
et al., 1990). Consequently, PP-2A has been more commonly used to assay DSP toxins. The first 
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most commonly used PP-2A enzyme for these tests was sourced from rabbit skeletal muscle 
(Cohen et al., 1989; Holmes et aI., 1990; MacKintosh et al., 1990; Takai and Mieskes, 1991; 
Simon and Vemoux, 1994; Honkanen et al., 1996a; Shimizu et al., 1998). Later, Vieytes et al., 
(1997) showed that PP-2A sourced from human red blood cells, yields IS-fold more activity (i.e. 
fluorescence) with the same amount of protein then the former PP-2A source. Thus, in recent 
years, PP-2A sourced from human red blood cells has become the enzyme of choice for use in 
the PPINA (Tubaro et al:, 1996; Mountfort et al., 1999; Leira et al., 2000; Mountfort et al., 
2001; Mountfort et al., 2005). Protein phosphatase type 1 has generally been the enzyme of 
choice for MC analysis in the past, mainly because the cloned catalytic subunit ofPP-1 has been 
commercially available (van Dolah and Ramsdell, 2001). Many recombinant forms ofPP-1 have 
also been developed (Zhang et al., 1992; An and Carmichael, 1994; Zhang, 1994; Heresztyn and 
Nicholson, 2001). 
Fluorimetric methods (ICso for OA and PP2A 1.5 nM using MUMP) are inherently more 
sensitive than colorimetric methods (ICso for OA and PP2A 2.0 nM using substrate p-NPP), 
utilising similar preparation procedures (Mountfort et al., 1999). Radioisotope assays have 
similar detection limits to fluorimetric substrates. However, they require expensive radioisotope 
facilities and purified protein phosphatases are more widely available. Unlike colorimetric 
substrates, fluorimetric substrates do not exhibit shifts in inhibitory activity as a result of 
differing enzyme dilutions (Mountfort et aI., 1999). Fluorimetric assaysbave also been shown to 
reduce the need for sample clean-up than absorbance-based methods (van Dolah and Ramsdell, 
2001). 
There has been considerable development of the PPINA to detect DSP toxins in shellfish 
at the Cawthron Institute, Nelson. The first published PPINA developed at the Cawthron Institute 
by Mountfort et al. (1999) utilised PP-2A with a number of colorimetric and fluorimetric 
substrates, for the determination of OA in mussels. Fluorimetric substrates, such MUMP proved 
to be more sensitive and accurate than colorimetric substrates. The assay compared favourably to 
results obtained with ELISA and LC-MS. The method was modified by Mountfort et al. (2001) 
to include a hydrolysis step that converted the diol esters of OA (acyl OA) and other DSP 
derivatives (DTXs) to a more detectable OA and DTX-1, as prior to utilising this step, the assay 
lacked sensitivity towards the ester derivatives of these toxins. The addition of the hydrolysis 
step during the preparation of samples increased the sensitivity of this assay to incorporate all 
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DSP toxins. These assays have typically incorporated bovine serum albumin (BSA) and NiCh 
into the reaction mix as they are considered important cofactors in this type of assay system 
(Mountfort et al., 1999; Mountfort et al., 2003) (see Chapter 3 for more detail). Developments in 
the PPINA have now expanded to include detection of MCs (Mountfort et al., 2005). 
2.3.3.2 Method Specificity 
The PPINA is a very attractive screening tool as it measures the biologically active 
components of the sample. The PPINA can detect all of the toxin variants that have affinity to 
protein phosphatase enzymes (60-odd variants of MCs), which is essentially the strength of the 
assay. The results of the assay can be confounded if either, other phosphatase enzymes are 
present within a sample, or if protein phosphatase inhibiting toxins other than the one in question 
is present within a sample. 
Cyanobacteria have significant amounts of endogenous phosphorylase phosphatase 
enzymes which can mask (or add to) the inhibitory activity ofMCs or DSP toxins (Carmichael, 
1997). Shellfish also have significant amounts of protein phosphatase enzymes, which can 
confound the results of the assay. To overcome this, the samples are usually extracted with 
methanol which inhibits endogenous protein phosphatases before incorporation into the assay. 
Co-occurring toxins present a different problem. Microcystins have been identified in the 
north-eastern Pacific Ocean, and east Canadian and European mussels (Chen et al., 1993). 
Therefore, it is possible for MCs to co-occur with DSP toxins, especially in coastal and river 
inlets. The presence of OA in a sample of potable water is highly unlikely, so co-occurrence is 
not an issue for drinking water. However, it is possible for OA to co-occur with MCs in brackish 
water. The low specificity of the PPINA is therefore, both a disadvantage and an advantage. The 
PPINA would overestimate toxicity of the toxin in question, by detecting the toxicity of other 
protein phosphatase inhibiting toxins present in a sample. However, it would still be fulfilling its 
role of protecting the public by detecting all harmful toxins in the sample, unlike stoichiometric 
methods which would not detect other potentially harmful toxins. In addition, scientists at the 
Cawthron Institute who work with cyanobacteria and marine algae are not aware of blooms 
reported in co-existing areas within New Zealand (S. Wood and P. Holland, personal 
communication, 12 September 2005). 
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Other phosphatase inhibiting enzymes may also be present in a sample and potentially 
lead to false positive results, such as calyculin A, tautomyocin or motuparin (Carmichael, 1997). 
Calyculin A is a potent inhibitor of PP-1 and PP-2A, induces contraction of smooth muscle fibres 
and is a powerful tumour promoter (Ishihara et al., 1989). It was first isolated from a marine 
sponge Discodermia calyx, collected in Japan (Chin et al., 1995), although whether the toxin was 
produced from the sponge itself or if it was bioaccumulated has yet to be determined. Motuparin 
is another toxin presentm the Papua New Guinea sponge Theonella swihoei and has a similar 
structure to NODLN. Again, the production ofmotuparin has yet to be determined. Tautomyocin 
is a soil bacterium that is an inhibitor of protein phosphatase. Although all of these toxins may 
share the same binding site on protein phosphatase molecules, it is doubtful if high 
concentrations of calyculin A, tautomyocin or motuparin required to inhibit these enzymes 
would exist naturally in the environment. Tautomyocin has been shown to be unstable in solution 
and has a higher IC50 than that of OA and MC for PP-;-2A (IC5o 0.28 and 7.51 nM, for OA and 
tautomyocin, respectively) (Honkanen et al., 1994; Takai et al., 1995). Thus, tautomyocin is 
unlikely to compromise the assay. Calyculin A also has a higher ICso than that of OA for PP-2A 
(ICso 1.5 and 12 nM' for OA (Mountfort et a!., 1999) and calyculin A (Malarvannan and 
Mountfort, unpublished), respectively). However, other studies have shown calyculin A to 
produce similar sensitivity to that of PP-2A (ICso 0.3 nM for both OA and calyculin A 
(Honkanen et ai., 1994)). The inhibiting concentration of motuparin is unknown (Carmichael, 
1997). Whether the sponges, Discodermia calyx and Theonella swihoei, responsible for 
producing calyculin A and motuparin, are present where aquaculture or wild shellfish grow in 
coastalwate!s remains unknown. In addition, whether these toxins are capable of accumulating 
to such concentrations as to make the water toxic is unlikely, as such cases have not been 
reported. There have also been no reports of these sponges in New Zealand. Thus, calyculin A 
and motuparin are unlikely to compromise the assay. 
29 
2.4 Biosensors 
2.4.1 Biosensor development 
Biosensors are analytical devices that incorporate a biological element and are associated 
with, or integrated within, a physicochemical transducer or transducing micro system, which may 
be optical, electrochemical, thermometric, piezoelectric or magnetic (Rogers and Gerlach, 1996). 
Advantages of biosensors in comparison to bioanalytical assays include (Rogers and Gerlach, 
1996): 
~ High specificity. The advantage of biological sensmg elements IS the ability to 
distinguish between the analyte of interest and similar substances. 
~ Rapid analysis. Products can be directly and instantaneously measured. 
~ Simplicity. The receptor and transducer are integrated onto one single sensor. This is in 
contrast to the conventional assay, in which many steps are used and each step may 
require a reagent to treat the sample. 
~ Continuous monitoring capability. Biosensors can regenerate and re-use the immobilised 
biological recognition element. For enzyme-based biosensors, an immobilised enzyme 
can be used for repeated assays. Hence, these devices can be used for continuous or 
multiple assays. 
These characteristics, along with high sensitivity are all important components to a good 
biosensor d~si~. In essence, biosensors can potentially offer the specificity and sensitivity of 
biological-based assays packaged into convenient devices which allow for rapid and multiple 
analysis on-site (Rogers and Gerlach, 1996). 
With respect to algal toxins, biosensors could potentially play an important role in future 
monitoring programmes of toxic algae. An electrochemical immunosensor for OA and other 
seafood toxins responsible for ASP, NSP and pufferfish poisoning (domoic acid, brevetoxin and 
tetrodotoxin, respectively), has been developed by Kreuzer et al. (2002). The immunosensor is 
based on a disposable screen-printed electrode system (SPE) and alkaline phosphatase as the 
enzymatic label. The immunosensor for OA was shown to -be accurate, rapid «40 min), cost 
effective, disposable and sensitive (detection limit 4 ng/ml, ECso 32 ng/ml). 
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An immunosensor for OA using a quartz crystal microbalance (Tang et ai., 2002) and a 
semi-automated membrane chemiluminescent immunosensor for flow injection analysis of OA 
in mussels (Marquette et ai., 1999) have also been developed. The former immunosensor design 
showed a good long-term storage lifetime (38 days) however its sensitivity was not adequate for 
a biosensor (detection limit 1.9 ).lglml) (Tang et ai., 2002). The latter immunosensor design was 
rapid (20 min), had a low detection level (0.2 ).lg OAiIOO g of homogenate), could be applied to 
crude mussel extracts and was reproducible (could perform more than 30 OA determinations) 
(Marquette et ai., 1999). However, all of these immunosensors have the disadvantage of 
detecting specific toxin congeners only. 
An enzyme-inhibition bioelectrode biosensor test based on the capability of OA to inhibit 
the catalytic activity of acid phosphatase (AP) has been developed by Croci et ai. (2001). The 
biosep.sor uses AP to catalyse glucose-6-phosphate into glucose and inorganic phosphate, and 
then uses glucose oxidase (GOD) enzymes to oxidise glucose into gluconolactone and hydrogen 
peroxide. The intensity of the current flow registered by hydrogen peroxide is proportional to the 
catalytic activity of AP, which is inhibited by OA. The biosensor showed high sensitivity and 
produced results that were rapid and compared well to other analytical methods. Unlike the 
immunosensor methods, the latter biosensor method had a broad toxin detection range for 
phosphatase inhibiting toxins, although whether this was applicable for MC detection was not 
discussed. 
2.4.2 Application of the PPINA as a biosensor 
Currently, the PPINA is limited to a central location (Mountfort et ai., 1999; Mountfort et 
aI., 2001; Mountfort et ai., 2005) and only a small number of environmental samples analysed in 
the laboratory are identified as toxin positive (Garthwaite, 2000). Thus, there is potential for the 
PPINA to be developed into a portable biosensor for on-site analysis of MCs and OA in marine-
and fresh-water samples. The PPINA is based on a similar detection system as the enzyme-
inhibition biosensor (section 2.4.1) and could be developed in a similar format. The assay is also 
capable of detecting all intracellular and extracellular phosphatase inhibiting toxins including 
possible unidentified phosphatase inhibitors. The PPINA is more powerful than stoichiometric 
methods as it is functionally based, responding to different toxin congeners depending on their 
toxicity (Mountfort et aI., 2005). A 'fill and flow' biosensor format similar to that shown in 
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Figure 2-5, could represent a feasible extension of the assay, providing that protein phosphatase 
enzyme is amendable to immobilisation, and retains its activity and sensitivity to inhibition in 
this format (see the caption on Figure 2-5 for details on the design of the system). 
A protein phosphatase biosensor would avoid the time consuming and costly process of 
analysing multiple uncontaminated environmental samples in the laboratory. Some technical 
challenges would be present, as toxins are mostly cell-bound with little release into the 
environment until a bloom has collapsed (Watanabe et ai., 1988). Thus, it would need to be 
decided if water or algae should be tested. A method for homogenising algal cell samples in the 
field may need to be developed if the latter sample is to be measured. In the biosensor format, it 
is anticipated that the assay would have most value for use by regulatory authorities and other 
agencies concerned with toxin monitoring in potable water. It may also be applicable to the 
globa~ market as a potentially simple technique able to be used by non-skilled personnel to 
ensure that the regulatory limit for MCs meets the WHO standards in potable water (1 ~g/l). 
Monitoring of marine and freshwater micro algal toxins in New Zealand is clearly an 
important task to safeguard the health of the public, livestock and wildlife, and prevent economic 
loss to the shellfish industry. The range of current methods available for such analyses differs 
immensely in their methods of detection, strengths and weaknesses. If proven useful, the PPINA 
biosensor, could provide a rapid, on-site detection system for both fresh and marine water 
samples, serve as an early warning of toxin outbreaks (Mountfort et ai., 2001), and replace the 
mouse bioassay in routine analysis for MCs and DSP toxins. 
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Figure 2-5. Schematic diagram ofa typical 'fill and flow' channel biosensor. (a) TopXiew; (b) section view through 
cut A-B (Gooding and Hall, 1998). The sample well will contain a filter that retains the enzyme-bead complex. The 
biosensor is reminiscent of "dipstick" technology, but the biorecognition matrix (i.e. the immobilised enzyme beads) 
is located upstream of the detector electrode. Thus, the sample would not only fill the channel but also flow through 
it. The system would typically work as described: a small volume of the test solution (containing both the sample 
and assay components) is added in the well and the solution would flow by "gravity feed" through the channel and 
pass the electrode. The detector electrode current will be a function of the analyte concentration. Thus, the detection 
system would be based on a similar method as the PPINA, whereby the amount of substrate in the sample would 
indicate the presence of the toxin. This system would need to be optimised with regards to the flow rate, enzyme 
loading and channel dimensions to obtain the best response for the application. Refer to Gooding and Hall (1998) for 
more details regarding the development of this sytem. 
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Chapter 3 Method Development 
3.1 Introduction 
There have been significant developments in the PPINA to detect DSP toxins (OA and 
DTXs) and MCs (section 2.3.3.1). Recently, the PPINA method has evolved to test the suitability 
of a microfilter plate (Figure 3-1a) (Mountfort et at., manuscript in preparation-a), as opposed to 
the standard microwell plates used in previous experiments (Figure 3-1 b). The method employs 
an enzyme-immobilisation system, where PP-2A enzyme is immobilised onto sepharose 
microbeads prior to being used in the assay. The reaction system consists of an assay buffer 
(Tris) , NiCb (for enzyme stability), toxin, enzyme, and the substrate, MUMP, in a neutral 
mediUm. The assay is carried out in 96-well micro filter plates so that the enzyme can be retained 
in the filter after a test. The purpose of the enzyme immobilisation system, referred to as 'the 
immobilised PPINA', is that it can potentially serve as a vehicle towards the development of a 
prototype biosensor for onsite detection of DSP toxins and MCs in environmental samples. The 
immobilised PPINA is referred to as the pre-biosensor format and serves as an intermediate step 
in the process of development between the unimmobilised PPINA (i.e. the PPINA using 
unbound or free enzyme) (Mountfort et at., 1999) and the prototype bios.ensor. 
The immobilised PPINA has previously been tested using purified PP-2A obtained from 
human red blood cells (Mountfort et at., manuscript in preparation-a). However, there is 
potential to apply the immobilised PPINA to enzymes other than PP-2A, such as protein 
phosphatase type 1 (PP-l). In September 1994, recombinant PP-l (RPP-l) became 
commercially available. The RPP-l was isolated from a strain of E.coli that carries the coding 
sequence for rabbit skeletal muscle PP-l (Gisoform) (Zhang et at., 1992). The RPP-l has appeal 
as it has low sensitivity for MCs (0.04 nM) (Zhang et at., 1992) and is commercially available. 
In this chapter, optimal conditions for the immobilisation procedure using PP-2A and 
RPP-l enzyme were determined so that both enzymes were shown to express maximum activity. 
Optimisation experiments were performed on unimmobilised RPP-l prior to the immobilised 
tests for this enzyme, as it had not been previously used in the laboratory. The purpose of all the 
optimisation experiments was to determine conditions that produced the highest enzyme activity, 
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as this enabled any change in activity to be reliably detected in the presence of a toxin inhibitor, 
such as OA or MC 
a) 
b) 
Figure 3-1. Photos of a 96-wel1 microfilter plate (a), and a 96- microwel1 plate (b). The microfilter plate is used for 
the enzyme-immobilisation method (photo L. Al1um). 
3.2 Materials and Preparations 
3.2.1 Materials 
3.2.1.1 Chemicals 
Activated sepharose beads (CN-Br) were purchased from Amersham Pharmacia Biotech 
AB, Sweden and albumin bovine fraction V (BSA) was obtained from BDH Lab Services, 
England. Four-methylumbelliferyl phosphate disodium salt (MUMP) and ascorbic acid 2-
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phosphate were purchased from Sigma (Missouri, USA). All other chemicals were from the local 
commercial sources and of the highest possible grade. 
3.2.1.2 Enzymes 
Protein phosphatase enzyme type 2A (PP-2A) obtained from Upstate Biotechnology Inc 
(New York, USA), was isolated from human red blood cells as a heterodimer of 60 kDa and 
36 kDa subunits. Recombinant PP-I obtained from New England Biolabs (Massachusetts, USA) 
was isolated from E.coli that carries the catalytic subunit (37.5 kDa) of the Disoform of PP-1 
from rabbit skeletal muscle. 
3.2.2 Preparations 
3.2.2 .. 1 Substrate and BSA preparations 
The reaction substrate MUMP, was prepared· daily in 50 mM Tris buffer of pH 7.0 
(5 mg/IO ml diluted 1 :4). Stock solutions of 10 mg/ml BSA were prepared in distilled water and 
stored at -20°e. 
3.2.2.2 Enzyme preparations 
Protein phosphatase type 2A was supplied with a dilution buffer containing 20 mM 
MOPS, pH 7.5, 150 mM NaCl, 60 mM 2-mercaptoethanol, 1 mM MgCh, 1 mM EGTA, 0.1 mM 
MnCh, 1 mM DTT, 10% glycerol and 0.1 mg/ml BSA. Ten units (100 p,l) ofPP-2A were diluted 
in 1 ml of the supplied dilution buffer and 100 p,l aliquots were stored at -20°e. Recombinant 
PP-l was al~o ~upplied with a storage and reaction buffer containing 50 mM HEPES, 100 mM 
NaCI, 0.1 mM EDTA, 2 mM dithiothreitol (DTT), and 0.025% Tween 20 (final pH 7.5) in water. 
However, R.PP-1 was stored undiluted in 20 p,l aliquots (50 units) at -70°e. Thus, the reaction 
buffer for R.PP-1 was made up daily. 
3.2.2.3 Buffer preparations 
Coupling buffer 
The sodium phosphate buffer was prepared with 30.5 ml of 0.2 M of disodium hydrogen 
phosphate (Na2HP04) and 19.5 ml of 0.2 M of sodium dihydrogen phosphate (NaH2P04) and 
made up to 100 ml with distilled water (PH 7.0). The standard coupling buffer contained sodium 
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phosphate buffer, 0.05 M of potassium chloride (KCl) and 0.2 mM L-ascorbic acid 2-phosphate 
sesquimagnesium salt (C6H909P) and was stored at 4°C. 
Tris assay buffer 
Tris buffer, 50 mM Tris (hydroxymethyl) methylamine (BDH Chemicals, Poole, 
England) containing 0.1 mM of calcium chloride (CaCh), was made up in 500 ml of distilled 
water and adjusted to pH 7.0 using 2.5 mM of hydrochloric acid (HCI) and stored at 4°C. 
3.3 Assay and Immobilisation Methods for PP-2A 
3.3.1 Protein phosphatase 2A inhibition assay 
. The PPINA was based on a hydrolysis reaction between serine/threonine protein 
phosphatase enzymes and the colourless substrate, MUMP. Protein phosphatase enzymes 
dephosphorylated MUMP and reduced it to the· fluorescent compound, methylumbelliferone 
(MUM). 
PP 
MUMP -7 MUM + phosphate 
The resulting fluorescent product (MUM) was measured on a fluorescent microplate reader. 
Okadaic acid and MCs bind to protein phosphatase enzymes and inhibit binding of the enzyme to 
the substrate. Hence, toxin detection was based on the inhibition of product formation. 
Protocolfor the PP-2A inhibition assay 
The protein phosphatase type 2A inhibition assay was based on the method of Mountfort 
et al. (1999). The assay was carried out with unimmobilised enzyme in Nunc MaxisorpTM 
96-multiwell plates. The assay system for PP-2A contained 50 III of 50 mM Tris buffer (PH 7.0) 
and 0.1 mM CaCh, 120 III of buffer containing substrate (0.42 mM MUMP), 5 III of 40 mM 
NiCh (in distilled water), and 5 III of BSA (1 mg/ml of distilled water) and 10 III of PP-2A 
diluted 1:4 with Tris buffer (0.02 Units per assay, final concentration 1.5 nM) together with 10 III 
of sample extract or purified toxin standard, diluted in 10% methanol. The total assay volume 
was 200 Ill. Control wells did not contain the toxin or the sample extract but instead were 
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supplemented with additional 10% methanol to make up the final assay volume to 200 ,.Ll. 
Methanol was used as the solvent for the preparation of sample extracts (section 4.2.4) which 
was the reason it was included in the control. Blank wells did not contain the toxin, the sample 
extract or the enzyme but instead were supplemented with the same volume of 10% methanol as 
in the control and additional Tris buffer to bring it to the final assay volume of 200 Ill. Samples 
were analysed in triplicate. 
The reaction was started by automatic injection of the reaction substrate in a fluorimeter 
(Fluostar BMGTM Reader, BMG Lab Technologies, Offenberg, Germany), which was pre-
warmed together with the assay mix at 37°C for 15 minutes. The substrate was added 
automatically after the first reading cycle. The incubation period for the enzyme reaction was 
approximately 1 hour at 37°C. The hydrolysis of MUMP was determined by the fluorescent 
detection on the automated microplate reader fluorimeter using real time kinetics (approximately 
60 cycles with 10 flashes in each cycle), with settings.for extinction at 355 nm and emission at 
460 nm. Activity was determined by linear regression of the reaction curves and expressed as 
units/min. 
3.3.2 Protocols for the immobilised PP-2A assay 
The immobilised PP-2A inhibition assay has been developed by (Mountfort et at., 
manuscript in preparation-a). The immobilised assay is based on the safile process as the PP-2A 
inhibition assay described in section 3.3.1. However, prior to conducting the assay, the enzyme 
was immobilised onto activated sepharose microbeads, instead of adding it to the assay as a 
liquid. The immobilised assay also had a different assay volume and assay components (see next 
section). The procedure utilises the specific binding between activated sepharose and protein 
phosphatase enzymes. The immobilised assay was carried out in Millipore Multiscreen™ 96-well 
microfilter plates, instead of the standard 96-multiwell plate. Thus, the enzyme-bead complex is 
retained in the micro filter well for re-use. 
Enzyme immobilisation procedure 
Freeze-dried activated CN-Br sepharose beads (100 mg) were washed 15 times in 
distilled water (1 ml) to remove additives. Washing was by inverted mixing and pulse 
centrifugation (2054 x g), and the supernatant was removed in between washes by pasteur 
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pipette. Protein phosphatase type 2A (100 /11 aliquots equivalent to 1 unit) was mixed with 1 ml 
of standard coupling buffer and added to 100 mg of washed beads. The enzyme-bead complex 
was spun overnight in microfuge tubes at 2-4°C on a rotating disc (approximately 60 rev/min). 
The enzyme was immobi1ised onto the beads for a minimum period of 20 hours. 
The enzyme-bead complex was washed with 1 ml of 50 mM Tris buffer to remove 
unimmobilised enzyme from the solution. Washing consisted of slow inverted mixing and pulse 
centrifugation (2054 x g). The process was repeated for a total of 2 washes with the supernatant 
removed in between washes by pasteur pipette. The enzyme-bead complex equivalent to 50 mg 
of beads was transferred to wells of a 96-well Multiscreen™ Filter Plate (Millipore, MA, USA) 
in approximately 350/11 of buffer. The microfilter plate was vacuum filtered using a vacuum 
manifold (Millipore, MA, USA) attached to an Air Cadet® vacuum pressure station (Bio1ab 
Scie~tific Ltd, USA) to remove the liquid from the enzyme-bead complex (Figure 3-2). Tris 
buffer (100 /11) was added to each well, which was filtered a second time. The plate was then 
ready for use in the assay or for storage. Storage of the micro filter plate, consisted of adding 
100 /11 of Tris buffer to each well and storing the plate at 2°C. 
Immobilised PP-2A inhibition assay 
Preliminary experiments with the immobilised PP-2A assay did not include the toxin or 
the sample extract in the assay system. Assay conditions for the imrriobi1ised system followed 
conditions as for the unimmobilised enzyme (section 3.3.1) except that undiluted PP-2A was 
added to the system. Bovine serum albumin was also excluded from the assay as the intention 
was to keep the immobilised system as .simp1e as possible for potential application as a 
biosensor. The immobilised assay system for PP-2A contained 0.5 units of PP-2A immobi1ised 
to 50 mg of beads (approximately 100/11 in volume), 25/11 of 50 mM Tris buffer (PH 7.0) and 
0.1 mM CaClz, 120 /11 of buffer containing substrate (0.42 mM MUMP) and 5 /11 of 40 mM of 
NiClz. The total volume for the immobilised system was 250/11 (150/11 liquid volume). This 
differed to the unimmobilised assay which had a liquid volume of 150 Ill. Thus, the immobilised 
assay was slightly more concentrated than the latter. Blank wells did not contain the enzyme or 
the sepharose beads but instead, were supplemented with 100 /11 of Tris buffer to make up the 
final assay volume to 250 /11. The reaction was measured using the same procedure as previously 
described in section 3.3.1. 
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Figure 3-2. A photo of the filtration system using the 96-well microfilter plate. Liquid is vacuumed filtered through 
the microfilter plate and is deposited in the conical flask . The immobilised enzyme-bead complex is retained in the 
microfilter plate for re-use (photo L. Allum). 
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3.4 Experiments for Optimisation Studies 
3.4.1 Optimisation experiments for PP-2A 
The immobilised PP-2A assay had previously undergone only limited preliminary testing. 
Thus, it was necessary to experiment with components in the immobilisation procedure and in 
the assay system, to determine if the activity of the enzyme could increase under different assay 
conditions. The following tests have been referred to as 'optimisation experiments' with the 
purpose of optimising conditions for the PP-2A assay. 
3.4.1.1 Optimal coupling buffer and stability of enzyme activity 
Changes were made to components in the coupling buffer, to determine if additional 
enzyme can be immobilised onto the microbeads. Protein phosphatase type 2A was immobilised 
by the standard immobilisation procedure (1 unit per 100 mg of beads) (section 3.3.2) in 8 
different coupling buffers, as shown in Table 3-1. The assay was run in duplicate for each 
coupling buffer according to the standard immobilised assay system for PP-2A (section 3.3.2). 
The degree of immobilisation would be reflected in enzyme activity measurements. Thus, the 
optimal coupling buffer would be the one that yields the highest enzyme activity (i.e. the test that 
exhibit the highest production of MUM). 
In conjunction with the coupling buffer optimisation test, the length of time the activity 
of the PP-2A enzyme would be stable was determined, by conducting the assay repeatedly up to 
1000 hours after immobilisation. This showed the trend in enzyme activity overtime, and 
revealed when the enzyme became stable and how long the enzyme was active in the 
immobilised system. Experiments with different assay conditions can only be performed on the 
immobilised enzyme once it becomes stable. 
3.4.1.2 Optimal assay pH 
Changes were made to the assay pH to determine if pH influenced enzyme activity. 
Protein phosphatase type 2A was immobilised by the standard immobilisation procedure (section 
3.3.2) using the optimal coupling buffer. The immobilised PP-2A assay was conducted in 
triplicate according to the standard assay protocols (section 3.3.2). The following pH 
combinations for PP-2A were tested 331 hours after immobilisation: 5.5, 6.5, 7.0, 7.5, 8.5 and 
distilled water (pH 5-6). The pH of Tris buffer in all assay components was adjusted prior to the 
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assay. In one test, replacing Tris buffer with distilled water, the substrate was diluted to the same 
concentration in distilled water, and water was added to the reaction mix in place of Tris buffer. 
Since the fluorimeter can inject only one substrate solution at one pH into each well in a variable 
pH test, 120 j..tl of substrate was added manually prior to incubation instead of being injected 
automatically after the first cycle by the fluorimeter. The optimal pH for the assay was 
determined by the system that produced the highest enzyme activity. 
Table 3-1: Layout of coupling buffer test for immobilised PP-2A 
Coupling buffer Coupling buffer combinations 
components 1 2 3 4 5 6 7 8 
Sodil.lm phosphate buffer 
(pH7t + + + + 
0.05 MKCl + + + + 
0.2 mM Ascorbic acid b + + + + 
50 mM Tris (PH 7) + + + + 
a 
see section 3.2.l for preparation of buffer 
b L-Ascorbic acid 2-phosphate sesquimagnesium salt (C6H90 9P) 
3.4.1.3 Optimal coupling buffer pH for immobilisation 
Cha.l1ges_ were made to the pH of the optimal coupling buffer (identified in section 
3.4.1.2) to determine if additional enzyme can be immobilised onto the microbeads by shifting 
the pH. Protein phosphatase type 2A was immobilised by the standard immobilisation procedure 
(section 3.3.2) using the optimal coupling buffer adjusted to pH 7.0 and pH 8.0. The assay was 
conducted in duplicate at optimal assay pH, according to the standard assay protocols (section 
3.3.2). The optimal coupling buffer was determined by the system that produced the highest 
enzyme activity. 
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3.4.1.4 Optimal assay cofactors 
Changes were made to cofactors in the assay to determine if enzyme activity could be 
enhanced when exposed to different assay components. Bovine serum albumin and NiCh were 
tested in the immobilised system by their addition or removal to the assay mix. Bovine serum 
albumin was tested at 5 ~l of 10 mg/ml stock. This was a higher concentration than that used in 
the unimmobilised enzyme assay (section 3.3.1), because elevated levels of BSA in the assay 
have been shown to lessen the confounding effects when testing environmental samples 
(Mountfort et ai., manuscript in preparation-b). Thus, a higher concentration of BSA was tested. 
Nickel chloride was tested at the standard concentration of 1.3 mM by adding 5 ~l of 40mM. 
Protein phosphatase type 2A was immobilised by the standard immobilisation procedure 
(section 3.3.2) using the optimal coupling buffer at optimal pH. Assay combinations were tested 
in duplicate according to standard assay protocols (3.3.2), approximately 200 hours after 
immobilisation as shown in Table 3-2, with additional'Tris buffer to supplement the volume to 
250 JLl as necessary. The optimal assay cofactor combinations were determined by the reaction 
mix that produced the highest enzyme activity. 
Table 3-2: Layout matrix for immobilised PP-2A cofactor test 
Cofactor 
BSA 
NiCh 
1 
+ 
+ 
Cofactor combinations 
2 3 
+ 
+ 
3.4.1.5 Recovery of enzyme activity in immobilising procedures 
4 
Although 0.5 U of PP-2A are immobilised onto 50 mg of microbeads during the 
immobilisation procedure, not all the enzyme binds to the sepharose beads during this process. 
Preliminary studies (Mountfort et ai., manuscript in preparation-a) have shown that 
approximately 2% of PP-2A is retained in the system once the enzyme has reached stability. To 
validate these preliminary findings, the proportion of enzyme immobilised onto the microbe ads 
43 
during the immobilisation procedure (i.e. recovery of enzyme) was determined by comparing the 
activity of the immobilised enzyme with the activity of unimmobilised enzyme, using a known 
I 
amount of enzyme added to both systems. To ensure that both the unimmobilised and 
immobilised systems had the same assay conditions, both assays were conducted at pH 8, 
without BSA, and contained a liquid assay volume of 150 I.d. The immobilised and 
unimmobilised PP-2A assays were conducted according to standard assay protocols (section 
3.3.2 and 3.3.1, respectively), with the exception of those changes above. 
3.4.2 Optimisation experiments for unimmobilised R.PP-1 
The commercial availability of R.PP-1 (Zhang, 1994) allowed investigations of the 
suitability of this enzyme for toxin detection in this laboratory for the fIrst time. Initial 
optirrp.sation experiments for R.PP-1 were carried out with the unimmobilised enzyme to reduce 
the cost and time for analysis. 
The R.PP-1 enzyme was supplied in a 200 jll volume, consisting of 500 Units (0.4 U per 
jll, as opposed to PP-2A which consisted of 0.01 U per jll). Thus, for the unimmobilised assay, 
RPP-1 was diluted 1: 50 with buffer (in comparison to a 1:4 dilution for PP-2A) and 10 jll of the 
diluted enzyme (0.5 U) was added to the assay mix. All optimisation experiments for 
unimmobilised RPP-1 followed similar assay conditions as the unimmobilised PP-2A assay 
(section 3.3.1). However all optimisation experiments were carried oufwithout toxinor sample 
extract in the reaction mix. Bovine serum albumin was added to the assay at a higher 
concentration (5 jll of 10 mg/mI, instead of 1 mg/mI) for the same reason as discussed in section 
3.4.1.4. 
The unimmobilised assay system for RPP-1 contained 60 jll of Tris buffer (PH 7.5), 
10 J.tl of diluted R.PP-1 (0.5 U, 10 jll R.PP-1 diluted to 500 jll in Tris buffer, pH 7.5), 120 J.tl of 
buffer containing substrate (0.42 mM MUP), 5 J.tl of 40 mM of NiCh, and 5 J.tl of 10 mg/ml 
BSA. All assays were carried out in a fInal assay volume of 200 J.tl. The assay was conducted at 
pH 7.5 as this was the assay pH used by the suppliers of the enzyme. All unimmobilised RPP-1 
enzyme tests were conducted based on this assay system unless otherwise stated. 
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3.4.2.1 Optimal storage, temperature and pH conditions 
Storage conditions and assay buffer 
Recombinant PP-1 was supplied with a storage and reaction buffer which was tested 
against the Tris buffer used for PP-2A, to determine a suitable storage and assay buffer. Storage 
conditions for RPP-1 included: 
1) RPP-1 diluted with with reaction buffer (1:2.5), and stored at -20°C for approximately 
48 hours 
2) RPP-1 stored undiluted at -20°C for approximately 48 hours 
3) R.PP-1 stored undiluted at -70°C for approximately 48 hours 
The unimmobilised PPINAs were carried out in triplicate with the R.PP-1 enzyme stored as 
above (three storage conditions) in a) Tris buffer, and b) reaction buffer, according to the assay 
system previously described (section 3.4.2). The amount of diluted enzyme added to the assay 
was corrected so that the same concentration of enzyme was tested across the three treatments. 
Temperature and pH 
Assay tests experimenting with different temperature and pH conditions were conducted 
to determine if the enzyme activity could be increased under different temperature and pH 
conditions. To test the effect of temperature and pH, the unimmobilised RPP-l assay was 
carried out with the optimal reaction buffer, according to the procedure described in section 
3.4.2, at 30°C and 37 °C, at pH 7.0, 7.5 and 8.0. All components of the assay were adjusted to 
the respective pHs. The assay was conducted with R.PP-l stored under optimal conditions. 
Optimal temperature and pH conditions were determined by the reaction mix that produced the 
highest enzyme activity. 
3.4.2.2 Optimal assay cofactors 
Assay cofactors 
To test the influence of assay co factors on protein phosphatase activity, changes were 
made to the reaction mix to test the removal effect of BSA (5 pJ of 10 mg/ml) or NiCh (5 III of 
40 mM) from the system. The assay was carried out in triplicate with a) Tris buffer, and b) 
reaction buffer, as previously described in section 3.4.2. Both of these buffers were tested to 
determine if the performance of the assay could be increased by altering components in the 
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assay. The layout of the reaction matrix is shown in Table 3-3. All other assay components 
remained unchanged. The optimal assay cofactors were determined by the reaction mix that 
produced the highest enzyme activity. 
Table 3-3: Layout of matrix for unimmobilised R.PP-l cofactor test 
Cofactor 
BSA 
NiCh 
Metal co/actors 
1 
+ 
+ 
2 
+ 
Cofactor combinations 
3 
+ 
4 
Recombinant PP-l was supplied with 10 mM of manganese chloride (MnCh) as 
according to the suppliers' data sheet for R.PP-l (product P0754L), enzyme activity is MnCh 
dependant. To test the dependence of R.PP-l on MnCh, phosphatase activity was tested with or 
without BSA (5,u1 of 10 mg/ml) as shown in Table 3-4. In conjunction, another assay system 
was also tested substituting MnCh with NiCh, so that the enzyme activity in both assay systems, 
(i.e. with either MnCh or NiCh) could be compared with or without BSA. The assays were 
carried out simultaneously in Tris buffer (PH 8) according to the protocol previously described 
(in section 3.4.2) with the exception of changes made to the reaction mix as stated above. The 
optimal metal cofactors were determined by the reaction mix that produced the highest enzyme 
activity. 
Optimal BSA concentration 
The optimal concentration of BSA for the R.PP-l assay was determined by testing BSA 
at several concentrations, ranging from 0.1- 30.1 JlM (volumes ranged from 2 ,ul of 0.5 mg/ml to 
20,u1 of 15 mg/ml). The assay system was carried out in triplicate in Tris buffer (pH 8) as 
previously described (section 3.4.2) with the optimal metal cofactor. 
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Optimal MnCl2 concentration 
The optimal concentration of MnCh for the RPP-l assay was tested at several 
concentrations ranging from 0.06-4.0 mM (volumes ranged from 5/.d of 1 mM to 15 f.tl of 
40 mM). Two other assay conditions were also tested concurrently, one which substituted MnCh 
with 5 f.tl of 40 mM NiCh (1.3 mM), and the other without metal addition. The assay was carried 
out in duplicate under the three assay conditions as previously described (section 3.4.2) in Tris 
buffer (PH 8) with the optimal concentration of BSA. 
Table 3-4: Layout of matrix for unimmobilised R.PP-lmetal cofactors 
Cofactor Cofactor combinations 
Metal chloridea 
BSA 
Ni 
+ 
1 2 
Mn 
+ 
Ni 
aTwo tests were conducted simultaneously using a) NiCh and b) MnCh 
3.4.3 Optimisation experiments for immobilised R.PP-1 
Mn 
The optimal conditions for the unimmobilised RPP-l assay, dit-ermined in section 3.4.2, 
were applied to the immobilised assay procedure as a starting system to optimise the 
experimental conditions for the immobilised RPP-l assay. Optimisation experiments for the 
immobilisec!. RPP-l enzyme followed the optimisation tests conducted for the immobilised 
PP-2A enzyme (described in section 3.4.1). Recombinant PP-l was immobilised using the same 
immobilisation procedure for PP-2A (section 3.3.2), with the optimal RPP-l concentration for 
immobilisation detennined as in section 3.4.3.1. 
The immobilised assay system for RPP-l contained 25 f.tl of Tris buffer (pH 8.0), 120 f.tl 
of buffer containing substrate (0.334 mM MUMP), 5 f.tl of 40 mM of MnCh, and 100 Jll of the 
enzyme-bead complex. All immobilised RPP-l tests were conducted based on this assay system 
unless otherwise stated. The total volume for the immobilised system contained 250 f.tl (150 f.tl 
liquid volume) and the assays were conducted without BSA for the same reasons as for the 
immobilised PP-2A (to keep the system as simple as possible). Blank wells did not contain the 
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enzyme or sepharose beads but instead were supplemented with 100 pJ of Tris buffer to make up 
the final assay volume to 250 pJ. Optimisation experiments did not involve the addition of the 
sample extract or the toxin standard. All experiments were carried out in duplicate. 
3.4.3.1 Optimal enzyme concentration for immobilisation 
The concentration of RPP-l required to give adequate phosphatase activity in the 
immobi1ised system was· tested at several concentrations. The immobi1isation procedure was 
carried out as previously described (section 3.3.2) with the following concentrations of undiluted 
RPP-1 (stored at -70°C) immobilised onto 100 mg of beads: 10 Units (4 Ill), 25 Units (10 Ill), 
and 62.5 Units (20 Ill). The immobilised assay procedure was carried out for RPP-1 (section 
3.4.3) with NiCh replacing MnCh, as this test was initiated before it was discovered that MnCh 
was ~ better cofactor than NiClz, The optimal enzyme concentration will be selected as the 
system that produced the highest activity with minimal enzyme input. 
3.4.3.2 Optimal coupling buffer and stability of enzyme activity 
Recombinant PP-1 was immobi1ised by the standard immobilisation procedure (3.3.2) 
with the optimal concentration of the enzyme in 8 different coupling buffers, as shown in Table 
3-1. The assay was carried out according to the assay system described previously (section 
3.4.3). The optimal coupling buffer and stability of enzyme activity was determined as 
previously described for PP-2A (section 3.4.1.1) up to 600 hours after immobilisation. 
3.4.3.3 Optimal assay pH 
Changes- were made to the assay pH to determine if pH influenced enzyme activity in the 
immobilised system. Recombinant PP-l was immobi1ised by the standard immobilisation 
procedure (3.3.2) with the optimal coupling buffer at pH 7. Optimal assay pH for RPP-1 was 
tested 195 hours after immobilisation (i.e. when the enzyme reached stability) at pH 7 and 8, 
according to the assay system described previously (section 3.4.3), but with changes made to the 
assay pH. The Tris buffer in all assay components were adjusted for pH and the substrate 
delivery system changed to manual addition (see section 3.4.1.2) to accommodate variable pH in 
a single experiment. The optimal assay pH was determined as previously described for PP-2A 
(section 3.4.1.2). 
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3.4.3.4 Optimal coupling buffer pH 
Recombinant PP-l was immobilised by the standard immobilisation procedure (3.3.2) 
with the optimal coupling buffer adjusted to pH 7 or 8. The assay was conducted in duplicate 
according to the assay system described previously (section 3.4.3). The optimal coupling buffer 
pH was tested at 195 hours after immobilisation (i.e. when the enzyme reached stability) at assay 
pH 8. The optimal coupling buffer pH was chosen as the system that produced the highest 
enzyme activity. 
3.4.3.5 Optimal assay co factors 
Recombinant PP-l was immobilised by the standard immobilisation procedure (3.3.2) 
using the optimal coupling buffer at optimal pH. Changes were made to assay cofactors in the in 
the immobilised R.PP-l system to test the addition or removal effect of BSA or MnCh on 
phosphatase activity. Bovine serum albumin was tested at the optimal concentration range of 
BSA in the unimmobilised RPP-l assay. Magnesium chloride was tested at the standard 
concentration of 1.3 mM (5 III of 40 mM). The RPP-l assay was conducted in duplicate 
according to the assay system described previously (3.4.3) with changes made to assay cofactors. 
Assay combinations were tested approximately 200 hours after immobilisation (i.e. when the 
enzyme reached stability) as shown in Table 3-2 (replacing NiCh with MnCh). 
3.4.3.6 Recovery of enzyme activity in immobilising procedures 
The proportion of enzyme immobilised onto the microbeads during the immobilisation 
procedure (i.e. recovery of enzyme, section 3.4.1.5), was determined by comparing stable 
immobilised enzyme activity with unimmobilised enzyme activity, using a known amount of 
enzyme added to both systems. To ensure that both the unimmobilised and immobilised systems 
had the same assay conditions, both assays were conducted at pH 8 with MnCh (5 Jl.I of 40 mM), 
and contained a liquid assay volume of 150 Ill. The only exception was that BSA (5 III of 
10 mg/ml) was added to the unimmobilised assay only (as BSA was required for adequate 
enzyme activity in this system). The immobilised and unimmobilised R.PP-l enzyme assays 
were conducted according to standard assay protocols (section 3.4.3 and 3.4.2, respectively), 
with the exception of those changes above. The recovery of RPP-l in the immobilised system 
was compared to the recovery values for immobilised PP-2A. 
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3.4.4. Statistical analysis 
Statistical analysis for all data was performed using 'R' software version 1.7.0. All 
optimisation experiments were analysed using ANOV A. Statistical analysis was only performed 
on enzymes when activity had become stable. When mean effects and interactions were 
significant, these were further explored using Fischers' s least significant difference test. Tukey's 
honestly significant difference test was performed on data when multiple levels of a factor were 
compared (i.e. pH test for PP-2A). Linear regression was also performed on the pH test for 
PP-2A. 
Only a limited number of data points were used for each test (some more than others), as 
the procedure was costly and subsequently, replication was limited. Therefore, in some cases the 
assumptions are probably not fulfilled (due to the lack of data points, departures from normality 
and heterogeneity of variances could not be adequately assessed). Thus, more weight was 
assigned to trends which showed differences in enzyme activity between treatments. Where 
outliers were evident, the data could not be eliminated due to lack of data points. All the data was 
well balanced and replicated equally. Any data that showed large deviation from normality were 
logged transformed prior to analyses to normalise variances. 
3.5 Optimisation Results 
The results have been set out so that the optimisation experiments for each immobilised 
enzyme, PP-2A and R.PP-l, are displayed simultaneously. Although it does not follow the layout 
of the rnethQds, it provides a more suitable structure in which to compare the activities of the two 
different immobilised enzymes. The optimisation experiments for the unimmobilised R.PP-l will 
be displayed first, in the order that the experiments were conducted. This will be followed by the 
results for the optimisation experiments in the order that the experiments were conducted for 
both ofthe immobilised enzymes. 
3.5.1 Optimisation experiments for unimmobilised R.PP-1 
3.5.1.1 Optimal storage conditions and optimal assay buffer, temperature and pH 
Table 3-5 shows the rate of reaction of R.PP-l utilising MUMP with different assay and 
storage buffers, and different storage methods. The data suggests that both the buffer and storage 
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conditions had an effect on enzyme activity, which was confirmed by a significant interaction 
detected between enzyme buffer and storage conditions (p<O.05). 
Table 3-5: Comparison of unimmobilised R.PP-l reaction rates utilising different assay and 
storage conditions (PH 7.5). 
Assay and storage 
buffera 
Storage methodb RateC (nmol/ml/min) 
Tris Bufferl 
Supplied Reaction 
Bufferd2 
a pH 7.S 
dilutecf stored at 
undiluted stored at 
undiluted stored at 
-70oe 
dilutecf stored at 
undiluted stored at 
undiluted stored at 
b The approximate duration of storage for all enzymes was less than 48 hours 
C Values are means of triplicate determinations (subtracted from the blank) 
d Blank 0.063 nmol/mllmin which is the mean of triplicate determinations 
· 0.111 ±0.032 
1\ 
0.597±0.040 
1\ 
0.671±0.006 
· 0.040±0.009 
· 0.033±0.004 
· 0.032±0.012 
e Enzyme dilution 1 :2.S, enzyme:buffer. The concentration of the enzyme in the diluted test was the same as the 
enzyme concentration in the undiluted tests (O.S U per assay) 
*A For the Tris buffer and the supplied reaction buffer the means within each column followed by different symbols 
are significantly different (p<O.OS) 
1.2 The rate of the reaction between the Tris buffer and the supplied reaction buffer is significantly different (p<O.OS) 
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Figure 3-3, shows that the reaction rate (mean of enzyme activity) for the diluted enzyme 
(dotted line) is substantially lower compared to the rates for the undiluted enzymes (undiluted 
high and undiluted low) in a Tris storage buffer. The graph also reveals that enzyme activity is 
largely affected by assay buffer, with enzyme activity noticeably higher in a Tris buffer than in 
the supplied reaction buffer. The highest enzyme activity was with the undiluted enzyme stored 
at -70D C in the Tris assay buffer. Therefore, optimal storage conditions for R.PP-l was stored 
undiluted at -70°C, and Tris buffer was selected as the optimal assay buffer. 
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Figure 3-3. Interaction plot showing the influence of storage buffer and enzyme storage conditions on R.PP-l 
activity. Enzyme activity is on the y-axis (units/min). Undiluted high, refers to enzyme stored undiluted at -70DC. 
Undiluted low, refers to enzyme stored undiluted at _20DC. Diluted, refers to the enzyme stored diluted with buffer at 
_20DC. The concentration of enzyme was the same for both the diluted and undiluted tests (0.5 U per assay). The 
duration of storage for all enzymes was less than 48 hours. The encircled areas indicate that enzyme activity is 
highest in Tris Buffer (as opposed to enzyme activity in the Supplied Buffer), and that enzyme activity in Tris buffer 
is affected by storage conditions. 
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Although the supplied reaction buffer was adequate as a storage buffer (there was 
virtually no difference in enzyme activity between storage methods for the supplied reaction 
buffer), the supplied reaction buffer was not suitable for use in the assay system proposed here. 
This was because certain components in the supplied reaction buffer were binding with the 
substrate in the assay, as the blank: wells that contained no enzyme, were producing fluorescent 
products. 
Table 3-6 shows the reaction of R.PP-l utilising MUMP as a function of assay pH and 
temperature. A large significant difference was detected between assay pH (p<0.05) and assay 
temperature (p<0.05). The data was log transformed to normalise variances. This was consistent 
with the observed trend that showed optimal activity was obtained at a temperature of 37°C and 
at an assay pH of 8.0 (Figure 3-4). 
Table 3-6: Comparison ofR.PP-l reaction rates (nmoUmlImin) utilising different 
temperature and assay pHs. 
pH 
7.0* 
7.5" 
8.0# 
0.034±0.0100 
0.388±0.028c 
0.614±0.015d 
a Values are m~ans of duplicate determinations. 
Temperaturea 
O. ff3±0.033° 
0.525±0.020c 
1.328±0.086d 
bed For the temperature test, the means within each column followed by different symbols are significantly different 
(p<O.05) 
M# The mean reaction rates for the pH test are all significantly different (p<O.05) 
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Figure 3-4. Boxplot ofR.PP-l activity (log transfonned) against temperature (left, median and variance 0.388 and 
0.29 mpollml/min, respectively) and pH (right, median and variance 0.53and 0.62 nmol/ml/min, respectively). 
Enzyme activity is on the y-axis (units/min). The boxplots indicate that RPP-l enzyme exhibits highest activity at a 
higher temperature (37°C) and a higher pH (pH 8). See Table 3-6 for 
3.5.1.2 Optimal assay cofactors 
Table 3-7 shows the reaction rate for unimmobilised R.PP-1 utilising MUMP with 
different assay buffers, and different assay cofactors. The data showed that the reaction rate 
using the supplied reaction buffer did not substantially change in response to the different assay 
cofactors and the activity remained low for all cofactor combinations, due to high activity in the 
blank wells (see section 3.5.1.1). Consequently, experiments with the supplied reaction buffer 
-_. -~ 
were concluded. In contrast, the reaction rate for RPP-1 using Tris buffer increased in response 
to the assay cofactors. A significant difference was detected between co factors treatments in the 
Tris Buffer (p<O.05). The highest enzyme activities were evident when BSA was incorporated in 
the reaction mix. However, a significant difference was not detected between BSA which had the 
highest activity, and NiCh and BSA (second highest) when analysed using Tukey's HSD test. 
Thus, for the purpose of keeping NiCh in the assay, the most optimal assay cofactors selected for 
RPP-1 in a Tris buffer was with BSA and NiCh. 
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Table 3-7: Comparison ofR.PP-l reaction rates (nmol/ml/min) using different assay 
cofactors and assay buffers. 
Assay Buffer Assay Cofactorsa 
BSA & NiCl2 BSA NiCl2 None 
Supplied 0.011±0.047D 0.00±0.055D 0.009±0.037D 0.014±0.028D 
reaction buffer 
Tris buffer 0.181±O.055c 0.256±0.041 c 0.110±0.018d 0.014±0.013e 
a Values are means of triplicate detenninations. 
bede The means within each row followed by different symbols are significantly different (p<O.05) 
Table 3-8 shows the reaction rate between R.PP-l and MUMP utilising different metal 
cofactors. The data suggests that both BSA and metal chloride had an effect on enzyme activity, 
which was confirmed by a significant interaction detected between BSA and metal chloride 
treatments (p<O.05). Figure 3-6 shows that the enzyme activity is significantly higher with 
MnCh than with NiCh in the presence of BSA in the reaction mix. Hence, the most optimal 
assay cofactors selected for R.PP-l was with BSA and MnCh. 
Table 3-8: Comparison of R.PP-l reaction rates using different assay cofactors in Tris. 
Metalsa Activity (nmollml/min)b 
Without BSA With BSAc 
MnCh 
NiCh 
0.124±0.010d 
0.076±0.030f 
a Concentration of metals was at 5 /-ll of 40mM (l.3mM) 
b Values are means of duplicate detenninations 
C Concentration of BSA was at 5 /-l! of 10 mg/m! 
0.582±0.013e 
0.264±0.0429 
defg The means within each column and row followed by different symbols are all significantly different (p<O.05) 
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Figure 3-5. Interaction plot showing the influence of metal chloride and BSA on R.PP-l activity. Enzyme activity is 
on the y-axis (units/min). BSA 1, refers to the assay with BSA (solid line). BSA 0, refers to the assay without BSA 
(dotted line). The concentration ofBSA was at 5 !AI of 10 mg/m1. The concentration ofMnCh and NiCh was at 5 !AI 
of 40mM (l.3mM). The encircled areas indicate that the R.PP-l enzyme exhibits higher activity in the presence of 
MnCh, rather than NiC12, and that activity is higher when BSA is the assay. 
Table 3-9 and Table 3-10 show the reaction rate for R.PP-1 utilising MUMP as a function 
of BSA and MnCh concentration, respectively. The data on BSA and R.PP-1 revealed a 
parabolic relationship (Figure 3-7a) with an optimal concentration of BSA in the assay in the 
range of 100-300 Ilg/ml. Similar results were shown with MnCh as the reaction rate of R.PP-1 
was proportional to MnCh concentration with near maximum activity at 1.3 mM 
(5 ).ll of 40 mM) (Figure 3-7b). The table and graph also show that the concentration range of 
MnCh is near the optimum. In contrast to the results shown in Table 3-7, where R.PP-1 activity 
was higher with BSA and without NiCh, the results in Table 3-10 show that R.PP-1 activity is 
higher with BSA and MnCh at all concentrations of the metal. This further verifys the 
importance of MnCh for the R.PP-1 enzyme. Thus, the optimal assay co factors for 
unimmobilised R.PP-1 are with BSA (5 ).ll of 5 mg/ml) and MnCh (5 III of 40 mM). 
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Table 3-9: Comparison of R.PP-l reaction rates using different concentrations of BSA. 
BSA BSA Activity (nmol/ml/min)a 
[amount per assay (ng)] (volume added to assay) 
0 0 0.222±0.070 
1.0 2 ~l of 0.5 mg/ml 0.883±0.002 
2.5 5 ~l of 0.5 mg/ml 1.044±0.093 
5.0 5 ~l of 1 mg/ml 1.095±0.080 
25.0 5 ~l of 5 mg/ml 1.229±0.037 
50.0 5 ~l of 10 mg/ml 1. 199±0.073 
150.0 10 ~l of 15 mg/ml 1.010±0.026 
300.0 20 ~l of 15 mg/ml 0.825±0.027 
a Values are means of duplicate determinations. 
Table 3-10: Comparison ofR.PP-l reaction rates using different concentrations of MnCh 
in Tris buffer. 
Metals (mM) Molarity in assay (J,tM) Activitya(Q.Jllollml/min) 
MuCh 0.06 0.572±0.034 
0.6 0.785±0.069 
1.3 0.863±0.044 
2.6 0.911±0.070 
4 0.921±0.048 
NiCh 1.3 0.409±0.026 
No Metals 0 0.314±0.022 
a Values are means of duplicate determinations. 
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3.5.2 Optimisation experiments for immobilised enzyme 
3.5.2.1 Optimal R.PP-1 concentration for immobilisation 
Figure 3-7 shows the reaction rate of immobilised RPP-l with different enzyme 
concentrations as a function of time. The data revealed that there was a significant difference in 
activity between the three enzyme concentrations (p<O.OS). However, a significant difference 
was not detected between the two higher enzyme concentrations (p>O.OS). Thus, the optimal 
RPP-l concentration required to produce adequate activity overtime, with minimal enzyme 
input, was 12.S Units per SO mg of sepharose beads (? value, 0.89S9). This concentration of 
enzyme (12.S Units) was equivalent to adding 10 JlI of undiluted RPP-1 to 100 mg of sepharose 
beads. 
3.5.2:2 Optimal coupling buffer and stability of enzyme activity 
Figure 3-8 shows the reaction rate of immobilised (a) PP-2A and (b) RPP-1, as a 
function of time utilising different coupling buffers during the immobilisation procedure (section 
3.3.2). The results for PP-2A (Figure 3-8a) indicate that there was a large significant difference 
in enzyme activity between the two coupling buffers (p<O.OS). The sodium phosphate buffers 
consistently produced a higher reaction rate in the immobilised PP-2A assays. Within the two 
buffer groups, there were no significant differences detected between-buffers with or without 
KCI and/or ascorbic acid (p>O.OS), which was consistent with the trend detected. Thus, the 
optimal coupling buffer for PP-2A was chosen as the original coupling buffer for which this 
procedure was initially designed, which was the sodium phosphate buffer with O.OS M KCl and 
0.2 mM ascorbic acid. 
The results for R.PP-1 (Figure 3-8b) showed a similar result to that of PP-2A. A large 
significant difference in RPP-1 activity was detected between the two coupling buffers (p<O.OS), 
with the sodium phosphate buffer consistently producing a higher reaction rate. There were also 
no significant differences detected between buffers with or without KCI, and/or ascorbic acid 
(p>O.OS), which was consistent with the trend detected. Hence, the sodium phosphate buffer with 
O.OS M KCl and 0.2 mM ascorbic acid, was chosen as the optimal coupling buffer for the RPP-l 
enzyme. 
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Figure 3-7. Reaction rate for immobilised R.PP-l utilising different enzyme concentrations at various time intervals 
after immobilisation. Symbols: tl, 31.25; ., 12.5; X, 5 Units of enzyme per 50 mg of beads. R.PP-l was 
immobilised by the standard procedure with activity determined under standard assay conditions for determination 
at 37°C at pH 8.0. Each value represents the mean of duplicate determinations ± standard deviation. 
Figure 3-8 also revealed that PP-2A and R.PP-l were relatively stable overtime. 
Preliminary tests (Mountfort et at., manuscript in preparation-a) have shown that an 
immobilisation system has high enzyme activity initially, which declines around 150-200 hours 
after immobilisation and eventually levels off (i.e. activity becomes stable). Both enzymes were 
stable around 200 hours after immobilisation and remained as such for the full length of the 
experiments (i.e. 600 hours for R.PP-l and 1000 hours for PP-2A). Thus, these results are 
consistent with preliminary findings. There were slight fluctuations in enzyme activity overtime 
with PP-2A. Natural fluctuations in enzyme activity have been shown in preliminary tests, 
particularly where there have been incomplete evacuations in washing the enzyme-bead complex 
from the previous run (Mountfort et at., manuscript in preparation-a). 
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3.5.2.3 Optimal assay pH 
Figure 3-9 shows the reaction rate of PP-2A as a function of time at different assay pHs. 
The results showed a trend between an increase in pH and an increase in enzyme activity over 
time (i 0.9869). A significant difference was detected at all assay pH combinations, excluding 
assay pH S.S and 6.S using Tukey HSD. Maximum enzyme activity was achieved at a pH of 8.S, 
which consistently produced higher enzyme activity overtime (0.6 nmol MUM/ml/min) (Figure 
3-10). The pH test was primarily designed to see if the assay could run at pH 8.0, which is 
compatible with the pH of seawater (the assay has already been shown to be compatible with the 
pH of freshwater which is roughly around pH 7). Thus, an assay pH of 8 was chosen as the 
optimal assay pH for immobilised PP-2A. 
Water was not included in the statistical analyses as it was not the intention of the design. 
Water was only included in the study to determine how the system could hold its pH, if for 
example, a 1 ml volume of lake water was added to the' system to test for Mes. Enzyme activity 
in the wells containing water were maintained at a high level but fluctuated over time. This was 
not surprising as water has a poor buffering capacity. Further tests with water will be required if 
a large volume of either, sea or fresh water, is intended for the system. 
Figure 3 -11 shows the reaction rate of R.PP -1 as a function of time at different assay pHs. 
The results showed that an assay pH of 8 produced significantly higher activity than in an assay 
pH of 7 (p<O.OS). Thus, an assay pH of 8 was chosen as the optimal assay pH for immobilised 
R.PP-l. 
3.5.2.4 Optimal coupling buffer pH 
Figure 3-12 shows the reaction rate of PP-2A as a function of time using the standard 
coupling buffer at pHs 7.0 and 8.0. The data for PP-2A revealed that the reaction rate between 
coupling buffer pH 7.0 and 8.0 was not statistically different (p>O.OS), which was consistent with 
the trend observed. Therefore, the optimal coupling buffer for PP-2A remained as pH 7.0. 
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Figure 3-8. Reaction rate for immobilised PP-2A (a) and R.PP-I (b) utilising different coupling buffers at various 
time intervals after immobilisation. Symbols donate coupling buffer composition: . , Na phosphate buffer, KCI and 
ascorbate; ... , Na phosphate buffer and KCI; ., Na phosphate buffer and ascorbate; , Na phosphate; e ; Tris, KCI 
and ascorbate; /l., Tris and KCI; 0, Tris and ascorbate; D, Tris. PP-2A and R.PP-I were immobilised by the standard 
procedure (1 U112.5 U respectively per 100mg of beads) in 8 coupling buffers with activity determined under 
standard conditions for determination at 37°C at pH 7.0 for PP-2A, and pH 8.0 for R.PP-I. Each value represents the 
mean of duplicate determinations ± standard deviation . 
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Figure 3-9. Reaction kinetics for immobilised PP-2A using a different assay pH. Assay pH was tested as indicated 
by the arrow at 331 hours after immobilisation. Symbols denote pH values: .,5.5; . , 6.5; . , 7.0; 0 , 7.5; 0 , 8.5; 
- , water (pH 5-6). PP-2A was immobilised by the standard procedure (I Unit per 100mg of beads) in coupling 
buffer pH 7.0, with activity determined under standard conditions for determination of PP-2A at 37°C. Each value 
represents the mean of duplicate determinations ± standard deviation. 
Figure 3-13 shows the reaction rate of R.PP-1 as a function of time using the standard 
coupling buffer at pHs 7.0 and 8.0. Coupling buffer was tested at approximately 195 hours after 
immobilisation (as indicated by the arrow on Figure 3-13), enzyme immobilised with a coupling 
buffer pH of 8.0, showed statistically higher activity than enzyme immobilised with a coupling 
buffer of pH 7.0 (p<0.05). Thus, for the R.PP-l enzyme, a pH of 8.0 was selected as the optimal 
coupling buffer pH. 
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Figure 3-10. The mean reaction rate for immobilised PP-2A showing the influence of assay pH on phosphatase 
activity. Each value represents the mean of eight duplicate readings taken between 283 to 648 hours after 
immobilisation ± standard deviation. 
3.5.2.5 Optimal assay cofactors 
Figure 3-14 shows the reaction rate of PP-2A (a) and R.PP-1 (b) as a function of time 
utilising different assay cofactors. Protein phosphatase type 2A was tested with NiCh, while 
R.PP-1 was tested with MnCh. The results for PP-2A revealed that a large significant difference 
was detected between NiCh and the other cofactor treatments (p<O.05). The results for R.PP-l 
revealed that a large significant difference was detected for MnCh only (p<O.05) which is 
consistent with the trend. The trend for both enzymes shows that the reaction rate was higher for 
the immobilised system containing metal chloride only. Thus, the optimal conditions for the 
immobilised system were selected as NiCh and MnCh, for PP-2A and R.PP-l, respectively. 
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Figure 3-11. Reaction rate for immobilised R.PP-l utilising different assay pHs at various time intervals after 
immobilisation. Assay pH was tested at 195 hours after immobilisation as indicated by the arrow. Symbols denote 
pH values in assay buffer: A, 7.0; D, 8.0. The same enzyme system was tested independently with two assay pHs, 
which is why the values are not aligned. R.PP-I was immobilised by the standard procedure (25 Units per 100mg of 
beads) in coupling buffer pH 7.0 with activity determined under standard conditions .f<?r determination of R.PP-I at 
37°C. Each value represents the mean of duplicate determinations ± standard deviation. 
3.5.3 Recovery of the enzymes in immobilising procedures 
Table 3-11 shows the proportion of PP-2A and R.PP-1 immobilised onto the microbeads 
during the immobilisation procedure. Recombinant PP-1 had better recovery than PP-2A, as a 
higher percentage of the R.PP-1 enzyme was recovered during the immobilisation procedure, in 
comparison to recovery values for the PP-2A enzyme. Both enzymes however, showed higher 
recovery percentages to preliminary studies (around 2% recovery)(Mountfort et al., manuscript 
in preparation-a), which suggests that the optimisation tests have been effective. 
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Figure 3-13. Reaction rate for immobilised R.PP-l utilising a different coupling buffer pH at various time intervals 
after immobilisation. Symbols denote pH values: ., 7.0; D, 8.0 for coupling buffer pH. R.PPl activity was 
determined under standard assay conditions at assay pH 8. Optimal coupling buffer was tested 195 hours after 
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Figure 3-14. Reaction kinetics for immobilised PP-2A (a) and R.PP-I (b) with different assay cofactors. Symbols 
represent assay cofactors: . , NiCh or MnCh and BSA; . , BSA; . , NiCI2 or MnCI2; . , No metals or BSA. Assay 
combinations were tested as indicated by the arrow approximately 200 hours after immobilisation. PP-2A was tested 
with 1.3 mM NiCI2 and 5 J.tl of 10 mglml of BSA. R.PP-I was tested with 1.3 mM MnCI2 and 5 J.tl of 5 mglml of 
BSA. Both enzymes were immobilised by the standard procedure with activity determined under standard assay 
conditions for determination at 37°C. Each value represents the mean of duplicate determinations ± standard 
deviation. 
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Table 3-11: The recovery of enzyme immobilised on microbeads. 
Enzyme Activity of enzyme Activity of enzyme equivalent to % Recovery 
(nmollmllmin) that added to 100 mg beads of 
immobilised 
Immobilised Unimmobilised Immobilised Unimmobilised 
enzyme a enzyme b enzyme C enzyme d 
enzyme 
PP_2Ae O.45±O.O5 O.63±O.O2 O.99±O.10 31.65±l.O5 3.15 
RPP_lf 1.52±O.O6 1.55±O.O5 3.03±O.12 77.45±2.55 3.91 
a observed activity of immobilised enzyme in the standard immobilised system (0.5 and 12.5 Units per 50 mg of 
beads tor PP-2A and R.PP-l, respectively). 
b observed activity for unimmobilised enzyme (0.02 and 0.5 Units for PP-2A and R.PP-l, respectively) (10ul diluted 
in 500ul of buffer). 
C and d amended activities assuming enzyme equivalent to 500 III of enzyme added to100 mg of beads (equivalent to 
1 and 25 U ofPP-2A and R.PP-l, respectively, which is the amount of enzyme used for immobilisation). 
e activity was determined under optimised conditions for unimmobilised and immobilised PP-2A (section 3.4.1.5). 
Assay cofactors included 1.3 mM NiCh in an assay pH of 8 and coupling buffer pH 7.0. 
f activity was determined under optimised conditions for unimmobilised and immobilised R.PP-l (section 3.4.3.6). 
Assay cofactors included 1.3 mM MnCh in an assay pH of 8 and a coupling buffer of pH 8.0. BSA 
(5 {tl of 5 mg/ml) was added to the unimmobilised test only. 
3.6 Discussion 
The objective of the optimisation experiments was to develop the microfilter-plate 
technique to obtain the highest activity possible for the immobilised PP-2A and RPP-l enzymes, 
while keeping the system as simple as possible. The intent of this objective was fulfilled for both 
enzymes. A suitable system for the immobilised PP-2A and RPP-l enzyme was developed that 
can maintain good enzyme activity over a long period of time. High enzyme activity is important 
for a detection system, as marginal differences in the inhibition of enzyme activity (from toxins), 
can be detected. 
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The optimisation experiments for the unimmobilised RPP-1 enzyme demonstrated a 
number of fmdings. Firstly, the supplied reaction and storage buffer was not suitable for the 
assay substrate, MUMP. Although the supplied buffer worked well as a storage buffer, by 
preserving the activity of the enzyme, there were one or more components in the buffer that were 
unspecifically binding to the substrate and causing the fluorescent product, MUM, to be 
produced. Secondly, the optimisation experiments for unimmobilised RPP-1 demonstrated 
higher activity at higher pH (PH 8) and temperature (37°C). Thirdly, RPP-1 was confIrmed to be 
MnCh dependant, as higher activity was observed with MnCh than with NiCh (0.58 and 0.26 
nmol MUM/mllmin, respectively). This was consistent with the manufactures instructions (New 
England Biolabs, P0754S). Fourthly, unimmobilised RPP-1 required BSA for adequate activity 
(0.58 and 0.12 nmol MUM/ml/min, with and without BSA, respectively). This differed to the 
fIndings for the immobilised RPP-1 system, which showed higher activity without BSA (0.5 and 
1.2 nmol MUMlml/min, with and without BSA, respectively). 
Similar trends were observed for PP-2A and RPP-1 in relation to assay parameters (in 
both the immobilised and unimmobilised system), with the exception of the influence of BSA. 
For example, both enzymes showed higher enzyme activity at elevated pHs. Both enzymes also 
showed highest enzyme activity when metal chloride cofactors were present in the reaction mix 
(RPP-1 required MnCh for adequate activity, while PP-2A had adequate activity with NiCh). 
Protein phosphatase type 2A was not tested with MnCh. Therefore, it is not known if higher 
activity could be obtained with MnCh as opposed to NiCh This could potentially be addressed 
in future experiments, although it may not be necessary. 
The _9ptimisation experiments for the unimmobilised enzymes have also shown that the 
PP-2A enzyme was more effective at dephosphorylating MUMP, than the RPP-1 enzyme. For 
example, in the optimised system, one unit of unimmobilised RPP-1 typically released 3 nmol of 
phosphate/ml/min from 250 IlM MUMP (fmal substrate molarity in assay), while one unit of 
unimmobilised PP-2A typically released 30 nmol ofphosphatelmllmin from 250!J.M MUMP. A 
similar pattern was shown in the immobilised enzyme systems. For example, 1 Unit of PP-2A 
applied to 100 mg of beads was sufficient to produce adequate activity (determined by Mountfort 
et ai., manuscript in preparation-a), while 25 Units of RPP-1 were required to produce adequate 
enzyme activity in 100 mg of beads (concentrations tested in this study were 10,25 and 62.5 U, 
r2 value 0.8959). The different volumes of enzyme input would most likely explain the 
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differences in the amount of fluorescence produced between the two enzymes that were 
constantly shown throughout this chapter. For example, immobilised R.PP-1 consistently showed 
activity greater than 1 nmol MUM/ml/min, while PP-2A consistently showed enzyme activity 
less than 1 nmol MUM/mllmin when the enzyme was stable. 
The activity of the RPP-1 enzyme toward MUMP has been demonstrated here, possibly 
for the fIrst time. Previous enzyme assays carried out with RPP-1 have shown activity ofRPP-1 
toward the following substrates, para-nitrophenyl (p-NPP) (An and Carmichael, 1994), 32p_ 
labelled phosphorylase a (Zhang et al., 1992; Zhang, 1994) and phosvitin (Heresztyn and 
Nicholson, 2001). Although RPP-1 is not as effective at dephosphorylating MUMP as PP-2A, it 
still produced reasonable activity for the amount of enzyme input. 
With the exception of the preliminary study carried out by (Mountfort et al., manuscript 
in preparation-a) there have been no other studies that have used an immobilised method similar 
to the one described here for PP-2A and RPP-1. Thus, a comparison of these results to other 
studies is limited. Both immobilised enzymes showed good stability overtime (over 600 hours) 
and generally reached stability between 100-200 hours after immobilisation. This concurs with 
preliminary results for PP-2A which showed enzyme stability for up to 1000 hours after 
immobilisation and generally approached stability within 100 hours (Mountfort et al., manuscript 
in preparation-a). It should be noted that the length of 'time' for the enzyme to become stable 
may not be related to enzyme stability. Rather, the 'number of times' the plate had been run 
through an assay, may be a better indicator of the enzyme reaching stability. An example of this 
finding is discussed here. Usually 5-7 assays are performed on a microplate before enzyme 
stability is s~own. These assays are performed to show the activity trend over time. Thus, they 
indicate when the enzyme has reached stable activity and can be used for toxin detection (i.e. the 
remaining enzyme in the system is strongly bound to the microbeads and thus, activity should 
not fluctuate over time). One experimental microplate with PP-2A was left for over 100 hours 
without being used in an assay, after the enzyme had been immobilised onto the beads. The 
activity of this enzyme revealed a lag effect, where the activity curve was shifted to the right and 
the enzyme reached stability at approximately 250 hours after immobilisation (6 assay cycles), in 
comparison to the standard enzyme stability profile which is normally reached after 150 hours 
after immobilisation (6 assay cycles) (see appendix 7.5). This lag effect has been observed in 
other studies (Goussain and Mountfort, unpublished). This potentially suggests that the stability 
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of the enzyme was more related to frequency of washing, rather than time. If this is the case, then 
the immobilisation procedure needs to be amended to include more than 2 washes of the 
enzyme-bead complex (section 3.3.2) before the beads are transferred to the microfilter plate, as 
this should reduce the period of time for the enzyme to reach stability. However, more 
experiments are required to adequately test this. 
The results from the recovery table (Table 3-11) suggest that a higher proportion of 
RPP-1 enzyme was recovered during the immobilisation procedure than that recovered with 
PP-2A. In other words, more R.PP-1 enzyme adhered to the sepharose beads during the 
immobilisation procedure in relation to enzyme input (recovery of immobilised enzyme was 
3.91 %), than the amount retained with PP-2A (recovery of immobilised enzyme was 3.15%). 
These enzyme recovery values are higher than those obtained in preliminary experiments with 
PP-2A which showed a recovery of approximately 2% of enzyme in the immobilised system 
(Mountfort et ai., manuscript in preparation-a). Thus, the RPP-I enzyme had a better ability to 
be retained in the system, than the PP-2A enzyme. 
There were some differences between the levels of measurable activity between 
experiments. For example, in the stability experiment for PP-2A (Figure 3-8) enzyme activity 
plateaued (i.e. became stable) at around 0.2 nmol MUM Iml/min. In comparison, PP-2A activity 
in the cofactor experiment (with the same enzyme input) maintained stability at around 0.6 nmol 
MUM Iml/min under the same conditions (Figure 3-13). Natural fluctuations in enzyme activity 
between tests are normal and have been shown in preliminary tests with PP-2A (Mountfort et ai., 
manuscript in preparation-a). The reason for this cannot be explained. Natural enzyme variation 
should not by ofconcem as similar fluctuations occur in both control and treatment wells. 
One of the drawbacks of the immobilised system is the cost associated with using a high 
concentration of enzyme when only approximately 3-4% is retained in the system during the 
immobilisation process. Ten units of PP-2A costs US$339.00 (Upstate cell signalling solutions, 
#26330), while 500 units of RPP-1 costs US$420.00 (New England Biolabs, #P0754L). There 
are also high costs involved with shipping an enzyme that needs to be transported with dry ice, 
which can exceed the cost of the enzyme themselves (as is the case for RPP-1 shipping to NZ). 
The total cost (including shipping) for obtaining PP-2A and RPP-l was approximately NZ$725 
(10 units) and NZ$1400 (500 units), respectively. This translates into NZ$72.50 for one unit of 
PP-2A, and NZ$70.00 for 25 units ofRPPI ($2.80 per unit), which is the minimal concentration 
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required for immobilisation (hence the minimal cost to perfonn a test on one sample). This is, 
however, the greatest expense as the cost to conduct the assay is minimal, once the fluorimeter 
has been purchased. Furthennore, the costs are quite low when compared to other methods. For 
example, the cost to run one sample through LC-MS to detect DSP toxins is $725 (A. Thompson, 
personal communication, 5 March 2006). 
In summary, PP-2A and R.PP-1 can be successfully applied to the immobilised PPINA 
fonnat. Both enzymes showed good activity and remained active over a long period. The 
unimmobilised method is time efficient, straightforward, and the whole procedure can be 
perfonned in less than 2 hours. In comparison, the immobilised PPINA is considerably more 
time consuming due to the lengthy immobilisation procedure (can take several hours depending 
on the number of samples being tested) and the period of time, or number of washes, for the 
enzymes to become stable (approximately 120 hours). However, once the enzyme is stable, it is 
possible to carry out multiple assays in a short period of time (results generally obtained within 
1.5 hours). The washing procedure carried out between assay runs is simple and rapid. Both 
enzymes can maintain activity when stored at 4°C for at least one month. Although the costs to 
purchase the enzymes were high, the multiple assay procedure is a pathway to reaching to the 
final product, the prototype biosensor. Thus, the high cost involved with the enzyme can 
eventually be minimised. For example, other less expensive sources of enzymes have become 
available for testing, such as the Yasumoto R.PP-1. Costs can also be minimised by further 
optimising the immobilisation procedure so that more enzyme can be retained in the system and 
hence, less .enzyme needs to be used. The microfilter-plate technique for PP-2A and R.PP-1 is 
now in an optimal fonnat to test the feasibility of this method for MC and OA detection. 
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Chapter 4 Feasibility Studies for Development of a 
Biosensor for Okadaic Acid and Microcystins 
4.1 Introduction 
Feasibility studies were carried out with the PP-2A and the R.PP-1 enzyme, to determine 
if the immobilised PPINA could potentially translate to a prototype biosensor for the detection of 
MC and DSP toxins (OA and DTXs) in the aquatic environment. Favourable features for a 
PPINA biosensor are high sensitivity (i.e. ICso below 10 nM for either toxin), a broad toxin 
detection range (i.e. <0.1 to > 1 0 nM), and re-usability of the assay after toxin has been added to 
the system (i.e. residual toxin does not bind to the enzyme once washed from the system and 
inhibit enzyme activity). Optimal conditions for the immobilised PP-2A and R.PP-1 enzyme 
assays were determined in Chapter 3. These conditions were applied to the immobilised assay 
system to ascertain dose-response curves for each toxin with each enzyme. The re-usability of 
the assay system was also tested under those conditions. The robustness of the immobilised 
enzymes were tested by analysing environmental samples naturally contaminated with DSP 
toxins and MCs, and comparing the results with values obtained from.<?ther analytical methods. 
It was anticipated that at least one of the enzymes would fulfil the criteria of a biosensor for at 
least one of the toxins. 
4.2 Materials and Preparations 
4.2.1 Toxins 
Okadaic acid (OA) (purity grade >96%) was obtained from the National Research 
Council, Institute for Marine Biosciences, Canada. Microcystin-LR (MC-LR) (purity grade 
2::96%) in methanol was obtained from Alexis® Biochemicals, California, USA. 
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4.2.2 Preparation of algal extracts for PPINA and LC-MS 
Water samples were collected from several lakes in New Zealand with dense 
cyanobacterial blooms that were naturally contaminated with MCs and NODLNs. The samples 
(V) were collected from the North Island by Susie Wood, Massey University, while the samples 
(E and L) were collected as part of the New Zealand Marine Biotoxin testing program on the 
North and South Island (refer to Table 4-4). Water samples were extracted by mixing with an 
equal volume of 0.2% formic acid in acetonitrile (breaks down algal cells), sonicating for 10 
minutes and then centrifuging (12,000 x g for 10 mins). Aliquots of the supernatant were diluted 
with 80% methanol at variable dilutions depending on the algal concentration of the extract: 
V.432, 431 and 433 and E.329 diluted 1:9 (methanol/water), V.436 diluted 1: 1 (methanol/water), 
and L.F diluted 1:3 (methanol/water). 
4.2.3 Preparation of mussel extracts for PPINA 
Mussels (Perna canaliculus) naturally contaminated with OA were collected as a part of 
the New Zealand Marine Biotoxin testing program. Whole mussel tissue (approximately 5 g wet 
weight) was homogenised for 1 minute using an Ultra Turrax blender (type T25B, IKA) with 
90% methanol in the ratio 1 part by weight to 5 parts by volume (Mountfort et al., 1999). 
Methanol was used to dissolve endogenous protein phosphatases. The suspension was 
centrifuged (4,355 x g) and the supernatant removed and stored at -20°C~--
4.2.4 Preparation of mussel extracts for LC-MS 
Mussel extracts were collected as described in section 4.2.3, and prepared for LC-MS by 
Paul McNabb, Cawthron Institute, by the method of MacKenzie et al. (2002). Whole mussel 
tissue was homogenised using a blender. The mussel homogenates were then extracted by 
blending 2 g homogenate with 18 ml methanol/water (9:1 v/v) for 3 minutes. The extract was 
centrifuged (3000 x g for 15 min) and 1 ml supernatant transferred to an autosampler vial for 
LC-MS analysis. 
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4.3 Methods 
4.3.1 Protocol for the immobilised PPINA 
The immobilised PPINA was carried out based on the fmal optimised experiments as 
described in chapter 3. Both the RPP-1 and PP-2A enzymes were immobilised according to the 
protocol for the enzyme immobilisation procedure as detailed in section 3.3.2. 
The optimised immobilised assay system for PP-2A based on the results in section 3.5.2, 
contained 0.5 Units of PP-2A immobilised to 50 mg of beads (approximately 100 III in volume), 
120 III of reaction substrate (0.334 mM MUMP in 50 mM Tris buffer, pH 8.0),5 III of 40 mM of 
NiCh, 15 III of 50 mM Tris buffer (pH 8.0), and 10 III of purified toxin standard or sample 
extract . 
. The optimised immobilised assay system for RPP-1 based on the results in section 3.5.2, 
contained 12.5 Units of RPP-1 immobilised to 50 mg of beads (approximately 100 III in 
volume), 120 III of reaction substrate (0.334 mM MUMP in 50 mM Tris buffer, pH 8.0), 5 11,1 of 
40 mM of MnCh, 15 III of 50 mM Tris buffer (PH 8.0) and 10 III of purified toxin standard or 
sample extract. 
The final assay volume for the immobilised system was 250 III (150 III liquid volume). 
Control wells did not contain the toxin or the sample extract, but instead were supplemented with 
10 III of distilled water (to derive a calibration curve) or 90% methanol/water mix (for sample 
extraction) to make up the assay liquid volume to 150 Ill. Blank wells did not contain the 
enzyme, the sepharose beads, the toxin or the sample extract, instead the wells were 
supplementeg with the same volume of water or 90% methanol/water mix as in the control and 
100 III of 50 mM Tris buffer to make up the final assay volume to 250 Ill. The experiment was 
carried out in duplicate unless otherwise stated. The reaction rate was measured by the 
fluorimetric procedure as described in section 3.3.1. 
4.3.2 Method for the unimmobilised PPINA 
Protein phosphatase type 2A 
The unimmobilised PP-2A inhibition assay was carried out as described in section 3.3.1, 
with the following changes to the assay mix: 5 III of 10 mglml BSA (instead of 5 III of 1 mglml), 
assay pH 8 (instead of pH 7), and a total assay volume of 150 III (instead of 200 Ill). These 
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changes were made so that the activity of the unimmobilised assay system could be directly 
compared to the activity of the immobilised assay system (section 4.3.1), under the same assay 
conditions. The only exception to this was that the unimmobilised system contained BSA while 
the immobilised system did not. This was because the unimmobilised assay has previously been 
shown to produce more optimal enzyme activity with BSA (Mountfort et al., manuscript in 
preparation-b). 
Recombinant PP-l 
The optimised assay system for unimmobilised RPP-l was based on the fmal optimised 
method as described in section 3.5.1. The optimised assay system contained 10 III of diluted 
RPP-l (0.5 Units) (diluted 1:50 with 50 mM Tris buffer, pH 8.0), 120 III of buffer containing 
substr:ate (0.42 mM MUMP) , 5 III of 40 mM of MnCh, 5111 of 10 mg/ml BSA and 10 III of 
purified toxin standard or sample extract. 
The final assay volume for the unimmobilised system was 150 Ill. Control wells did not 
contain the toxin or the sample extract, instead were supplemented with 10 III of distilled water 
(to derive a calibration curve) or 90% methanol/water mix (for sample extraction) to make up the 
final assay volume to 150 Ill. Blank wells did not contain the enzyme, the toxin or the sample 
extract but instead were supplemented with the same volume of water or 90% methanol/water 
mix as in the control, and 10 III of Tris buffer to make up the final assay volume to 150 Ill. The 
experiment was carried out in triplicate unless otherwise stated. The reaction rate was measured 
as described in section 3.3.1. 
4.3.3 Oose~Response Curves 
4.3.3.1 Okadaic acid calibration curve 
Okadaic acid dilutions for calibration curves were prepared from stock solution of OA in 
methanol (24.1 Ilg/ml). The stock solution was diluted with distilled water and added to the assay 
mixture to generate a dose-response curve for immobilised PP-2A and R.PP-l in the range of 
0.001-2000 and 0.1-2000 nM, respectively. These ranges were arrived at by noting the detection 
range for OA and PP-2A in other studies (Mountfort et al., 1999). The immobilised enzyme 
assays were conducted according to assay conditions described in section 4.3.1. A dose-response 
curve was also generated for unimmobilised PP-2A and RPP-l (section 4.3.2) in the range of 
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0.0001-1000 and 0.01-2000 nM, respectively. The unimmobilised enzyme assays were 
conducted according to assay conditions described in section 4.3.2. The dose-response curves 
were expressed as % activity against the control (i.e. % activity test = (activity of test sample/ the 
activity of the control sample) x 100). 
4.3.3.2 Microcystin-LR calibration curve 
Effect of pH 
The effect of pH on the MC-LR dose response curve was tested. This was because MCs 
are mostly found in freshwater, which has an approximate pH range of 7. This differs to the pH 
of seawater, which has a pH around 8. Therefore, it was preferable to change the assay pH when 
measuring MCs in freshwater, so that it was consistent with the sample pH. To determine if pH 
had an influence on inhibition by MC-LR, dose-response curves for unimmobilised PP-2A were 
generated at both pH 7.0 and 8.0. Although it would have been preferable to test the effect of pH 
in the immobilised system, there was only sufficient enzyme to test this in the unimmobilised 
system. 
Microcystin-LR dilutions for calibration curves were prepared from stock solution of 
MC-LR in methanol (100 Ilg/ml). The stock solution was diluted with distilled water and added 
to the assay mixture to generate a dose-response curve for unimmobilised PP-2A in the range of 
0.01-670 nM. These ranges were arrived at by noting the detection range for MC-LR and PP-2A 
in other studies (Mountfort et al.) 2005). The unimmobilised PP-2A assay was conducted at pH 
7.0 and 8.0 according to assay conditions described in section 4.3.2 (with the exception of pH 
change). The dose-response curves were expressed as % activity of the control. If pH influenced 
the dose-response curves there would be a shift in the ICso andlor assay detection limit. 
Dose-response Curves 
Diluted stock solutions of MC-LR in water were added to the assay mixture to generate a 
dose-response curve for immobilised PP-2A and R.PP-l in the range of 0.067-3350 nM. Based 
on the results of the previous test (section 4.3.3.2) and because MCs are mostly found in 
freshwater, all dose-response curves for MC-LR were conducted at pH 7.0. The immobilised 
enzyme assays were conducted according to assay conditions described in section 4.3.1 (with the 
exception of pH change). The dose-response curves were generated for unimmobilised PP-2A 
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and R.PP-l in the range of 0.0067-3350 and 0.0067-670 nM, respectively. These ranges were 
arrived at by noting the detection range for MC-LR and PP-2A in other studies (e.g. Mountfort et 
aI., 2005). The unimmobilised enzyme inhibition assays were conducted according to assay 
conditions described in section 4.3.2 (with the exception of pH change). The dose-response 
curves were expressed as % activity of the control. 
Effect of Bovine serum albumin 
Bovine serum albumin was added to the unimmobilised assay system for two reasons. 
Firstly, BSA inclusion in the reaction mix produced higher enzyme activity, especially with the 
R.PP-l. Secondly, BSA addition eliminated the matrix effects of environmental samples by 
binding to non-specific components in the reaction mix (i.e. it allowed for specific binding 
betwe,en non-confounding components (e.g. toxin) and the enzyme and thus led to a more 
sensitive assay) (Mountfort et ai., manuscript in preparation-b). Bovine serum albumin was 
excluded from the immobilised system for two reasons. Firstly, the exclusion of BSA in the 
reaction mix lead to a higher enzyme activity in the immobilised system. Secondly, the intention 
of the immobilised system was to keep it as simple as possible for potential application as a 
biosensor. 
Since the two assay systems were different with respect to BSA, the addition of BSA in 
the reaction mix was tested in the immobilised PP-2A assay to determine if it had an effect on 
the dose-response curve for MC-LR. Thus, dose-response curves for immobilised PP-2A were 
compared with or without BSA (5 p.l of 10 mg/ml) at pH 7.0. The immobilised enzyme 
inhibition as§ay~ were conducted according to assay conditions described in section 4.3.2 (with 
the exception of pH change and BSA addition), The dose-response curves were expressed as % 
activity of the control. If BSA influenced the dose-response curves there would be a shift in the 
IC50 and/or assay detection limit for PP-2A. 
4.3.4 Recovery of immobilised enzyme activity after treatment with OA and 
MC-LR 
To determine if the immobilised PPINA could be used as a re-usable biosensor, the 
immobilised assay was tested for re-usability after the toxin was added to the system. That is, if 
enzyme activity would recover to its original activity following treatment with the inhibiting 
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toxin. A re-usable assay would allow for toxin analyses of multiple environmental samples in the 
field. Essentially, enzyme re-usability was tested by filtering the enzyme with Tris buffer 
(referred to as washing) after toxin was added to the system and retesting the assay to determine 
if the enzyme activity had returned to its original activity. The number of times the enzyme had 
to be washed, before activity could be restored to pre-toxin levels, was a factor to be considered 
if the system had potential application as a re-usable biosensor. Thus, the enzyme recovery 
experiment tested whether the toxin permanently bound to the enzyme once added to the system, 
or if it was possible to remove the toxin from the system by washing with Tris buffer. 
To determine if washing the enzymes removed the inhibitory effect of OA and MC-LR, 
each microwell was washed with 100 J.l.1 of 50 nM Tris buffer prior to conducting each assay. 
The washing process was repeated to show the level of residual toxin in the system after a given 
number of washes. For the immobilised assay system to be re-usable, washing should allow the 
enzyme activity to return close to its original activity. The recovery experiment was tested with 
immobilised PP-2A against OA and MC-LR, and R.PP-1 against MC-LR only. Recombinant 
PP-1 was not tested against OA because the calibration curves (section 4.3.3.1) revealed that it 
was unsuitable to detect this toxin. 
4.3.5 Analysis of environmental samples using the modified PPINA 
The robustness of the immobilised PP-2A and RPP-1 enzynie- assays were tested by 
adding environmental samples into the assay system and determining the accuracy of its 
measurement, by comparing it with other methods (e.g. LC-MS and other PPINAs). The 
performance_ .of_ the PPINA was judged by the sensitivity of the assay to detect low toxin 
concentrations. Two types of environmental samples were tested, marine mussel extracts 
containing DSP toxins eOA and DTXs), and freshwater algal extracts containing MCs. Because 
of cost restrictions, only one immobilised enzyme assay was to be tested for each environmental 
sample. The immobilised enzyme that produced the most sensitive dose-response curve for OA 
or MC-LR was chosen to test for the relevant toxin in the sample extract. The dose-response 
curve for OA in the immobilised PP-2A assay system indicated greater sensitivity to OA than the 
R.PP-1 enzyme (Figure 4-1). Thus, the immobilised PP-2A system was tested using the mussel 
extracts. For comparative purposes, the unimmobilised PP-2A assay was also tested with the 
same mussel extracts. These mussel extracts have been tested previously with the PP-2A assay 
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and LC-MS analysis (Mountfort and Truman, 2001). The results from the current study were 
compared to these in terms of accuracy. 
Although the immobilised PP-2A system was more sensitive with MC-LR than the 
immobilised RPP-1 system, there was not sufficient PP-2A enzyme left to test the algal extracts 
using the immobilised system. Thus, the immobilised RPP-1 enzyme was tested for MCs with 
the algal extracts. For comparative purposes, the same algal extracts were also tested using the 
unimmobilised RPP-1 and PP-2A assay (uses much less enzyme than the immobilised system). 
These algal extracts have been previously tested with the unimmobilised PP-2A assay 
(Mountfort, unpublished) and LC-MS (Holland, unpublished), and therefore, the results from the 
current study were compared to these in terms of accuracy. 
4.3.5.1 Detection of okadaic acid in mussel extracts 
Undiluted mussel extract tests 
For determination of OA in naturally contaminated mussel extracts, the immobilised 
PP-2A assay was conducted in duplicate for five mussel samples (see section 4.2.3 for the 
preparation of mussel extracts) as described in section 4.3.1. The unimmobilised PP-2A assay 
was conducted in triplicate with the five mussel samples as described in section 4.3.2. The 
concentration of OA in each mussel extract, was expressed as the % of inhibition of enzyme 
activity compared to the control (i.e. % activity test = activity of test sample/ the activity of the 
control sample x 100). See appendix 7.3, for the calculation of OA in mussel samples. The 
concentration of OA was expressed as !!g/kg of shellfish tissue. 
Diluted mussel extract tests 
Recent studies with the PPINA (Mountfort et al., manuscript in preparation-b) have 
shown that when concentrated mussel extracts were added to the PP-2A assay, the results were 
unreliable as many interfering substances in the mussel tissue other than the toxin, prevented the 
binding of the substrate with the enzyme. This problem was overcome by diluting the mussel 
extracts with 16% methanol. Therefore, the unimmobilised PP-2A assay was tested with a range 
of diluted mussel extracts in order to identify levels giving inhibition in the linear portion of the 
curve. It was not possible to test a range of diluted mussel extracts in the immobilised system 
(although this would have been most useful) due to the small quantity of PP-2A available for 
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experimentation (the immobilised PP-2A system utilises 25 times more enzyme per test 
compared to the unirnmobilised PP-2A assay). Thus, only undiluted extract was tested with the 
immobilised system. 
Serial dilutions of each mussel extract were made in distilled water in a ratio of 1:4 (v/v 
extract/water). Five and 10 pJ aliquots of each sample at 1:4 dilution were added to the 
unimmobilised PP-2A assay in triplicate as described in section 4.3.2. The two volumes (5 and 
10 Ill) of each sample were added to the assay to obtain a more thorough estimate, as the mean of 
these values were used in determining the toxin levels in each sample. Control wells contained 
the same dilution of methanol in water as in the experimental wells. For example, for 1 0 ~ 
additions of the 1:4 extract in the experimental wells, the control wells were supplemented with 
10 III of 90% methanol diluted 1:4 with water. The concentration of OA was expressed as Ilg/kg 
of shellfish tissue. 
The mussel extract assay was then repeated using a 1:2 dilution of extracts, because the 
1:4 dilution produced results that were similar to the control values (i.e. very little toxin was 
detected in the extracts, as the samples may have been too diluted). Five and 10 III aliquots of 
each sample at the 1:2 dilution were added to the unirnmobilised PP-2A assay in triplicate as 
described previously for the 1:4 dilution. 
4.3.5.2 Detection of microcystins in algal extracts 
Dilution of algal extracts 
Based on the previous results for the irnmobilised PP-2A mussel sample test (section 
4.3.5.1), the sample extract was diluted before being added to the irnmobilised assay. Therefore, 
for determination of MCs in naturally contaminated algal extracts, serial dilutions of extracts 
were made in distilled water in a ratio of 1:4 (v/v extract/water, as described in section 4.2.2). 
Ten III aliquots of the diluted extract were added to the irnmobilised R.PP-l assay in duplicate, 
as described in section 4.3.1. Five and 10 III aliquots of the diluted extract were added to the 
unirnmobilised R.PP-l assay (for reasons discussed in 4.3.5.l) in triplicate, as described in 
section 4.3.2. Control wells for both assays contained the same dilution of methanol in water as 
in the experimental wells. The concentration of MC in each algal extract was expressed as Ilg/L. 
The calculation ofMCs in algal samples is shown in appendix 7.2.4. 
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Further dilution of algal extracts 
The 1:4 diluted algal extracts strongly inhibited the llllimmobilised enzyme (inhibited the 
enzyme by more than 90%). Thus, it was necessary to further dilute the 1:4 extracts to obtain 
sensible accurate readings from the calibration curve. Serial dilutions of the 1:4 diluted extracts 
were made in distilled water to a ratio of 1 :39 (v/v extract/water) (see section 4.2.2 for the 
preparation of algal extracts). Five and 10 ILl aliquots of the diluted extract were added to the 
unimmobilised R.PP-l assay in triplicate, as described in section 4.3.2. The unimmobilised 
PP-2A assay was also tested with the diluted algal extracts to compare the sensitivities of the 
enzymes. Five and 10 ILl aliquots of the diluted extract (1 :39) were added to the llllimmobilised 
PP-2A assay in triplicate as described in section 4.3.2. Control wells for both assays contained 
the same dilution of methanol in water as in the experimental wells. The concentration of MC in 
each (J,lgal extract was expressed as )lg/L. 
4.3.6 Analysis of environmental samples using other PP-2A inhibition 
assays 
4.3.6.1 Detection of okadaic acid in mussel extracts 
The mussel extracts that were tested in section 4.3.5.1, were tested for DSP toxins in 
2001, based the PP-2A inhibition assay previously described by MOlllltfort et al. (1999) (section 
3.3.1). The concentration of DSP toxins was expressed as )lg/kg of OA equivalent in shellfish 
tissue. The calculation of nsp toxins in mussel samples is shown in appendix 7.3. 
4.3.6.2 Detection of microcystin in algal extracts 
The algal extracts described in section 4.3.5.2, were tested for MC in 2005, based on the 
PP-2A inhibition assay previously described (Molllltfort et aI., 1999) (section 3.3.1). The 
concentration of MC was expressed as )lg/L of MC-LR equivalents. The calculation of MC in 
mussel samples is shown in appendix 7.4. 
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4.3.7 Analysis of environmental samples using LC-MS 
4.3.7.1 Detection of okadaic acid in mussel extracts using LC-MS 
Unhydrolysed mussel extracts were analysed for DSP toxins by Paul McNabb, Cawthron 
Institute, by the method of MacKenzie et al. (2002) using a Waters 2790 LC system and Quattro 
Ultima triple quadrupole mass spectrometer system (Micromass Ltd, UK). Chromatographic 
separation was performed using a Phenomonex Luna C18 column (150 x 2 mm2) with 5 j.llTI, 
packing. A gradient from 13% to 77% acetonitrile containing a constant concentration of buffer 
(4 mM ammonium hydroxide and 50 mM formic acid) was run between 2 and 10 min and held at 
77% acetonitrile until 25 min. The electro spray ionisation interface (ESI) was operated in both 
positive and negative modes (capillary potential 3.0-3.5 kV, desolvation temperature 350°C, 
sourc~ temperature 100°C, desolvation gas flow 500 1 N2/h, cone gas flow 50 1 N2/h). The mass 
spectrometer was operated in MS-MS modes with collision cell gas pressure (argon) set at 1.2 x 
10-3 T. For neutral loss and daughter ion scan experiments on YTX and derivatives, the cone 
voltage and collision energy were 100 V and 25 eV, respectively. For multiple reaction 
monitoring (MRM), the mass channels and optimal cone voltages and collision energies for each 
biotoxin were established from daughter ion studies with standards or extracts of contaminated 
shellfish. The MRM channels were monitored in windows that covered the elution of the 
compounds of interest (parent> daughter): ESI negative, capillary 3.0 kV, OA 803.5> 255.0 and 
DTX1 817.5 > 255.0. The various toxin groups were quantified by comparison with authentic 
standards for the major parent compounds (OA and DTX-1). 
4.3.7.2 Defectlon ofmicrocystin-LR in algal extracts using LC-MS 
Microcystins were separated by LC (Alliance 2695, Waters Corp., MA) using a 150 x 
2 mm Luna C18(2) 5 j.llTI column (Phenomenex, CA) with water/methanol/acetonitrile gradient 
containing 0.15% formic acid (0.2 ml/min,10 Jll injection). The Quattro Ultima TSQ mass 
spectrometer (Water-Micromass, Manchester) was operated in ESI positive with MRM using 
MS-MS channels set up for 13 MC and NODLN. The mlz 135 fragment from the protonated 
molecular cation was selected for each toxin (the doubly charged molecular species for MC-RR: 
the singly charged molecular species for all other toxin congeners). The instrument was 
calibrated with authentic standards of MC-RR, -YR, -LR and NODLN to give linear calibration 
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curves for concentrations over the range 5-200 ng/mI. The response factors for MC-RR and -LR 
were applied to other related toxins where no pure analytical standards were available. 
4.3.8 Statistical Analysis 
Statistical analysis for all data was performed using 'R' software version 1.7.0. Linear 
portions of the dose-response curves were analysed using linear regression. Only a limited 
number of data points were used for each test (some more than others), as the procedure was 
costly and subsequently, replication was limited. Therefore in some cases, the assumptions are 
probably not fulfilled (due to the lack of data points, departures from normality and 
heterogeneity of variances could not be adequately assessed). Where outliers were evident the 
data could not be eliminated due to lack of data points. However, all the data were balanced. 
4.4 Results 
4.4.1 Dose-response curves 
4.4.1.1 Dose-response curves for OA 
Figure 4-1 shows the dose-response for OA against unimmobilised and immobilised 
PP-2A and R.PP-1. The shape of the dose-response curve was similar for the unimmobilised and 
the immobilised PP-2A enzyme (Figure 4-1a). However there was a shift in the ICso values 
between the two different systems (Table 4-1), with the ICso for the unimmobilised and 
immobilised_system 5.5 nM and 55 nM, respectively. Thus, the immobilised enzyme was 
approximately 10-fold less sensitive. The detection range for PP-2A against OA is shown in 
brackets in Table 4-1. A strong linear relationship was observed for the unimmobilised 
(~ 0.8772) and immobilised (r2 0.9552) PP-2A enzyme. The high r2 value indicates that most of 
the data points were clustered close to the regression line (~ equals 1 for a perfect fit, while ~ 
close to 0 indicates scattered data and a weak relationship). This implies that the assays were 
performed with some confidence. 
A different trend was observed with the R.PP-1 enzyme, as activity was induced for both 
the immobilised (r2 0.8629) and unimmobilised (r2 0.7703) system between 10-200 nM and 
1-100 nM of OA, respectively (Figure 4-1 b). Consequently, very high ICso values were obtained 
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for both assay systems (Table 4-1). This indicates that the assay system used for RPP-1 was 
unsuitable to test for ~A. 
4.4.1.2 Dose-response curves for MC-LR 
Effect of assay pH 
Figure 4-2 shows the dose-response curve for the inhibition of unimmobilised PP-2A 
against MC-LR at pH 7 (~ 0.9607) and pH 8 (r2 0.9807). The pH did not shift the ICso or change 
the shape of the dose-response curve for unimmobilised PP-2A. Freshwater has a pH close to 7. 
Thus, all tests analysing freshwater algae for MCs were assayed at pH 7. 
Dose-response Curves MC-LR 
Figure 4-3 shows the dose-response for MC-LR against PP-2A and RPP-1 in both assay 
systems. The shapes of the dose-response curves were similar for the unimmobilised and 
immobilised PP-2A enzymes (Figure 4-3a)., However, there was a shift in the ICso values 
between the two different systems (Table 4-1), with the immobilised enzyme at least 20-fold less 
sensitive. The detection range for both enzymes against MC-LR is shown in Table 4-1. The ICso 
for the unimmobilised PP-2A was similar to values obtained for MC-LR against PP-2A from 
other studies (ICso 2.2 nM (Mountfort et ai., 2005)). A linear trend was observed for the 
unimmobilised (~0.8344) and immobilised (r2 0.7206) PP-2A enzyme.---
The shape of the dose-response curve and the ICso for the unimmobilised RPP-1 enzyme 
(Figure 4-3b) compared well with PP-2A, and the enzyme showed a higher sensitivity toward 
MC-LR than PP-2A (Table 4-1). A different trend was observed for the immobilised enzyme, as 
the curve could not be used to detect MC-LR below 40% activity of the control. Consequently, a 
very high ICso value was obtained for the immobilised R.PP-l enzyme against MC-LR (Table 
4-1), which was approximately 200-fold less sensitive when compared to the unimmobilised 
RPP-1 enzyme. A strong linear relationship was observed for the unimmobilised (~ 0.9845) and 
immobilised (r2 0.8961) RPP-1 enzymes. 
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Figure 4-1. Dose-response curves for the inhibition/stimulation of PP-2A (a) and R.PP-l (b) by ~A. Symbols 
denote enzyme treatment: .&., unimmobilised; 0, immobilised. In the immobilised system, each well contained 
enzyme immobilised onto 50 mg of beads at 0.5 and 12.5 Units for PP-2A and R.PP-1, respectively. In the 
unimmobilised system each well contained 0.02 and 0.5 Units of PP-2A and R.PP-1, respectively. Enzyme activity 
was determined at pH 8.0. Assay conditions were the same for both systems except that BSA was present in the 
unimmobilised system at 5 III of 10 mgiml and 5 mgiml for PP-2A and R.PP-1, respectively. Each value represents 
the mean of at least duplicate determinations ± standard deviation. 
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Figure 4-2. Dose-response curve for the inhibition of unimmobilised PP-2A by MC-LR at pH 7 (e) and pH 8 (~) . 
The concentration of PP-2A was 0.02 U. Enzyme acti vity was determined with BSA (5.02 jlM). Each value 
represents the mean of triplicate determinations ± standard deviation . 
4.4.1.3 Dose-response curves for MC-LR utilising different assay conditions 
Figure 4-4 shows the dose-response curve for MC-LR against immobilised PP-2A 
enzyme with (r2 0.9612), and without (r2 0.6853) BSA. The results indicated that the addition of 
BSA in the reaction mix did not shift the ICso or change the shape of the dose-response curve to 
any great extent. Although it would have been useful to test the effect of BSA on the 
immobilised system for the R.PP-l enzyme, there was only sufficient enzyme to test this in the 
immobilised system for PP-2A. Thus, it was assumed that when comparing the unimmobilised 
and immobilised systems, the presence or absence of BSA in the reaction mix would not have 
much influence on the outcome of the dose-response curve for either toxin. 
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Figure 4-3: Dose-response curves for inhibition of MC-LR by PP-2A (a) and R.PP-1 (b). Symbols denote enzyme 
treatment: "', unimmobilised; 0, immobilised. In the immobilised system each well contained enzyme immobilised 
onto 50 mg of beads at 0.5 and 12.5 Units for PP-2A and R.PP-1, respectively. In the unimmobilised system, each 
well contained 0.02 and 0.5 Units of PP-2A and R.PP-1, respectively. Enzyme activity was determined at pH 7.0. 
Assay conditions were the same for both systems except that BSA was present in the unimmobi1ised system at 5 fll 
of 10 mg/ml and 5 mg/ml for PP-2A and R.PP-1, respectively. Each value represents the mean of at least duplicate 
determinations ± standard deviation. 
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Table 4-1: Comparison ofICso (nM) values and toxin detection range for MC-LR and OA 
inhibition of, PP-2A and R.PP-l. 
PP-2A 
R.PP-1 
Enzyme 
unimmobilised 
immobilised 
unimmobilised 
unimmobilised 
immobilised 
a Value obtained by Mountfort et al. (2005) 
b Value obtained by Mountfort et al. (1999) 
C the detection ranges are an estimation only 
na not applicable 
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Figure 4-4: Dose-response curves for immobilised PP-2A with BSA at 5.02 J.l.M (e) and without BSA (L1) at 
pH 7.0. The concentration of PP-2A was 0.5 U. Each value represents the mean of at least duplicate detenninations 
± standard deviation. 
89 
4.4.2 Recovery of immobilised enzyme activity after testing with toxins 
4.4.2.1 Recovery of immobilised PP-2A activity after testing with OA and MC-LR 
Figure 4-5 shows the recovery of immobilised PP-2A activity after testing with OA and 
MC-LR Although enzyme activity increased as the number of washes increased, PP-2A activity 
did not reach the pre-toxin activity levels, even after the enzyme-bead complex had been washed 
100 times. This indicated that the immobilised PP-2A system was not re-usable and that some 
form of permanent binding had occurred between the toxin and the enzyme. 
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Figure 4-5: Recovery of immobilised PP-2A activity after treatment with toxins. Each colour represents the percent 
activity of the IC50 after: toxin addition C-), and after 10 C- ), 50 C-) and 100 C- ) washes. Each value represents the 
mean of duplicate determinations ± standard deviation. 
4.4.2.2 Recovery of immobilised R.PP-1 activity after testing with MC-LR 
Figure 4-6 shows the recovery ofRPP-l activity after testing with MC-LR Recombinant 
PP-l was not tested for recovery against OA due to reasons discussed previously (section 4.3.4). 
Results for immobilised RPP-l showed good recovery of enzyme activity after washing. 
Enzyme activity recovered completely to its original activity within 20 washes. This recovery 
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was based on the IC50 of 200 nM (Table 4-1). Therefore there is potential to use the immobilised 
R.PP-1 enzyme in a reusable biosensor method. 
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Figure 4-6: Recovery of immobilised R.PP-l activity after washing following treatment with MC-LR. Each value 
represents the percent activity of the ICso• Each value represents the mean of duplicate detenninations ± standard 
deviation. 
4.4.3 Determination of toxins in naturally contaminated samples 
4.4.3~1·Determination of DSP toxins in naturally contaminated mussel extracts 
Table 4-2 shows the concentration of DSP toxins (OA and DTXs) (nM) detected by the 
two assay systems (i.e. immobilised versus unimmobilised). The linear portion of the dose-
response curve for unimmobilised and immobilised PP-2A against OA was used for calculation 
of these samples [i.e. the % activity of the control is read off the linear portion of the dose-
response curve to obtain the concentration oftoxin (nM) in the sample (appendix 7.3)]. 
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Table 4-2: The concentration of OA equivalents (nM) in the mussel samples using the 
immobilised and unimmobilised PP-2A enzyme assays (measured off the immobilised and 
unimmobilised standard curves for PP-2A against OA). 
Mussel ilIa PP-2A 
Sample 
Immobilised Unimmobilised 
Undiluted Undiluted Diluted 1:2 
% activit yO nMo % activitl nMo % activitl 
BM 5 * * * * 121.03±7.67 
10 47.32±0.34 59 37.37±10.07 7 82.72±5.85 
Y2 5 * * * * 115.26±6.40 
10 60.33±0.74 40 38.02±6.00 6.8 93.09±4.21 
X2. 5 * * * * 103.56±6.52 
10 41.67±3.40 68 22.33±4.15 11 70.97±0.83 
038 5 * * * * 105.78±6.13 
10 52.32±1.05 53 31.87±4.48 8.5 75.17±2.72 
C7 5 nd nd nd nd 87.24±4.86 
10 34.51±3.26 93 11.13±0.82 23 47.36±3.38 
a volume of extract added to assay (Ill) 
b mean % activity of the control of duplicate detenninations ± standard deviation 
C mean % activity of the control of triplicate detenninations ± standard deviation 
dnM ofOA equivalent, read off the dose-response curve 
* no data 
nd not detected-
nMo 
nd 
1.9 
nd 
0.85 
nd 
2.9 
nd 
2.5 
1.5 
6.8 
Diluted 1:4 
% activitl nMo 
123.65±10.83 nd 
96.246.44 0.3 
112.99±4.25 nd 
96.28±6.81 0.3 
112.23±9.52 nd 
88.74±7.43 1.3 
111.52±5.82 nd 
95.37±5.38 0.6 
1 03.64±6. 75 0 
79.68±2.97 2.1 
Table 4-3 shows the concentration of DSP toxins (OA and DTXs) in Ilg/kg of mussel 
tissue (assuming that 5 ml of extract is equivalent to 1 g shellfish tissue), detected in the 
unimmobilised and immobilised PP-2A assay systems. The results were compared to values 
obtained from LC-MS and other PP-2A inhibition assay methods (Mountfort and Truman, 2001). 
The results indicate that there was considerable variability in toxin detection based on the 
dilution of the sample for the unimmobilised PP-2A assay. The most diluted mussel extract gave 
the lowest measurement of DSP toxins, while the undiluted extracts gave the highest levels of 
toxin. This is consistent with other findings that non-specific binding can occur with undiluted 
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samples resulting in the enzyme being stimulated by components in the sample other than the 
substrate (Mountfort et a!., manuscript in preparation-b). Thus, it is shown in the unimmobilised 
assays that the matrix effect is gradually reduced by using highly diluted samples. 
Table 4-3: Comparison of DSP toxin (OA and DTXs) concentrations in mussels between 
the unimmobilised and immobilised PP-2A inhibition assay and LC-MS. 
Mussel OA (J.l.g/kg mussel tissue) 
sample 
Immobilised Unimmobilised PP_2Acf LC_MSdf 
PP_2Aa PP_2Ab 
undiluted undiluted 1:2e 1:4e 1:4 
BM 3562.1 422.6 344.1 90.6 0 0 
Y2 2415.0 410.6 154.0 90.6 136.0±11 93.0 
X2 4105.5 664.1 525.3· 392.4 100.0±28 47.0 
038 3199.9 513.2 452.8 181.1 168.0±11 95.0 
C7 5614.9 138.8.6 887.5 633.9 34.0±28 239.0 
a 0.5 U ofPP-2A immobilised to 50 mg of microbe ads. Values are means of duplicate determinations. 
b 0.02 U ofPP-2A. Values are means of triplicate determinations. 
C Values obtained by Mountfort et ai. (2001) (Cawthron) ± SD. 
d Values obtained by McNabb (Cawthron) (Mountfort et ai., 2001) 
e Activity values for 5 III additions of mussel extract were too near 100% to provide a valid reading from the dose-
response curve.:. Thlls, only the 10 III additions were used here. 
f detection level approximately 0.01 nM 
The magnitude of the matrix effect can be seen in the substantial over-estimate of DSP 
toxins reported in the immobilised assay, which only tested undiluted samples. However, the 
magnitude of the difference is less than expected (IO-fold) considering there was a 10-fold 
decrease in sensitivity between the immobilised and unimmobilised PP-2A system (as shown in 
the dose-response curve for DSP toxins and PP-2A, section 4.4.1.1). There were also some 
differences between the unimmobilised PP-2A assay carried out in this study compared to those 
values obtained from the PP-2A inhibition assay carried out by Mountfort and Truman (2001) for 
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the same assay dilution. This may have been the result of slight differences in the assay methods. 
The one concerning factor is the high amount of DSP toxins detected in the blank sample (BM), 
compared to the nil levels reported in by Mountfort and Truman (2001) and LC-MS. This 
difference may be attributable to an error during the dilution series where the control may not 
have received 16% methanol, as this discrepancy has been shown in other studies (Mountfort. 
pers.com). 
While the unimmobilised PP-2A showed some effect of dilution, generally the values 
aligned to LC-MS particularly the 1:4 dilution. The results for LC-MS are not expected to be 
equal to the values obtained from the PPINA, as stoichiometric methods measures specific toxin 
congeners while the PPINA measures the total bioactivity ofthe sample. 
4.4.3.2 Determination of MCs in naturally contaminated algal extracts 
Table 4-4 shows the concentration of MCs (nM) detected by the two assay systems (i.e. 
immobilised versus unimmobilised). The linear portion of the dose-response curves for the 
unimmobilised and immobilised enzymes against MC-LR were used for calculation of these 
samples (as discussed in section 4.4.3.1). 
Table .4-5 shows the concentration of MCs in Jlg/L detected in the unimmobilised and 
immobilised R.PP-l assay system and the unimmobilised PP-2A assay. The results were 
compared to values obtained from the LC-MS (Holland, unpublished) and other PP2A inhibition 
assay methods (Mountfort, unpublished). The results indicate that there was variability in toxin 
detection based on the dilution of the sample for the unimmobilised R.PP-l assay. The most 
diluted algal extracts usually gave the highest measurement of MCs, which is contrary to the 
trend observed for the mussel samples for PP-2A. This indicates that inhibitory confounding 
compounds may have been present in the algal cells, compared to stimulatory confounding 
compounds which were likely to have been present in the mussel extracts. These compounds can 
interfere with the enzyme-toxin binding and confound the results of the assay. Thus, sample 
dilutions in the unimmobilised assays were shown to gradually reduce the matrix effect. The 
optimal sample dilution was between 1 :20 and 1 :40. However, two of the seven samples tested in 
the 1 :40 dilution (V.436 and V.432) detected a lower concentration of Mes than those detected 
in the 1:4 dilutions. Although these differences were marginal, it does suggest that the samples 
can be over diluted before incorporation in the assay. 
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Table 4-4: The concentration ofMC equivalents (nM) in the algal samples using the R.PP-l 
and PP-2A enzyme assays (measured off the immobilised and unimmobilised standard curves 
for RPP-l, and unimmobilised standard curve for PP-2A, against MC-LR). 
Algal ilIa R.PP-l 
Sample 
Immobilised Unimmobilised 
Diluted 1:4 Diluted 1:4 1:4 diluted 1: 1 0 
% activit yO nMo % activit/ nMo % activityC 
L.F1 5 * * 2.45±1.12 5 2.4±0.24 
10 36.32±1.39 1.25 1.12±0.21 25 1.38±0.87 
V.436 5 * * 10.71±0.65 2.6 96.87±7.22 
10 74.96±4.70 0.44 6.66±0.36 3.2 86.4±5.13 
V.432 5 * * 7.35±1.12 3.1 96.68±4.94 
10 95.27±8.61 0.22 4.96±0.50 3.8 77.75±6.25 
E.329 5 * * 5.63±0.52 3.5 71.63±1.35 
10 61.73±1.17 0.64 3.84±0.72 4.9 32.66±3.46 
V.431 5 * * 5.48±0.57 3.6 39.41±2.24 
10 57.59±1.25 0.69 3.71±0.63 4.6 10.71±1.00 
V.433 5 * * 9.35±0.30 2.4 86.27±2.88 
10 83.76±3.96 0.34 7.92±0.38 3 83.06±3.70 
a amount of extract added to assay (Ill) 
b mean % activity of the control of duplicate detenninations ± standard deviation 
C mean % activity of the control of triplicate detenninations ± standard deviation 
d nM of MC-LR equivalent, read off the dose-response curve 
* no data 
nMo 
6.2 
12 
0.2 
0.32 
0.2 
0.41 
0.49 
1.3 
1.1 
2.6 
0.32 
"----
0.35 
PP-2A 
Unimmobilised 
1:4 diluted 1: 1 0 
% activityC nMu 
18.57±3.40 8.5 
10.69±1.88 10.6 
78.77±4.98 1.4 
85.35±7.61 1.2 
80.33±4.40 1.4 
82.25±5.48 1.35 
74.58±5.82 1.65 
73.15±1.51 1.75 
71.22±5.70 1.9 
79.1±7.18 1.5 
83.4±15.48 1.25 
94.52±6.93 0.86 
There was also an approximate lO-fold decrease in sensitivity of MC detected between 
the immobilised and unimmobilised RPP-l for the same sample dilution. This is surprisingly 
less than the 200-fold decrease in sensitivity between the immobilised and unimmobilised 
RPP-l system, as shown in the dose-response curve for MC and RPP-l (section 4.4.1.2). There 
is some degree of similarity between the R.PP-l and PP-2A enzyme assays for the same sample 
dilution. Although in all samples, values are higher for the PP-2A assay. There is good 
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agreement between the PP-2A assay and PP-2A assay carried out by Mountfort (unpublished) for 
some of the samples tested (L.Fl, E.329 and V.433). There is some agreement between the LC-
MS and PP-2A assay for the 1 :40 dilution. There is also similarity between the unimmobilised 
R.PP-l assay and LC-MS, for one of the samples tested (V.43l). 
Table 4-5: Comparison of MC toxin concentrations in algal extracts among the 
unimmobilised and immobilised R.PP-l inhibition assay and LC-MS. 
Algal MC-LR equivalents (Jlg/L) 
sample 
Immobilised Unimmobilised 
R.PP_l a R.PP_lb R.PP_lb PP_2Ac 
1:4 1:4 1:40 1:4(/ 
L. F1 93 1306 9104 10298 
V.436 33 313 269 1493 
V.432 16 373 302 1548 
E.329 48 444 851 1884 
V.431 51 440 1791 1978 
V.433 25 291 369 1254 
a 12.5 U ofR.PP-l immobilised to 50 mg of microbe ads 
b 0.05 U ofR.PP-l. Values are means of triplicate determinations. 
c 0.02 U ofPP-2A. Values are means of triplicate determinations 
PP_2Adf 
1:4 1:20 
3385 13109 
290 538 
318 620 
698 1996 
396 * 
10918 1354 
d Values obtained by other PP-2A methods by Mountfort et ai. (2001) (Cawthron) ± SD. 
e Values obtained by LC-MS by Holland (Cawthron) 
f detection level 0.01 nM (check this figure) 
g mostly nodularin detected 
* no data 
4.5 Discussion 
LC_MSef 
310509 
768 
2845 
80 
1629 
2258 
The objectives of the feasibility studies were to determine if the PP-2A and R.PP-l 
enzymes could detect OA and MC in the immobilised, microfilter plate fonnat and to assess 
whether the method was feasible for development into a prototype biosensor. 
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This study has showed that the PP-2A and RPP-l enzyme can detect both OA and MC in 
the immobilised format. However, the immobilised system showed a much lower sensitivity 
towards both toxins in comparison to the unimmobilised system, for both enzymes. Protein 
phosphatase type 2A against OA showed the smallest difference in sensitivity between the 
unimmobilised and immobilised format (10 fold) while the RPP-l enzyme against MC-LR 
showed the largest difference (>200 fold). The detection limits for the PP-2A and RPP-l 
enzymes in the unimmobilised format against MC and OA (excluding RPP-l with OA) were 
less than or close to 1 nM for both enzymes. ill comparison, the detection limit for both enzymes 
in the immobilised system was less than or close to 10 nM for both toxins (excluding RPP-l 
with OA). This indicates that the detection limits for the immobilised systems were 
approximately 10 fold less sensitive, than the unimmobilised format. Recombinant PP-l activity 
was stimulated at certain concentrations of the OA, rather than inhibited. This trend was 
observed in both the immobilised and unimmobilised system. This, together with the low 
sensitivities of the enzyme towards OA, indicates that the use of R.PP-l should not be 
considered for detecting DSP. The dose-response test for unimmobilised PP-2A also revealed 
that assay pH does not change the dose-response curve or shift the ICso when tested with a 
MC-LR standard. 
Enzyme recovery tests with pure toxin standard revealed that permanent binding between 
OA and MC-LR probably occurred with PP-2A, but not between the RPP-l enzyme with MC-
LR. Recovery tests were not carried out for RPP-l and OA as this was an unsuitable enzyme for 
this toxin. Protein phosphatase type 2A activity cannot be recovered once OA and MC-LR have 
been added Jo the system, as enzyme activity remained below 80% of the control after 100 
washes. Consequently, this precludes the use of non-replaceable PP-2A in a biosensor format. ill 
contrast, RPP-l activity towards MC-LR showed that enzyme activity recovered to 100% after 
20 washes (enzyme activity recovered to 90% of the control within 10 washes). This indicates 
that permanent binding between RPP-l and MC-LR did not occur. Thus, the RPP-l enzyme can 
be incorporated in a re-usable detection system for MC-LR, as 20 washes is not unreasonable for 
a biosensor design. 
Toxin recovery tests for the environmental samples naturally contaminated with MCs and 
DSP toxins (OA and DTXs), revealed some problems with the immobilised, micro filter plate 
design. There was a significant over-estimate of the DSP toxins (OA and DTXs) when the 
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immobilised PP-2A assay was used to detect the toxins. Similarly, the results obtained using the 
unimmobilised PP-2A assay indicate that when the samples were either undiluted or diluted 1:2 
there was considerable ove:t:-estimate ofDSP toxins (OA and DTXs). However, when the sample 
extracts were diluted 1:4, as recommended in the published method (Mountfort et al., 1999), the 
overestimate of toxin was largely reduced. The over-estimate suggests that stimulatory 
substances were present in the extract that confounded the assay. Previous studies by Mountfort 
et al. (manuscript in preparation-b) have shown that these confounding effects can been reduced 
by modifying the assay, through the addition of elevated levels of BSA (350 )lg/ assay) and 
sodium cholate (10 )lg/ assay) to the reaction mix. Thus, the high toxin levels reported in the 
immobilised assay may be explained by the low levels of BSA present, to prevent the matrix 
effect. Apart from dilution of the extract, modifying the assay should remove the matrix effect 
caused by these substances. Additionally, the assay system developed in this study was 
optimised for maximum enzyme activity, but it was not optimised for testing environmental 
samples. Thus, the immobilised enzyme assay was applied to the detection of DSP toxins 
without having been optimised for detection in extracts. Optimal conditions for testing 
environmental samples are currently being developed for the immobilised PP-2A assay 
(Goussain and Mountfort, unpublished). 
The results from the toxin recovery test with the RPP-1 enzyme detecting natural levels 
of MCs in homogenated algal cells, also highlighted the need for sufficient sample dilution, as 
there was variability in toxin detection based on the dilution of the sample. Samples diluted 1:4 
tended to under estimate MCs, while samples diluted 1 :20 and 1 :40, produced MC levels that 
were more c_onsjstent with LC-MS. Thus, inhibitory substances were present in the less diluted 
samples that confounded the results of the assay. There was agreement between the 
unimmobilised PP-2A results of this study for most of the 1 :40 diluted samples tested, to that of 
the method carried out by Mountfort and Truman (2001) for the 1:20 diluted samples. There was 
also some agreement between results of the unimmobilised RPP-1 and PP-2A for the detection 
of MCs, although unimmobilised PP-2A consistently detected higher MC levels for the same 
sample dilution. The immobilised RPP-1 system was less sensitive (approximately 10 fold) than 
the unimmobilised RPP-l system for the same sample dilution. This was expected as the 
immobilised system is less sensitive than the unimmobilised system for R.PP-l, as discussed 
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previously in section 4.5. The lower detection levels were most likely due to the low dilution of 
the sample and the lack of BSA in the system. 
There was dissimilarity between results obtained for the PPINAs and LC-MS for both the 
mussel and algal extracts. For example, one algal sample analysed (L.Fl) by LC-MS detected a 
very high concentration of NODLN, but detection with the PPINA was much less. It is possible 
that the LC-MS measurement was an over-estimate. Conversely, LC-MS and PPINA values may 
not be similar, as the latter method is measuring toxicity and does not detect each congener. 
The results of the current study have shown some consistent trends with other studies. 
For example, the sensitivities of the unimmobilised enzymes were consistent with reports in the 
literature. The sensitivity of unimmobilised R.PP-l toward MC-LR were consistent with 
publis~ed reports for the same enzyme source (ICso range: 0.3-0.9 nM depending on the 
substrate) (Zhang et at., 1992; An and Carmichael, 1994; Heresztyn and Nicholson, 2001; 
Rapala et at., 2002). Similarly, the sensitivity of unimmobilised PP-2A toward MC-LR was 
consistent with that reported in the literature from the same enzyme source (ICso 2.2 nM, 
Mountfort et at., 2005). The sensitivity ofR.PP-l toward OA (ICso 600 nM) was approximately 
lO-fold less than that reported in the literature (ICso 60 nM). However, this was the result of one 
study only (Zhang et at., 1992). Similarly, the sensitivity ofPP-2A toward OA (ICso 5.5 nM) was 
slightly lower than those reported in the literature (ICsorange: 0.1-1.5 nM) (Tubaro et at., 1996; 
Vieytes et at., 1997; Leira et at., 2000; Mountfort et at., 2001). The sensitivity ofPP-2A towards 
MC-LR and OA varies considerably (ICso range: 0.006-1 and 0.2-2, respectively) (Cohen et at., 
1989; Holme~. et at., 1990; Honkanen et at., 1990; MacKintosh et at., 1990; Takai and Mieskes, 
1991; Simon and Vemoux, 1994; Toivola et at., 1994; Ash et at., 1995; Honkanen et at., 1996a; 
Vieytes et at., 1997), depending on the source of the enzyme. Thus only those sourced from 
human red blood cells were included in this discussion. 
The dose-response curves also consistently produced a sigmoidal shape, similar to 
calibration curves obtained in other studies (Tubaro et at., 1996; Vieytes et at., 1997; Leira et at., 
2000; Mountfort et at., 2001). The trends between experiments were also similar with the 
immobilised format consistently producing a curve with a shift to the left of the unimmobilised 
format. Thus, with dose-response curves, there can be some degree of certainty in the 
reproducibility of results. Hence, this should not affect the interpretation of the data. In contrast, 
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the results obtained from the environmental samples require further clarification. A single assay 
run with either PP-2A or R.PP-1 in this type of assay system is liable to yield results which could 
be questioned. Thus, the assay tests for algal and shellfish extracts should be repeated to verify 
the results obtained in this study. 
A further finding in this study was the large variability in toxin detection based on the 
dilution of the sample. The study revealed that an increase in sample dilution in both the mussel 
and algal tests reduced the matrix effects and made the values approach those determined by LC-
MS. This highlights the importance of determining an adequate sample dilution for toxin 
detection. Generally, a 1:4 sample dilution is appropriate for mussel extracts, while the algal 
extracts required a higher dilution of between 1 :20 and 1 :40. 
Storage of the sample may have also affected the comparison of the results of this study, 
with other reports (Mountfort et ai., 2005; Mountfort et al., manuscript in preparation-b). 
Okadaic acid is very stable when stored under suitable conditions and thus, should not degrade 
significantly over time. However, MCs are less stable and therefore, can degrade on storage. 
Thus, this could be one of the reasons for the lower MC values reported in the algal extract by 
Mountfort et al. (2005), as it was carried out several months after this study. 
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Chapter 5 Discussion and Future Research 
Biosensors have been developed for a wide range of study areas including the medical 
field, food analysis, defence/bioterrorism, and environmental applications (Kroger and Law, 
2005). Many of these sensor formats have been commercialised and are applied in routine 
analysis, however, only a few have been targeted at the aquatic environment (Kroger et al., 
2002). Biosensors for algal toxins have received even less attention, and there appears to be only 
a small number of developments reported in the literature (Carter et al., 1993; Cheun et al., 1996; 
Cheun, 1998; Marquette et al., 1999; Croci, 2001; Kreuzer, 2002; Tang et al., 2002). Of these, 
most are concerned with the detection of OA. The monitoring of toxic algae is important to safe 
guard· human health, prevent negative impacts on livestock and wildlife, and prevent the 
degradation of the aquatic environment. Currently, monitoring for algal toxins in New Zealand is 
limited to the laboratory, and is analysed using the mouse bioassay and LC-MS. There are 
several problems with the mouse bioassay, mostly concerned with its low efficiency, sensitivity 
and reliability. Liquid chromatography with mass spectrometry also has disadvantages, as it can 
only be carried out by specialised personnel and does not detect the total toxin bioactivity. The 
high cost of these procedures is also a problem. With the increasing occurrence and spread of 
toxic algae locally and globally, and the rigorous monitoring regimes that are required by law, 
there is now a demand to develop biosensors for rapid, on-site detection of algal and 
cyanobacterial toxins. Biosensors reduce the cost and time to conduct laboratory tests, as only 
toxin· positive samples would be analysed in the laboratory for confirmation of toxicity. 
Biosensor assays can also potentially be carried out by untrained personnel, such as farm and 
aquaculture managers. 
The results of this study form part of an intermediate phase to determine if the 
immobilised PPlNA can translate into a pre-biosensor format for detection of MCs and DSP 
toxins (OA and DTXs). The method was optimised using two protein phosphatase enzymes, 
PP-2A and R.PP-1 against the substrate MUMP. Both of these enzymes produced activity curves 
that were consistent for an immobilised system and showed high activity and stability profiles. 
The total cost of the PP-2A and R.PP-1 enzymes (including shipping) were similar, when the 
effectiveness of the enzyme to dephosphorylate the substrate was considered. This study was 
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also the fIrst to demonstrate the use of the fluorimetric substrate, MUMP for the RPP-1 assay (in 
both the immobilised and unimmobilised format), as previous RPP-1 assays have mainly utilised 
colorimetric substrates, namely pNPP and malachite green (Zhang et aI., 1992; An et al., 1994; 
Heresztyn et al., 2001; Rapala et al., 2002). 
The performance of the PP-2A and RPP-1 enzymes in the pre-biosensor format were 
approximately 10-fold less sensitive for MC-LR and OA detection compared to the 
unimmobilised PPINA format. The detection limits of unimmobilised the PP-2A and RPP-1 
enzymes against MC-LR were 1 and 0.2 nM, respectively. These detection ranges are consistent 
with those of other PPINA investigations reported in the literature for MCs (Zhang et al., 1992; 
An et al., 1994; Heresztyn et al., 2001; Rapala et al., 2002; Mountfort et al., 2005). This 
detection range also falls within the proposed safe WHO guideline value of 1 Jlg/L for MC-LR in 
drinking water (roughly equivalent to 1 nM) (World Health Organization, 2003). The detection 
limit for the immobilised the PP-2A and R.PP-1 enzymes against MC-LR however, are 10 and 
2 nM, respectively, which is close to, but does not fall, within the safe regulatory guidelines. 
The detection limit for unimmobilised PP-2A against OA was 1.2 nM, which IS 
consistent with PPINA ranges reported in the literature for OA (Zhang et al., 1992; Tubaro et al., 
1996; Leira et aI., 2000; Mountfort et al., 2001). The detection limit for unimmobilised PP-2A 
falls within the guideline level of 160 Jlg/kg mussel meat set by the European Commission on 
Standards (European Commission, 2002). The detection limit of the immobilised PP-2A enzyme 
against OA was 15 nM. This detection limit is slightly higher than the current biosensor designs 
for OA and is outside the regulatory guidelines (Croci et aI., 2001; Kruezer et al., 2002). Thus, 
the PP-2A and RPP-1 assay limits in the pre-biosensor format do not conform to regulatory 
guidelines for MC-LR and OA, at this stage of the developmental phase. In addition, the RPP-1 
enzyme assay against OA was not considered suitable for OA detection as enzyme activity was 
induced for both the immobilised and unimmobilised assay system between 10-200 nM and 
1-100 nM of OA, respectively. 
The pre-biosensor format for the PP-2A and RPP-1 enzyme was tested for re-usability 
by noting the activity of the enzymes once OA and MC had been washed from the system. 
Recombinant PP-1 could be applied to a reusable biosensor system as permanent binding did not 
occur between the enzyme and MC-LR (OA was not tested for re-usability with RPP-1). This 
indicates that multiple assays could be performed using the same enzyme, which would reduce 
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the assay costs. In comparison, the immobilised PP-2A enzyme cannot be incorporated into a 
biosensor as a re-usable component, as permanent binding occurred between the enzyme and 
both toxins. Thus, for the PP-2A enzyme assay system to be applicable in a biosensor design, it 
must be in the form of a discardable system. For example, the enzyme-bead complex could be a 
discardable unit within the biosensor model, i.e. after an environmental sample has been tested 
the enzyme will need to be discarded. Most other biosensor designs for OA are also based on 
single-use systems (Croci et al., 2001; Kruezer et al., 2002). Single-use systems have the 
advantage over re-usable systems in that it avoids the problem of deterioration of the biosensor 
element when analysing environmental matrices (Baeumner, 2003). 
The pre-biosensor format was also tested with environmental samples. Protein 
phosphatase type 2A and R.PP-1 enzymes were tested with mussel extracts naturally 
conta~nated with DSP toxins (OA and DTXs) and with algal extracts containing natural levels 
of MCs, respectively. At this stage, the method is not designed to test samples in the presence of 
complicated matrices that exist within mussel and algal extracts. However, this exercise was 
carried out so that the robustness of the method could be compared to the results from other 
methods, such as LC-MS and other PPINA methods, and an assessment of modifications to the 
assay (if necessary) could be made based on these results. 
The mussel and algal tests highlighted some important findings about the pre-biosensor 
method. Firstly, it showed how matrix effects in the assay, caused by collfounding substances in 
the sample extract, can interfere with the enzyme-toxin binding. This highlights the constraints 
of the assay for use in testing samples with complex matrices, such as mussel and algal extracts. 
Secondly, the study emphasised the importance of sample dilution for maximising toxin 
. --"-
detection. Matrix effects and sample dulitions are factors that need to be seriously taken into 
consideration when developing this type of assay system. Future studies modifying this 
technique need to address these issues. Goussain and Mountfort (unpublished) have recently 
demonstrated that modifying the immobilised PP-2A enzyme assay method by altering certain 
components, such as the immobilisation buffer and the assay volume, increased the detection 
limit for OA by a factor of 5 (ICso 12 nM). This detection range is adequate for a biosensor 
format for DSP toxins using PP-2A. 
The intended outcome of this ongoing study is the development of a prototype biosensor 
for MC and DSP toxin detection. The method has not yet reached this stage. Further studies are 
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necessary to address the following issues: 1) increasing the perfonnance and sensitivity of the 
irnmobilised enzyme to detect naturally occurring MCs within a detection range that is consistent 
with regulatory guidelines; 2) assessing other protein phosphatase enzymes that might be more 
suitable and sensitive for the biosensor design; 3) detennining a more suitable method for 
washing to enhance the recovery of the irnmobilised enzyme for re-use and; 4) re-assessing assay 
conditions of the irnmobilised enzyme that best allow the assay to accurately determine DSP 
toxins and MCs. It is likely that in the future, such studies will be carried out with PP-2A, as 
most aspects of the experiments conducted in this thesis, have shown that the PP-2A enzyme is a 
better contender than the R.PP-1 enzyme. 
A good biosensor design has the following characteristics: high sensitivity, easy to 
perform, rapid, high sample throughput, re-usable and high specificity (Baeumner, 2003). The 
metho.d described in this study perfonns well to the aforementioned characteristics. The 
advantages of this method regarding the speed of analysis, simplicity of design and the detection 
of total toxin bioactivity, give this biosensor fonnat great potential to have the leading edge over 
other laboratory based methods reported todate. It also has considerable potential to compete 
with current biosensor designs for DSP toxins which detect specific toxin congeners only 
(Marquette et al., 1999; Kreuzer, 2002; Tang et al., 2002). There have been no biosensors 
developed to test for MCs todate. With the global increase in marine and freshwater algal 
outbreaks, there is a need to develop an on-site detection system for MCs and DSP toxins in 
environmental samples. 
In summary, this study has shown that: 1) PP-2A is the preferred enzyme over R.PP-1 for 
OA and MC_det~ction, because of the enhanced sensitivity given by this enzyme to both toxins 
and, 2) the detection limit of the irnmobilised PP-2A enzyme towards MC-LR and OA is close to 
the levels prescribed by regulatory agencies. Thus, there is sufficient justification for the 
irnmobilised PP-2A enzyme method to be considered for translation into the prototype biosensor 
format. Further developments are currently underway with the PP-2A enzyme to increase the 
sensitivity of the system before incorporation into a prototype fill-flow biosensor (Goussain and 
Mountfort, unpublished). 
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Chapter 7 Appendices 
Appendix 7-1: Common microcystin structures [MCs identified from species and 
strains of Anabaena, Hapalosiphon, Microcystins, Nostoc and Planktothrix (Rinehart et 
al.,1994)] 
Microcystin (Me) Molecular weight Molecular formulae 
MC-LA 909 C46H67N70 12 
MC-LAba 923 C47H69N7012 
. MC-AR 952 C49H66NIOO12 
MC-YA 959 C49H6SN7013 
[D-Asp3] MC-LR 966 C47H70N IOO12 
[Dha7] MC-LR 980 C48H72NIO()12 
[DMAddas] MC-LR 980 C48H72NIO()12 
MC-LF 980 C48H72NIOO12 
MC-LR 985 CS2H71N7()12 
[D-Asp3,D-Glu(()CH3)6] MC-LR 994 C49H74NIOO12 
[(6Z)1-Addas] MC-LR 994 C49H74NIOO12 
[L-Ser7] MC-LR 994 C49H74NIOO12 
. MC-L~ 998 C48H74N IOO13 
MC-IHirR 1001 CS2H71N7()13 
[D-Asp3, ADMAddas] MC-LR 1008 CSOH76NIO()12 
[D-Glu-()CH6] MC-LR 1008 C49H72NIO()13 
[D-Asp3, Dha7] MC-RR 1008 CSOH76NIO()12 
[L-MeSer7] MC-LR 1009 C47H71N13()12 
[Dha7] MC-FR 1012 C49H76NIO()13 
[ADMAddas] MC-LR 1024 CS3H70NIO()12 
[D-Asp3, ADMAddas] MC-LHar 1022 CSOH74N1o()13 
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[D-Asp3] MC-RR 1022 C501l74~IO()13 
[Dha7] MC-RR 1023 C481173~13()12 
MC-FR 1023 C481173~13()12 
MC-M(O)R 1028 C521172~IO()12 
[Dha7] MC-lIphR 1028 C481172~IOOI3S [: l: 
[Dha7] MC-FR 1028 C521172~IOO12 g 
[D-Asp3, Dha7] MC-lItyR 1030 C511170~IOO13 
[Dha7] MC-YR 1030 C511l70~lOO13 
[D-Asp3] MC-YR 1030 C511170~10013 
MC-YM((») 1035 C511169~7014S 
[ADMAdda5] MC-LlIar 1036 C511176~10013 
MC-RR 1037 C491175~13()12 
[(6Z)- Adda5] MC-RR 1037 C491175~13()12 
c. 
[D-Serl, ADMAdda5] MC-LR 1038 C501l74~IO()14 
[ADMAdda5, MeSer7] MC-LR 1040 C501l76~IO()14 
[L-Ser7] MC-RR 1041 C481175~13()13 
[D-Asp3, MeSer7] MC-RR 1041 C481175~13()13 
MC-YR 1044 C521172~IOO13 
[D-Asp3] MC-lItyR 1044 C521172~IOO13 
[Dha7] MC-lItyR 1044 C521172~IOO13 
MC-(1I4) YR 1048 C521176~IOO13 ~ 
. [l)-G~~.-()C2113(CII3)OIl2] MC-LR 1052 C521180~IOO13 
MC-lItyR 1058 C531174~IOO13 
[L-Ser7] MC-lItyR 1062 C521174~IOO14 
MC-YR 1067 C541173~II012 
[L-Melan7] MC- LR 1115 C521181~l1014S 
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Appendix 7-2: Microcystin and Nodularin toxicity values [toxicity of some Mes 
and NODLNs based upon an Lp. lethal dose 50% response (LDso) in laboratory mouse 
or rat injections (Rinehart ef al., 1994)]. 
Toxin LD50 (Jig/kg) 
Nodularin (NODLN) 50 
[D-Asp3] NODLN 75 
[DMAdda3] NODLN 150 
[6(Z)- Adda3] NODLN >2000 
[D-Glu-OCH4] NODLN DihydroNODLN >1200 
[D-MeAbu5] NODLN 150 
[L-MeAbu5] NODLN 150 
MC-LR 50 
MC-LA 50 
MC-YR 70 
MC-RR 600 
MC-AR 250 
MC-LY 90 
MC-FR 250 
MC-WR 150-200 
MC-YM(O) 56 
MC-M(O)R -- 700-800 
MC-HtyR 80-100 
MC-HilR 100 
[D-Asp3] MC-LR 50 
[D-Aspl] MC-RR 250 
[Dha7] MC-LR 250 
[D-Asp3] MC-LR 150 
[L-MeLan7] MC-LR 1000 
[D-Glu-OCH6] MC-LR >1000 
121 
[D-Glu-OC2H3(CH3)OH6] MC-LR >1000 
[DMAdda5] MC-LR 90-100 
[ADMAdda5] MC-LR 60 
[D-Asp3, ADMAdda5] MC-LR 160 
[ADMAdda5] MC-LHar 60 I; [ 
[6(Z)-Adda5] MC-LR >1200 
[6(Z)-Adda5] MC-RR >1200 
[L-MeAla7] MC-LR 85 
[D-MeAla7] MC-LR 100 
I 
~ -. 
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Appendix 7-3: Calculation of DSP toxins in mussel extracts. 
The procedure for determining the concentration of DSP toxins (OA and DTXs) in 
mussel samples follows the method of (Mountfort et al. 2003). The results are expressed as OA :': 
equivalents. 
Step 1: Read off the nM of OA equivalents from the dose-response curve of % activity versus 
OA developed using the OA standard (= nM OA added) determined for each enzyme. 
Step 2: Determine the pmol per assay volume (150 Ill) (= nM OA added x [15011 000]). 
Step 3: Determine the pg OA per assay (= step 2 x 805) 
Note, the molecular weight ofOA is 805 g/mol. 
Step 4: Determine the pg per m1 of extract added and correct for volume added 
(= [step 3 x 1000]/amount of extract added to assay, i.e. either 5 or 10 Ill.) 
Step 5: Determine the Ilg per m1 and correct for the extract dilution 
(= [step 411000 000] x extract dilution). 
Note, the dilution for mussel extracts were 1:2 and 1 :4. 
Step 6: Mean results from the 5 and 10 III volumes of each extract added to the assay 
Step 7: Determine Ilg per 5 m1 of extract (= step 6 x 5) 
Step 8: Calculate Ilg per 100 g of shellfish tissue assuming that 5 m1 extract is equivalent to 1 g 
shellfish tissue (= step 7 x 100) 
Step 9: Convert this figure to Jlg/kg of shellfish tissue. 
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Appendix 7-4: Calculation of MCs in algal extracts. 
The procedure for detennining the concentration of MCs in algal samples follows the method of 
(Mountfort et ai. 2003). The results are expressed as MC-LR equivalents. 
Step 1: Read off the nM of MC-LR equivalents from the dose-response curve of % activity 
versus MC-LR developed using the MC-LR standard (= nM MC-LR added) determined for each 
enzyme. 
Step 2: Determine the pmol per assay volume (150 Ill) (= nM MC-LR added x [150/1000]). 
Step 3.~ Determine the pg MC-LR per assay (= step 2 x 995). 
Note, the molecular weight for MC-LR is 995 g/mo!. 
Step 4: Determine the pg per m1 of extract added and correct for volume added 
(= [step 3 x 1000]/amount of extract added to assay, i.e. either 5 or 10 Ill.) 
Step 5: Determine the Ilg per m1 and correct for the extract dilution 
(= [step 411000000] x extract dilution). 
Note, the dilution for algal extracts was 1:4 and 1:9. 
Step 6,' Mean-results from the 5 and 10 III volumes of each extract added to the assay and express 
the results in Ilg/l. 
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Appendix 7-5: Reaction kinetics for immobilised PP-2A showing the lag 
effect in enzyme stability as a result of washing frequency 
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Time after immobilisation (h) 
Symbols donate the washing frequency overtime: 0, washing frequency at regular intentals; ... , washing frequency 
at irregular intervals (an initial delay in time between the first and second wash of> 100 hours). The 
concentration ofPP-2A was 0.5 U. Each value represents the mean of triplicate detenninations ± standard 
deviation. 
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